<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 7, 1996
REGISTRATION NO. 333-04855
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
AMENDMENT NO. 1
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
---------------
UNIPHASE CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 94-2579683
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER IDENTIFICATION NUMBER)
INCORPORATION OR ORGANIZATION)
163 BAYPOINTE PARKWAY
SAN JOSE, CALIFORNIA 95134
(408) 434-1800
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
KEVIN N. KALKHOVEN
PRESIDENT AND CHIEF EXECUTIVE OFFICER
UNIPHASE CORPORATION
163 BAYPOINTE PARKWAY
SAN JOSE, CALIFORNIA 95134
(408) 434-1800
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)
---------------
COPIES TO:
MICHAEL C. PHILLIPS, ESQ. DAVID J. SEGRE, ESQ.
MORRISON & FOERSTER LLP J. ROBERT SUFFOLETTA, ESQ.
755 PAGE MILL ROAD WILSON SONSINI GOODRICH & ROSATI
PALO ALTO, CA 94304-1018 PROFESSIONAL CORPORATION
(415) 813-5600 650 PAGE MILL ROAD
PALO ALTO, CA 94304-1050
(415) 493-9300
---------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after this Registration Statement becomes effective.
If any of the securities being registered on this form are to be offered
pursuant to dividend or interest reinvestment plans, please check the
following box. [_]
If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or
interest reinvestment plans, check the following box. [_]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [_]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [_]
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT
SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS
REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH
SECTION 8(A) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT
SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID
SECTION 8(A), MAY DETERMINE.
===============================================================================
<PAGE>
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
+INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A +
+REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE +
+SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY +
+OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT +
+BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR +
+THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE +
+SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE +
+UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF +
+ANY STATE. +
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
SUBJECT TO COMPLETION, DATED JUNE 7, 1996
2,000,000 SHARES
[UNIPHASE LOGO]
COMMON STOCK
All of the 2,000,000 shares of Common Stock offered hereby are being sold by
Uniphase Corporation ("Uniphase" or the "Company"). The Company's Common Stock
is traded on the Nasdaq National Market under the symbol "UNPH." On May 29,
1996, the last reported sale price of the Common Stock on the Nasdaq National
Market, after giving effect to the stock split described below, was $31.00 per
share. See "Price Range of Common Stock."
The Company's Board of Directors recently approved a two-for-one stock split
in the form of a 100% stock dividend to be paid June 3, 1996 to holders of
record on May 20, 1996 (the "Stock Split"). Share and per share data in this
Prospectus have been adjusted to reflect the Stock Split.
SEE "RISK FACTORS" COMMENCING ON PAGE 5 FOR A DISCUSSION OF CERTAIN FACTORS
THAT SHOULD BE CONSIDERED BY PROSPECTIVE PURCHASERS OF THE COMMON STOCK OFFERED
HEREBY.
-----------
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION
PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
================================================================================
<TABLE>
<CAPTION>
Price to Underwriting Proceeds to
Public Discount (1) Company (2)
- -------------------------------------------------------------------------------
<S> <C> <C> <C>
Per Share............................. $ $ $
Total (3)............................. $ $ $
</TABLE>
================================================================================
(1) See "Underwriting" for information concerning indemnification of the
Underwriters and other matters.
(2) Before deducting expenses payable by the Company estimated at $550,000.
(3) The Company has granted to the Underwriters a 30-day option to purchase up
to 300,000 additional shares of Common Stock solely to cover over-
allotments, if any. If the Underwriters exercise this option in full, the
Price to Public will total $ , the Underwriting Discount will total $
and the Proceeds to Company will total $ . See "Underwriting."
The shares of Common Stock are offered by the several Underwriters named
herein, subject to receipt and acceptance by them and subject to their right to
reject any order in whole or in part. It is expected that delivery of the
certificates representing such shares will be made against payment therefor at
the office of Montgomery Securities on or about June , 1996.
-----------
MONTGOMERY SECURITIES
ALEX. BROWN & SONS
INCORPORATED
UNTERBERG HARRIS
JOSEPHTHAL LYON & ROSS
INCORPORATED
June , 1996
<PAGE>
AVAILABLE INFORMATION
The Company is subject to the reporting requirements of the Exchange Act,
and in accordance therewith, files, annual and quarterly reports, proxy and
information statements and other information with the Securities and Exchange
Commission (the "Commission"). Such reports, proxy statements and other
information can be inspected and copied at the public reference facilities
maintained by the Commission at its office at Room 1034, 450 Fifth Street,
N.W., Washington, D.C. 20549, and at the Commission's regional offices at
Northwestern Atrium Center, 500 West Madison Street, Suite 1400, Chicago,
Illinois 60661 and 7 World Trade Center, Suite 1300, New York, New York 10048.
Copies of such materials can be obtained from the public reference section of
the Commission, 450 Fifth Street, N.W., Washington, D.C. 20549, at prescribed
rates. The Company's Common Stock is quoted on the Nasdaq National Market and
reports, proxy statements and other information concerning the Company can be
inspected at the National Association of Securities Dealers, Inc., 9513 Key
West Avenue, Rockville, Maryland 20850.
This Prospectus constitutes a part of a Registration Statement on Form S-3
(herein, together with all amendments, schedules and exhibits, referred to as
the "Registration Statement") filed by the Company with the Commission under
the Securities Act. This Prospectus does not contain all of the information
set forth in the Registration Statement and certain parts are omitted in
accordance with the rules and regulations of the Commission. For further
information with respect to the Company and the Common Stock offered hereby,
reference is made to such Registration Statement. Statements contained in this
Prospectus as to the contents of any contract or other document referred to
are not necessarily complete, and in each instance, reference is made to the
copy of such contract or other document filed as an exhibit or incorporated by
reference to the Registration Statement of which this Prospectus forms a part,
each such statement being qualified in all respects by such reference.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents heretofore filed by the Company with the Commission
(File No. 0-22874) pursuant to the Exchange Act are incorporated herein by
reference: (1) the Company's Annual Report on Form 10-K for the fiscal year
ended June 30, 1995 and (2) the description of the Company's Common Stock
contained in the Company's Registration Statement on Form 8-A filed with the
Commission on November 15, 1993; (3) the Company's Quarterly Reports on Form
10-Q for the fiscal quarters ended September 30 and December 31, 1995, and
March 31, 1996; and (4) the Company's Current Report on Form 8-K dated
February 8, 1996.
All reports and other documents subsequently filed by the Company pursuant
to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of
this Prospectus and prior to the termination of the offering of the Common
Stock hereunder shall be deemed to be incorporated by reference herein and to
be a part hereof from the date of the filing of such reports and documents.
The Company hereby undertakes to provide without charge to each person,
including any beneficial owner, to whom a copy of this Prospectus is
delivered, upon written or oral request of such person a copy of any or all of
the foregoing documents incorporated herein by reference (exclusive of
exhibits, unless such exhibits are specifically incorporated by reference into
such documents). Requests for such documents should be submitted in writing to
the Corporate Secretary at the corporate headquarters of the Company at 163
Baypointe Parkway, San Jose, California 95134 or by telephone at (408) 434-
1800.
Any statement contained in a document incorporated or deemed to be
incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Prospectus to the extent that a statement contained
herein or in any other subsequently filed document that also is or is deemed
to be incorporated by reference herein modified or supersedes such statement.
Any statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of the Registration Statement or
this Prospectus.
IN CONNECTION WITH THIS OFFERING, THE UNDERWRITERS MAY OVER-ALLOT OR EFFECT
TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE COMMON STOCK
OF THE COMPANY AT A LEVEL ABOVE THAT WHICH MIGHT OTHERWISE PREVAIL IN THE OPEN
MARKET. SUCH STABILIZING, IF COMMENCED, MAY BE DISCONTINUED AT ANY TIME.
IN CONNECTION WITH THIS OFFERING, THE UNDERWRITERS AND OTHER SELLING GROUP
MEMBERS MAY ENGAGE IN PASSIVE MARKET MAKING TRANSACTIONS IN THE COMMON STOCK
ON THE NASDAQ NATIONAL MARKET IN ACCORDANCE WITH RULE 10B-6A UNDER THE
SECURITIES EXCHANGE ACT OF 1934. SEE "UNDERWRITING."
2
<PAGE>
PROSPECTUS SUMMARY
The following summary is qualified in its entirety by the more detailed
information appearing elsewhere in this Prospectus and other information
incorporated by reference herein. Unless otherwise noted, all information in
this Prospectus (i) assumes no exercise of the Underwriters' over-allotment
option, and (ii) has been adjusted to reflect a two-for-one stock split in the
form of a 100% stock dividend to be paid on June 3, 1996 (the "Stock Split").
THE COMPANY
Uniphase Corporation ("Uniphase" or the "Company") is an optoelectronics
company that designs, develops, manufactures and markets laser subsystems,
laser-based semiconductor wafer defect examination and analysis equipment and
fiber optic telecommunications equipment products. Optoelectronics is a
technology that extends the speed and capacity of conventional electronic
solutions by addressing many of the constraints of the electron with the
particle of light, the photon. A common source of the photon in optoelectronics
is the laser. By combining electronics, photonics and software, optoelectronics
has enabled new technologies such as CD-ROMs and fiber optic communication, and
has created new solutions for existing markets.
Since its founding, Uniphase has shipped over one million lasers and has
become a leading supplier of laser subsystems for OEMs in the biotechnology,
industrial process control, semiconductor wafer inspection, and graphics and
printing markets. The Company focuses on selling its laser subsystems to such
customers at the design-in phase of a product, creating the potential for
recurring sales throughout a product's life. The Company has leveraged its
expertise in gas lasers to develop smaller, more efficient solid state lasers,
which the Company believes will be the primary commercial laser technology in
the future.
The Company's strategy is to leverage its core competencies in laser
technology to develop highly focused and differentiated applications where
there is a convergence of market need and optoelectronic technology. The
Company's knowledge of laser technology enabled it to introduce an
optoelectronics application for the semiconductor capital equipment industry,
the Ultrapointe laser imaging system (the "Ultrapointe System"), in June 1993.
The Ultrapointe System works in conjunction with automated inspection systems
from vendors such as Tencor Instruments ("Tencor") and KLA Instruments ("KLA")
to enable semiconductor manufacturers to more accurately identify and classify
defects. This defect examination and analysis procedure enables semiconductor
manufacturers to improve yields by identifying and containing process problems.
As of March 31, 1996, the Company had sold 63 Ultrapointe Systems to leading
semiconductor manufacturers worldwide. In November 1995, Tencor became the
exclusive OEM reseller of the Ultrapointe System. In May 1996, the Company
introduced its Identifier software product, an optional feature that provides
automatic defect classification ("ADC") capability for Ultrapointe Systems.
Working in conjunction with the Ultrapointe System, the Identifier software
automates the defect classification process, thereby improving the precision
and repeatability of defect classification.
The Company extended its optoelectronic product offerings into the
telecommunications equipment market by acquiring Uniphase Telecommunications
Products, Inc. ("UTP") in May 1995. UTP designs, develops, manufactures and
markets high-speed external modulators and transmitters for fiber optic
networks in the long-haul telecommunications and cable television ("CATV")
industries. In May 1996, the Company acquired two affiliated companies, GCA
Fibreoptics Ltd. ("GCA") and Fiberoptic Alignment Solutions, Inc. ("FAS") which
the Company intends to combine and operate under the name Uniphase Fiberoptic
Products, Ltd. ("UFP") as a division of UTP. The acquisition of UFP expands the
Company's presence in the optoelectronic communications market. UFP custom
packages laser diodes, light emitting diodes ("LEDs") and photodetectors for
OEMs for use in fiber optic networks.
3
<PAGE>
THE OFFERING
<TABLE>
<S> <C>
Common Stock offered........................ 2,000,000 shares
Common Stock to be outstanding after the Of-
fering..................................... 15,814,264 shares (1)
Nasdaq National Market symbol............... UNPH
Use of proceeds............................. General corporate purposes,
including working capital, capital
expenditures and possible
acquisitions.
</TABLE>
SUMMARY CONSOLIDATED FINANCIAL DATA
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
NINE MONTHS ENDED
FISCAL YEARS ENDED JUNE 30, MARCH 31,
----------------------------------------------- -----------------
1991 1992 1993 1994 1995 1995 1996
------- ------- ------- ------- ------- -------- --------
<S> <C> <C> <C> <C> <C> <C> <C>
CONSOLIDATED STATEMENT OF
OPERATIONS DATA:
Net sales............... $23,480 $26,405 $27,314 $32,922 $42,282 $ 30,146 $ 47,342
Gross profit............ 8,822 9,794 9,444 12,855 18,169 12,768 22,240
Operating expenses:
Research and
development........... 2,031 2,381 1,986 3,058 3,710 2,707 4,093
Royalty and license.... 939 1,023 986 1,212 1,172 995 1,205
Selling, general and
administrative........ 3,557 4,221 5,417 (2) 5,693 (2) 7,355 5,176 8,942
Infrequent or unusual
charges:
Acquired in-process
research and
development.......... -- -- -- -- 4,460 (3) -- --
Loss on sale of
product line......... -- -- -- -- 891 (3) -- --
Litigation (4)........ -- 397 2,381 (355) -- -- --
------- ------- ------- ------- ------- -------- --------
Total operating
expenses............... 6,527 8,022 10,770 9,608 17,588 8,878 14,240
------- ------- ------- ------- ------- -------- --------
Income (loss) from
operations............. 2,295 1,772 (1,326) 3,247 581 3,890 8,000
Net income (loss)....... $ 1,456 $ 1,127 $ (798) $ 2,231 $ 735 $ 2,706 $ 5,661
Net income (loss) per
share.................. $ 0.24 $ 0.19 $ (0.14) $ 0.27 $ 0.07 $ 0.27 $ 0.44
Shares used in per share
calculation............ 6,080 5,888 5,510 8,274 10,082 9,966 12,962
</TABLE>
<TABLE>
<CAPTION>
MARCH 31, 1996
--------------------
AS
ACTUAL ADJUSTED (5)
------- ------------
<S> <C> <C>
CONSOLIDATED BALANCE SHEET DATA:
Working capital............................................ $51,033 $109,383
Total assets............................................... 96,700 155,050
Long-term obligations...................................... -- --
Total stockholders' equity................................. 86,845 145,195
</TABLE>
- --------
(1) Based on the number of shares of Common Stock outstanding as of May 20,
1996. Excludes (i) approximately 2,411,430 shares of Common Stock reserved
for issuance pursuant to the exercise of stock options outstanding under
the Company's stock plans as of March 31, 1996, having a weighted average
exercise price of $6.44 per share, and (ii) approximately 293,500 shares of
Common Stock reserved for future grants or issuance under the Company's
stock plans.
(2) In fiscal 1993, includes $217,000 of expenses relating to the
reorganization of the Company's international operations and $300,000 of
expenses accrued for certain intellectual property matters. In fiscal 1994,
it was determined that the costs related to the intellectual property
matters would not have to be paid, and, accordingly, such costs were
reversed. See "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and Note 14 of Notes to Consolidated Financial
Statements.
(3) During fiscal 1995, the Company incurred charges totaling $5.4 million,
primarily for acquired in-process research and development and, to a lesser
extent, for the loss on the sale of the Company's diode laser product line.
The acquired in-process research and development resulted primarily from
the cash purchase of UTP from United Technologies Corporation for a total
purchase price, including acquisition expenses, of $8.7 million. Such
charges reduced net income per share for fiscal 1995 by $0.33. See Notes 10
and 11 of Notes to Consolidated Financial Statements.
(4) During fiscal years 1992 and 1993, the Company accrued litigation costs of
$397,000 and $2.4 million, respectively, pertaining primarily to a patent
infringement action brought against the Company, and to a lesser extent in
fiscal 1993, for actions against the Company by certain former employees.
The patent infringement action was settled in fiscal 1993. Due to the
settlement of one of the former employee actions in fiscal 1994 at a cost
less than anticipated and the re-evaluation of the potential liability with
respect to the remaining outstanding lawsuit, the Company reversed $355,000
of accrued legal expense in fiscal 1994. See Note 14 of Notes to
Consolidated Financial Statements.
(5) Adjusted to reflect the sale of 2,000,000 shares of Common Stock offered
hereby, at an assumed public offering price of $31.00 per share, after
deducting the underwriting discount and estimated offering expenses and
receipt of the proceeds therefrom. See "Use of Proceeds" and
"Capitalization."
4
<PAGE>
RISK FACTORS
In evaluating the Company's business, prospective investors should carefully
consider the following factors in addition to the other information presented
in this Prospectus and in the documents incorporated by reference herein. The
statements contained in this Prospectus that are not purely historical are
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including
but not limited to statements regarding the Company's expectations, hopes,
beliefs, intentions or strategies regarding the future. Actual results could
differ materially from those projected in any forward-looking statements as a
result of a number of factors, including those detailed in this "Risk Factors"
portion of this Prospectus as well as those set forth elsewhere in this
Prospectus. The forward-looking statements are made as of the date of this
Prospectus and the Company assumes no obligation to update the forward-looking
statements, or to update the reasons why actual results could differ
materially from those projected in the forward-looking statements.
RISKS ASSOCIATED WITH THE TELECOMMUNICATIONS EQUIPMENT MARKET
The Company entered the telecommunications equipment market by acquiring UTP
in May 1995. UTP designs, develops, manufactures and markets high-speed
external modulators and transmitters for fiber optic networks in the long-haul
telecommunications and CATV industries. The CATV and telecommunications
industries are characterized by rapidly evolving technology, intense
competition, fluctuations in capital spending and uncertainty surrounding the
level of governmental regulation. To compete successfully, the Company must
design, develop, manufacture and sell new products that provide increasingly
higher levels of performance and reliability. As new markets develop, the
Company must successfully develop new products for these markets to remain
competitive. There can be no assurance that the Company will successfully
develop new products, or that new products developed by the Company will
achieve market acceptance or not be rendered obsolete or uncompetitive by
products of other companies. Significant competitive factors include product
performance and reliability, product price, the capability to provide strong
customer support and service, customer relationships and breadth of product
line. There can be no assurance that the Company will be able to compete
successfully in the future with respect to these or any other competitive
factors or that competition in these markets will not have a material adverse
effect on the Company's business and operating results. In May 1996, the
Company acquired UFP. UFP custom packages laser diodes, LEDs and
photodetectors for OEMs for use in fiber optic networks for local
telecommunications and data communications. Prior to acquiring UFP, the
Company had not been engaged in local telecommunications and data
communications applications and has no experience in developing,
manufacturing, selling or supporting products for these applications. No
assurance can be made that the Company can successfully provide these
applications for the local telecommunications or data communications markets
or that it can successfully assimilate UFP into the Company's other business
operations.
UTP and UFP's products are designed to operate in CATV and other
communications networks that use fiber optic cable to transmit signals. Thus,
demand for the Company's products depends to a significant extent upon the
magnitude and timing of capital spending by CATV and telecommunications
operators for constructing, rebuilding or upgrading fiber optic systems which
in turn directly affects purchases by CATV and telecommunications equipment
suppliers. Furthermore, sales of the Company's CATV products are highly
dependent on the rate at which CATV OEMS and in turn, their customers, the
multiple systems operators ("MSOs"), move to adopt externally modulated
products operating at 1550 nanometers ("nm") for their trunk lines. Although
the Company believes that this technology offers certain advantages, there is
no assurance that OEMs and MSOs will continue to migrate to this solution. In
addition, the uncertainty regarding the level of governmental regulation and
regulatory reform affects capital expenditures in the CATV and
telecommunications industries. There can be no assurance that the Company's
business and operating results will not be materially and adversely affected
by these factors. See "Business--Products and Markets."
5
<PAGE>
CYCLICALITY OF SEMICONDUCTOR INDUSTRY
The Company's Ultrapointe Systems and a portion of its laser subsystems
businesses depend upon capital expenditures by manufacturers of semiconductor
devices, including manufacturers that are opening new or expanding existing
fabrication facilities, which, in turn, depend upon the current and
anticipated market demand for semiconductor devices and the products utilizing
such devices. The semiconductor industry is highly cyclical, and historically
has experienced periods of oversupply, resulting in significantly reduced
demand for capital equipment. The semiconductor industry is currently
experiencing a downturn which has led many semiconductor manufacturers to
delay or cancel capital expenditures. Certain of the Company's customers have
delayed or canceled purchases of the Company's Ultrapointe Systems. There can
be no assurance that the Company's operating results will not be materially
and adversely affected by these factors. Furthermore, there can be no
assurance that the semiconductor industry will not experience further
downturns or slowdowns in the future, which may materially and adversely
affect the Company's business and operating results. See "Business--Sales and
Marketing."
DECLINING MARKET FOR GAS LASERS; DEVELOPMENT AND OTHER RISKS RELATING TO SOLID
STATE LASER TECHNOLOGIES
To date, a substantial portion of the Company's revenue has been derived
from sales of gas laser subsystems. The market for gas lasers is mature and is
expected to decline as customers transition from conventional lasers,
including gas, to solid state lasers, which are currently expected to be the
primary commercial laser technology in the future. In response to this
transition, the Company has devoted substantial resources to developing solid
state laser products and has introduced its initial solid state products. To
date, sales of the Company's solid state laser products have been limited and
primarily for customer evaluation purposes. Solid state laser products are
still evolving, and there can be no assurance that the Company's solid state
laser products will be successfully designed into customers' products or
achieve commercial sales volumes. The Company believes that a number of
companies are further advanced than the Company in their development efforts
for solid state lasers and are competing with evaluation units for many of the
same design-in opportunities that the Company is pursuing. It is anticipated
that the average selling price of solid state lasers may be significantly less
in certain applications than the gas laser products the Company is currently
selling in these markets. If the Company is unable to successfully make this
transition from gas to solid state lasers, its business, operating results and
financial condition will be materially and adversely affected. The Company
further believes it will be necessary to continue to reduce the cost of
manufacturing and to broaden the wavelengths provided by its laser products.
There can be no assurance that the Company will successfully develop new solid
state laser products, or that any solid state lasers products will achieve
market acceptance or not be rendered obsolete or uncompetitive by products of
other companies. See "Management's Discussion and Analysis of Financial
Condition and Results of Operations" and "Business--Company Strategy" and "--
Laser Products."
MANAGEMENT OF GROWTH; UFP ACQUISITION
The Company has experienced recent growth through both increased levels of
operations in its existing businesses and the acquisition of UTP in May 1995.
The Company is devoting significant resources to develop new solid state
lasers for OEM customers, to improve products and increase market penetration
of its Ultrapointe Systems and to increase its penetration of the CATV and
telecommunications industries. In addition, the Company is now increasing its
marketing, customer support and administrative functions in order to support
an increased level of operations from sales of its Ultrapointe Systems and its
telecommunications equipment products. No assurance can be given that the
Company will be successful in creating this infrastructure or that any
increase in the level of such operations will justify the increased expense
levels associated with these businesses.
In May 1996, the Company acquired UFP. The total purchase price of $9.1
million included aggregate consideration of $8.6 million for both GCA and FAS,
payable through a combination of cash and notes, and estimated direct
transaction costs of $500,000. As a result of acquiring UFP, the Company has
entered the local telecommunications and data communications markets in which
it had no previous experience, and has expanded
6
<PAGE>
its employee base by approximately 45 persons. The success of the UFP
acquisition will be dependent on the Company's ability to integrate UFP into
its existing operations as a division of UTP. UTP's ability to manage UFP will
be complicated by the geographical distance between UTP's facilities in
Bloomfield, Connecticut and Chalfont, Pennsylvania and UFP's locations in the
United Kingdom and in Batavia, Illinois. There can be no assurance that the
operations of UFP can be successfully integrated into UTP or that such
integration will not strain the Company's available management, manufacturing,
financial and other resources.
The Company also made capital expenditures to acquire certain properties in
San Jose, California totaling 109,000 square feet, which included land,
building and improvements for an aggregate purchase price of approximately
$11.0 million and continues to invest in property, plant and equipment needed
for its business requirements, including adding to manufacturing capacity
throughout the Company. Any failure to utilize these areas in an efficient
manner could have a material adverse effect on the Company.
The Company currently has no commitments with respect to any future
acquisitions. The Company, however, frequently evaluates the strategic
opportunities available to it and may in the future pursue acquisitions of
additional complementary products, technologies or businesses. Such
acquisitions by the Company may result in the diversion of management's
attention from the day-to-day operations of the Company's business and may
include numerous other risks, including difficulties in the integration of the
operations and products, integration and retention of personnel of the acquired
companies and certain financial risks. Future acquisitions by the Company may
result in dilutive issuances of equity securities, the incurrence of additional
debt, reduction of existing cash balances, amortization expenses related to
goodwill and other intangible assets and other charges to operations that may
materially adversely affect the Company's business, financial condition or
operating results. See "Management's Discussion and Analysis of Financial
Condition and Results of Operations."
VARIABILITY AND UNCERTAINTY OF QUARTERLY OPERATING RESULTS
The Company has experienced and expects to continue to experience significant
fluctuations in its quarterly results. The Company believes that fluctuations
in quarterly results may cause the market price of its Common Stock to
fluctuate, perhaps substantially. Factors which have had an influence on and
may continue to influence the Company's operating results in a particular
quarter include the timing of the receipt of orders from major customers,
product mix, competitive pricing pressures, the relative proportions of
domestic and international sales, costs associated with the acquisition or
disposition of businesses, products or technologies, the Company's ability to
design, manufacture and ship products on a cost effective and timely basis, the
delay between incurrence of expenses to further develop marketing and service
capabilities and realization of benefits from such improved capabilities, the
announcement and introduction of cost-effective new products by the Company and
by its competitors, and expenses associated with any intellectual property
litigation. In addition, the Company's sales will often reflect orders shipped
in the same quarter that they are received. Moreover, customers may cancel or
reschedule shipments, and production difficulties could delay shipments. The
timing of sales of the Company's Ultrapointe Systems may result in substantial
fluctuations in quarterly operating results due to the substantially higher per
unit price of these products relative to the Company's other products. In
addition, the Company sells its telecommunications equipment products to OEMs
who typically order in large quantities and therefore the timing of such sales
may significantly affect the Company's quarterly results. The timing of such
OEM sales can be affected by factors beyond the Company's control, including
demand for the OEM's products and manufacturing issues experienced by OEMs. In
this regard, the Company recently experienced a temporary rescheduling of
orders by one OEM telecommunications customer. As a result of the above
factors, the Company's results of operations are subject to significant
variability from quarter to quarter. See "Management's Discussion and Analysis
of Financial Condition and Results of Operations--Quarterly Results of
Operations," "Business--Semiconductor Capital Equipment Products" and "--
Backlog."
7
<PAGE>
The Company's operating results in a particular quarter may also be affected
by the acquisition or disposition of other businesses, products or technologies
by the Company. For example, in the fourth quarter of fiscal 1995, the Company
incurred charges totaling $5.4 million, primarily for acquired in-process
research and development in connection with the Company's acquisition of UTP,
and to a lesser extent from the loss on the sale of the Company's diode laser
product line. Such charges reduced net income per share for the fourth quarter
of fiscal 1995 by $0.34 and for fiscal 1995 by $0.33. During the quarter ending
June 30, 1996, the Company incurred a charge of approximately $3.0 million in
connection with the cancellation of certain UTP options and granting of
replacement options to purchase Uniphase Common Stock to UTP employees in order
to operate UFP as a division of UTP. The Company will incur an additional
estimated charge of $4.5 million for acquired in-process research and
development in connection with the acquisition of UFP in the quarter ending
June 30, 1996. As a result of this expected in-process research and development
charge and the option grant related compensation expense, the Company expects
to record a net loss for the quarter ending June 30, 1996. There can be no
assurance that other acquisitions or dispositions of businesses, products or
technologies by the Company in the future will not result in substantial
charges or other expenses that may cause fluctuations in the Company's
quarterly operating results. See "Management's Discussion and Analysis of
Financial Condition and Results of Operations."
INTENSE INDUSTRY COMPETITION
The laser, semiconductor capital equipment, CATV and telecommunications
industries in which the Company sells its products are highly competitive. In
each of the markets it serves, the Company faces intense competition from
established competitors, many of which have substantially greater financial,
engineering, research and development, manufacturing, marketing, service and
support resources. The Company is a recent entrant into the semiconductor
capital equipment, the CATV and telecommunications marketplaces and competes
with many companies in those markets that have substantially greater resources,
including greater name recognition, a larger installed base of products and
longer standing customer relationships. In order to remain competitive, the
Company must maintain a high level of investment in research and development,
marketing, and customer service and support. There can be no assurance that the
Company will be able to compete successfully in the laser, semiconductor
capital equipment, CATV or telecommunications industries in the future, that
the Company will have sufficient resources to continue to make such
investments, that the Company will be able to make the technological advances
necessary to maintain its competitive position or that its products will
receive market acceptance. The semiconductor capital equipment market is
frequently affected by new product introductions and new technologies that make
existing production and inspection equipment obsolete. There can be no
assurance that others will not introduce products which compete with the
Ultrapointe System or which render the Ultrapointe System obsolete or
uncompetitive based on existing or new technologies. In addition, there can be
no assurance that technological changes or development efforts by the Company's
competitors will not render the Company's products or technologies obsolete or
uncompetitive. See "Business--Sales and Marketing" and "--Competition."
DEPENDENCE ON KEY OEM RELATIONSHIPS
In November 1995, the Company entered into an exclusive OEM resale agreement
with Tencor pursuant to which Tencor will distribute Ultrapointe Systems
through its worldwide distribution channels. As a result of such agreement, the
Company currently expects that Tencor will account for a majority of
Ultrapointe's net sales for the foreseeable future. In addition, one laser
subsystems customer, the Applied Biosystems Division of Perkin-Elmer
Corporation, accounted for approximately 11%, 12%, 12% and 13% of the Company's
net sales for fiscal years 1993, 1994, 1995, and the nine months ended March
31, 1996, respectively. The loss of orders from these or other OEM
relationships could have a materially adverse effect on the Company's business
and operating results.
ATTRACT AND RETAIN KEY PERSONNEL
The future success of the Company is dependent, in part, on its ability to
attract and retain certain key personnel. In particular, the Company's research
and development efforts are dependent on the Company being able to hire and
retain engineering staff with the requisite qualifications. Competition in
recruiting highly skilled engineering personnel is extremely intense, and the
Company is currently experiencing substantial difficulty in
8
<PAGE>
identifying and hiring certain qualified engineering personnel in many areas
of its business. No assurance can be given that the Company will be able to
successfully hire such personnel at compensation levels that are consistent
with the Company's existing compensation and salary structure. The Company's
future success will also depend to a large extent on the continued
contributions of its executive officers and other key management and technical
personnel, none of whom has an employment agreement with the Company and each
of whom would be difficult to replace. The Company maintains a key person life
insurance policy on its Chief Executive Officer, but it does not maintain such
insurance on any other persons. The loss of the services of one or more of the
Company's executive officers or key personnel or the inability to continue to
attract qualified personnel could delay product development cycles or
otherwise have a material adverse effect on the Company's business and
operating results. See "Business--Research and Development," "--Employees" and
"Management."
CONFLICTING PATENTS AND INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES;
POTENTIAL INFRINGEMENT CLAIMS
The laser, semiconductor capital equipment, CATV and telecommunications
industries in which the Company sells its products are characterized by
frequent litigation regarding patent and other intellectual property rights.
Numerous patents in these industries are held by others, including academic
institutions and competitors of the Company. Such patents could inhibit the
Company's ability to develop new products for such markets. From time to time,
the Company has received notices claiming that it has infringed third-party
patents or other intellectual property rights. While in the past licenses
generally have been available to the Company where third-party technology was
necessary or useful for the development or production of the Company's
products, there can be no assurance that licenses to third-party technology
will be available on commercially reasonable terms, if at all. Generally, a
license, if granted, would include payments by the Company of up-front fees,
ongoing royalties or a combination thereof. There can be no assurance that
such royalty or other terms would not have a significant adverse impact on the
Company's operating results. The Company is a licensee of a number of third
party technologies and intellectual property rights and is required to pay
royalties to these third party licensors on certain of its products. During
fiscal 1995 and the nine months ended March 31, 1996, the Company expensed
approximately $1.2 million and $1.2 million, respectively, in license and
royalty fees primarily in connection with its gas laser subsystems. In
addition, there can be no assurance that third parties will not assert claims
against the Company with respect to the Company's existing products or with
respect to future products under development by the Company. In the event of
litigation to determine the validity of any third-party claims, such
litigation could result in significant expense to the Company and divert the
efforts of the Company's technical and management personnel, whether or not
such litigation is determined in favor of the Company. In the event of an
adverse result in any such litigation, the Company could be required to expend
significant resources to develop non-infringing technology or to obtain
licenses to the technology which is the subject of the litigation. There can
be no assurance that the Company would be successful in such development or
that any such licenses would be available to the Company. In the absence of
such a license, the Company could be enjoined from future sales of the
infringing product or products. In fiscal years 1992 and 1993, the Company
incurred substantial legal expenses in connection with a patent infringement
action relating to the Company's current gas laser subsystems brought by
Spectra-Physics Lasers, Inc. ("Spectra-Physics"). While the Spectra-Physics
case has since been settled, no assurance can be given that, in the future,
the Company will be able to avoid similar actions by competitors or others or
that the Company will not be forced to initiate its own actions to protect its
proprietary position. See "Business--Patents and Proprietary Rights."
LIMITED PROTECTION OF INTELLECTUAL PROPERTY
The Company's future success depends in part upon its intellectual property,
including trade secrets, know-how and continuing technological innovation.
There can be no assurance that the steps taken by the Company to protect its
intellectual property will be adequate to prevent misappropriation or that
others will not develop competitive technologies or products. The Company
currently holds 30 U.S. patents on products or processes and certain
corresponding foreign patents and has applications for certain patents
currently pending. While three patents have been issued with respect to the
Company's Ultrapointe Systems, no assurance can be given that competitors will
not successfully challenge the validity of these patents or design products
that avoid infringement of the Company's proprietary rights with respect to
its Ultrapointe Systems. There can be no
9
<PAGE>
assurance that other companies are not investigating or developing other
technologies that are similar to the Company's, that any patents will issue
from any application pending or filed by the Company or that, if patents do
issue, the claims allowed will be sufficiently broad to deter or prohibit
others from marketing similar products. In addition, there can be no assurance
that any patents issued to the Company will not be challenged, invalidated or
circumvented, or that the rights thereunder will provide a competitive
advantage to the Company. Further, the laws of certain territories in which
the Company's products are or may be developed, manufactured or sold,
including Asia, Europe or Latin America, may not protect the Company's
products and intellectual property rights to the same extent as the laws of
the United States. See "Business--Patents and Proprietary Rights."
DEPENDENCE ON SOLE AND LIMITED SOURCE SUPPLIERS
Various components included in the manufacture of the Company's products are
currently obtained from single or limited source suppliers. A disruption or
loss of supplies from these companies or an increase in price of these
components would have a material adverse effect on the Company's results of
operations, product quality and customer relationships. For example, the
Company obtains all the robotics, workstations and many optical components
used in its Ultrapointe Systems from Equipe Technologies, Silicon Graphics,
Inc., and Olympus Corporation, respectively. The Company currently utilizes a
sole source for the crystal semiconductor chip sets incorporated in the
Company's solid state microlaser products and acquires its pump diodes for use
in its solid state laser products from SDL, Inc., Opto Power Corporation and
GEC. The Company also obtains lithium niobate wafers and specialized fiber
components used in its UTP products primarily from Crystal Technology Inc. and
Fujikura, Ltd., respectively. The Company does not have long-term or volume
purchase agreements with any of these suppliers, and no assurance can be given
that these components will be available in the quantities required by the
Company, if at all. Further, UTP depends on relatively specialized components
and it cannot be assured that its respective suppliers will be able to
continue to meet UTP's requirements. See "Business--Manufacturing".
DIFFICULTIES IN MANUFACTURE OF THE COMPANY'S PRODUCTS
The manufacture of the Company's products involves highly complex and
precise processes, requiring production in highly controlled and clean
environments. Changes in the Company's or its suppliers' manufacturing
processes or the inadvertent use of defective or contaminated materials by the
Company or its suppliers could adversely affect the Company's ability to
achieve acceptable manufacturing yields and product reliability. In addition,
UTP has previously experienced certain manufacturing yield problems that have
materially and adversely affected both UTP's ability to deliver products in a
timely manner to its customers and its operating results. The Company recently
began manufacturing UTP products at its newly constructed clean room at UTP's
Bloomfield, Connecticut facility and in May 1996 vacated the clean room space
leased from UTP's former parent corporation. No assurance can be given that
the Company will be successful in manufacturing UTP products in the future at
performance or cost levels necessary to meet its customer needs, if at all. In
addition, UTP established a new transmitter production facility in Chalfont,
Pennsylvania in March 1996 and consolidated the transmitter production line
previously located in Bloomfield, Connecticut into this facility in April
1996. The Company has no assurance that this facility will be able to deliver
the planned production quantities of transmitters to customers specifications
at the cost and yield levels required. To the extent the Company or UTP does
not achieve and maintain yields or product reliability, the Company's
operating results and customer relationships will be adversely affected. See
"Business--Manufacturing."
FUTURE CAPITAL REQUIREMENTS
The Company is devoting substantial resources to the development of new
products for the solid state laser, semiconductor capital equipment, CATV and
telecommunications markets. Although the Company believes that the net
proceeds from the sale of the Common Stock in this offering, together with
existing cash balances, cash flow from operations and available lines of
credit, will be sufficient to meet its capital requirements at least through
the end of calendar year 1997, the Company may be required to seek additional
equity or debt financing to compete effectively in these markets. The timing
and amount of such capital requirements cannot be precisely
10
<PAGE>
determined at this time and will depend on several factors, including the
Company's acquisitions and the demand for the Company's products and products
under development. There can be no assurance that such additional financing
will be available when needed, or, if available, will be on terms satisfactory
to the Company. See "Use of Proceeds" and "Management's Discussion and
Analysis of Financial Condition and Results of Operations--Liquidity and
Capital Resources."
VOLATILITY OF COMMON STOCK PRICE
The market price of the Company's Common Stock has recently been and is
likely to continue to be highly volatile and significantly affected by factors
such as fluctuations in the Company's operating results, announcements of
technological innovations or new products by the Company or its competitors,
governmental regulatory action, developments with respect to patents or
proprietary rights, general market conditions and other factors. Further, the
Company's net sales or operating results in future quarters may be below the
expectations of public market securities analysts and investors. In such
event, the price of the Company's Common Stock would likely decline, perhaps
substantially. In addition, the stock market has from time to time experienced
significant price and volume fluctuations that are unrelated to the operating
performance of particular companies. See "Price Range of Common Stock."
RISKS ASSOCIATED WITH INTERNATIONAL SALES
International sales accounted for approximately 31.8%, 28.9%, 30.3% and
25.2% of the Company's net sales in fiscal years 1993, 1994, 1995 and the nine
months ended March 31, 1996, respectively, and the Company expects that
international sales will continue to account for a significant portion of the
Company's net sales. The Company may continue to expand its operations outside
of the United States and to enter additional international markets, both of
which will require significant management attention and financial resources.
International sales are subject to inherent risks, including unexpected
changes in regulatory requirements, tariffs and other trade barriers,
political and economic instability in foreign markets, difficulties in
staffing and management and integration of foreign operations, longer payment
cycles, greater difficulty in accounts receivable collection, currency
fluctuations and potentially adverse tax consequences. Since substantially all
of the Company's foreign sales are denominated in U.S. dollars, the Company's
products may also become less price competitive in countries in which local
currencies decline in value relative to the U.S. dollar. The Company's
business and operating results may also be materially and adversely affected
by lower sales levels which typically occur during the summer months in Europe
and certain other overseas markets. Furthermore, the sales of many of the
Company's OEM customers are dependent on international sales and,
consequently, this further exposes the Company to the risks associated with
such international sales. See "Management's Discussion and Analysis of
Financial Conditions and Results of Operations" and "Business--Marketing and
Sales."
ISSUANCE OF PREFERRED STOCK; POTENTIAL ANTI-TAKEOVER EFFECTS OF DELAWARE LAW
The Board of Directors has the authority to issue up to 1,000,000 shares of
undesignated Preferred Stock and to determine the powers, preferences and
rights and the qualifications, limitations or restrictions granted to or
imposed upon any wholly unissued shares of undesignated Preferred Stock and to
fix the number of shares constituting any series and the designation of such
series, without any further vote or action by the Company's shareholders. The
Preferred Stock could be issued with voting, liquidation, dividend and other
rights superior to those of the holders of Common Stock. The issuance of
Preferred Stock under certain circumstances could have the effect of delaying,
deferring or preventing a change in control of the Company.
The Company is subject to the provisions of Section 203 of the Delaware
General Corporation Law prohibiting publicly-held Delaware corporations from
engaging in business combinations with certain stockholders for a specified
period of time without the approval of substantially all of its outstanding
voting stock. Such provisions could delay or impede the removal of incumbent
directors and could make more difficult a merger, tender offer or proxy
contest involving the Company, even if such events could be beneficial, in the
11
<PAGE>
short term, to the interests of the stockholders. In addition, such provisions
could limit the price that certain investors might be willing to pay in the
future for shares of the Company's Common Stock. The Company's Certificate of
Incorporation and Bylaws contain provisions relating to the limitations of
liability and indemnification of its directors and officers, dividing its
Board of Directors into three classes of directors serving three-year terms
and providing that its stockholders can take action only at a duly called
annual or special meeting of stockholders. These provisions also may have the
effect of deterring hostile takeovers or delaying changes in control or
management of the Company.
SUBSTANTIAL NUMBER OF SHARES ELIGIBLE FOR FUTURE SALE
Based on shares outstanding as of May 20, 1996, the Company will have
15,814,264 shares of Common Stock outstanding upon completion of this
offering. Subject to the lock-up agreements noted below, virtually all of
these outstanding shares will be available for immediate resale without
restriction following the completion of this offering. For a period of 90 days
from the date of this Prospectus, all executive officers and directors have
agreed not to sell or otherwise dispose of any of their shares of Common Stock
(plus an additional approximately 86,658 shares of Common Stock exercisable
under stock options vested as of 90 days from the date of this Prospectus)
without the prior written consent of Montgomery Securities. In addition, upon
completion of the offering, and based on options outstanding as of May 20,
1996, there will be outstanding options to purchase a total of approximately
2,520,016 shares of the Company's Common Stock under the stock option plans of
the Company. Sale of substantial amounts of such shares in the public market
or the prospect of such sales could adversely affect the market price of the
Company's Common Stock. See "Principal Stockholders" and "Underwriting."
12
<PAGE>
RECENT DEVELOPMENTS
In November 1995, the Company entered into a three-year agreement with
Tencor under which Tencor became the exclusive OEM reseller for the Company's
Ultrapointe Systems and the Identifier, the Company's ADC software product.
Under the agreement, Tencor will distribute the Ultrapointe System under its
own label worldwide and has the responsibility for installation and service of
the systems it sells. The Company retains the right to distribute its products
through its direct sales force and other channels. The agreement includes a
license providing Tencor with certain ADC technology and payments to the
Company to accelerate ADC development. In connection with the agreement,
Tencor acquired 665,568 shares of the Company's Common Stock for a net
purchase price of approximately $12.3 million.
In May 1996, the Company acquired UFP. The total purchase price of $9.1
million included aggregate consideration of $8.6 million, payable through a
combination of cash and notes, and estimated direct transaction costs of
$500,000. UFP custom packages laser diodes, LEDs and photodetectors for OEMs
for use in fiber optic networks for local telecommunications and data
communications. The Company intends to operate UFP as a division of UTP. The
Company expects to incur an estimated charge of $4.5 million for acquired in-
process research and development in connection with the acquisition of UFP in
the quarter ending June 30, 1996.
In addition, in order to operate UFP as a division of UTP, management
believes it was necessary to cancel options to purchase UTP stock previously
granted to UTP employees and to grant replacement options to such employees to
purchase Common Stock of the Company. As a result, the Company will incur
compensation expense totaling $4.4 million in connection with such option
grants which were effective on May 15, 1996. Of this total, $3.0 million
relating to options which have vested to date will be charged to expense
during the quarter ending June 30, 1996, and the remaining $1.4 million will
be charged to expense over the remaining three-year vesting period.
As a result of the expected in-process research and development charge in
connection with the UFP acquisition and the compensation expense in connection
with the option grants to UTP employees, the Company expects to record a net
loss for the quarter ending June 30, 1996.
USE OF PROCEEDS
The net proceeds to the Company from the sale of the 2,000,000 shares of
Common Stock offered by it hereby are estimated to be $58.4 million ($67.2
million if the Underwriters' over-allotment option is exercised in full),
based on an assumed public offering price of $31.00 per share and after
deducting the underwriting discount and estimated offering expenses. The
Company intends to use the net proceeds of this offering for general corporate
purposes, including working capital, research, development and engineering
expenses, capital expenditures and possible acquisitions of complementary
businesses, products or technologies. The manner in which the Company may
determine to pursue these activities may vary, and may take the form of joint
ventures or other arrangements with third parties or internal development.
Although the Company frequently reviews potential acquisition opportunities,
there are no present plans, agreements or commitments with respect to any such
transaction, and the Company is not currently engaged in any negotiation with
respect to any such acquisition. The Company anticipates that its capital
expenditures for fiscal 1997 will be approximately $4.0 million and that these
expenditures will be used to support the expansion of its current operations,
including the expansion into additional facilities. Pending the uses described
above, the net proceeds of this offering will be invested in short-term,
income producing investments. See "Management's Discussion and Analysis of
Financial Condition and Results of Operations--Liquidity and Capital
Resources."
13
<PAGE>
PRICE RANGE OF COMMON STOCK
The Common Stock trades on the Nasdaq National Market under the symbol UNPH.
The following table sets forth for the periods indicated the high and low sale
prices for the Common Stock as reported on the Nasdaq National Market, which
prices reflect the Stock Split.
<TABLE>
<CAPTION>
HIGH LOW
---- ---
<S> <C> <C>
FISCAL YEAR 1994
Second Quarter (from November 17, 1993).................... $ 4 5/8 $ 4
Third Quarter.............................................. 5 3/8 4 1/4
Fourth Quarter............................................. 4 5/8 3 3/8
FISCAL YEAR 1995
First Quarter.............................................. 5 1/2 3 7/8
Second Quarter............................................. 8 1/8 5 1/4
Third Quarter.............................................. 10 6 3/8
Fourth Quarter............................................. 12 1/8 8 7/8
FISCAL YEAR 1996
First Quarter.............................................. 19 1/16 10 3/8
Second Quarter............................................. 19 12 1/2
Third Quarter.............................................. 21 1/4 14 7/8
Fourth Quarter (through May 29, 1996)...................... 32 1/2 18 5/8
</TABLE>
On May 29, 1996, the last reported sale price of the Common Stock on the
Nasdaq National Market was $31.00 per share. As of May 29, 1996, there were
approximately 55 holders of record of the shares of outstanding Common Stock.
DIVIDEND POLICY
The Company has never declared or paid cash dividends on its Common Stock.
The Company currently intends to retain all future earnings for use in the
operation of its business, and, therefore, does not anticipate paying any cash
dividends in the foreseeable future. In addition, the Company's existing bank
line of credit prohibits the payment of cash dividends on shares of its
capital stock. See "Management's Discussion and Analysis of Financial
Condition and Results of Operations--Liquidity and Capital Resources" and Note
4 of Notes to Consolidated Financial Statements.
14
<PAGE>
CAPITALIZATION
The following table sets forth the capitalization of the Company at March
31, 1996 and as adjusted to reflect the sale of 2,000,000 shares of Common
Stock by the Company at an assumed public offering price of $31.00 per share,
after deducting the underwriting discount and estimated offering expenses, and
the application of the proceeds therefrom. This table should be read in
conjunction with the Consolidated Financial Statements of the Company,
including the related notes thereto, appearing elsewhere in this Prospectus.
<TABLE>
<CAPTION>
MARCH 31, 1996
--------------------
ACTUAL AS ADJUSTED
-------- -----------
(IN THOUSANDS)
<S> <C> <C>
Long-term debt............................................ $ -- $ --
-------- --------
Stockholders' equity:
Preferred stock, $0.001 par value; 1,000,000 shares
authorized, none issued and outstanding................ -- --
Common Stock, $0.001 par value; 20,000,000 shares
authorized, 13,694,138 shares issued and outstanding,
actual; and 15,694,138 shares issued and outstanding,
as adjusted (1)........................................ 14 16
Additional paid-in capital.............................. 72,188 130,536
Retained earnings....................................... 14,608 14,608
Foreign currency translation adjustment................. 35 35
-------- --------
Total stockholders' equity............................ 86,845 145,195
-------- --------
Total capitalization................................. $ 86,845 $145,195
======== ========
</TABLE>
- --------
(1) Excludes (i) approximately 2,411,430 shares of Common Stock issuable upon
exercise of stock options outstanding at March 31, 1996, at a weighted
average exercise price of $6.44 per share under the Company's stock option
plans, (ii) approximately 48,526 shares of Common Stock reserved for
future issuances pursuant to the Company's stock option plans and (iii)
approximately 244,974 shares of Common Stock reserved for future issuance
under the Company's stock purchase plan. See Notes 7 and 8 of Notes to
Consolidated Financial Statements.
15
<PAGE>
SELECTED CONSOLIDATED FINANCIAL DATA
The selected consolidated statement of operations data presented below for
the years ended June 30, 1991 and 1992 and the consolidated balance sheet data
as of June 30, 1991, 1992 and 1993 are derived from audited consolidated
financial statements of the Company, which have been audited by Ernst & Young
LLP but are not contained in this Prospectus. The selected consolidated
statement of operations data presented below for each of the three years in
the period ended June 30, 1995 and the consolidated balance sheet data as of
June 30, 1994 and 1995 are derived from consolidated financial statements of
the Company, which have been audited by Ernst & Young LLP, independent
auditors, and are contained elsewhere in this Prospectus. The unaudited
selected consolidated statement of operations data presented below for the
nine months ended March 31, 1995 and 1996 and the unaudited consolidated
balance sheet data as of March 31, 1996 have been prepared on the same basis
as the information derived from audited financial statements and, in the
opinion of management, contains all adjustments, consisting only of normal
recurring accruals, necessary for the fair presentation of the results of
operations and financial position for such periods. The selected consolidated
financial data set forth below is qualified in its entirety by, and should be
read in conjunction with, the Company's Consolidated Financial Statements and
related notes thereto and "Management's Discussion and Analysis of Financial
Condition and Results of Operations," which are included elsewhere in this
Prospectus.
<TABLE>
<CAPTION>
NINE MONTHS ENDED
FISCAL YEARS ENDED JUNE 30, MARCH 31,
------------------------------------------------- -----------------
1991 1992 1993 1994 1995 1995 1996
------- ------- ------- ------- ------- -------- --------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C> <C> <C> <C> <C>
CONSOLIDATED STATEMENT
OF OPERATIONS DATA:
Net sales............... $23,480 $26,405 $27,314 $32,922 $42,282 $ 30,146 $ 47,342
Cost of sales........... 14,658 16,611 17,870 20,067 24,113 17,378 25,102
------- ------- ------- ------- ------- -------- --------
Gross profit........... 8,822 9,794 9,444 12,855 18,169 12,768 22,240
Operating expenses:
Research and
development........... 2,031 2,381 1,986 3,058 3,710 2,707 4,093
Royalty and license.... 939 1,023 986 1,212 1,172 995 1,205
Selling, general and
administrative........ 3,557 4,221 5,417 (1) 5,693 (1) 7,355 5,176 8,942
Infrequent or unusual
charges:
Acquired in-process
research and
development.......... -- -- -- -- 4,460 (2) -- --
Loss on sale of
product line......... -- -- -- -- 891 (2) -- --
Litigation (3)........ -- 397 2,381 (355) -- -- --
------- ------- ------- ------- ------- -------- --------
Total operating
expenses............... 6,527 8,022 10,770 9,608 17,588 8,878 14,240
------- ------- ------- ------- ------- -------- --------
Income (loss) from
operations............. 2,295 1,772 (1,326) 3,247 581 3,890 8,000
Other income (expense),
net.................... (7) (9) 139 212 550 404 887
------- ------- ------- ------- ------- -------- --------
Income (loss) before
income taxes........... 2,288 1,763 (1,187) 3,459 1,131 4,294 8,887
Income tax expense
(benefit).............. 832 636 (389) 1,228 396 1,588 3,226
------- ------- ------- ------- ------- -------- --------
Net income (loss)....... $ 1,456 $ 1,127 $ (798) $ 2,231 $ 735 $ 2,706 $ 5,661
======= ======= ======= ======= ======= ======== ========
Net income (loss) per
share.................. $ 0.24 $ 0.19 $ (0.14) $ 0.27 $ 0.07 $ 0.27 $ 0.44
======= ======= ======= ======= ======= ======== ========
Shares used in per share
calculation............ 6,080 5,888 5,510 8,274 10,082 9,966 12,962
</TABLE>
<TABLE>
<CAPTION>
JUNE 30,
--------------------------------------- MARCH 31,
1991 1992 1993 1994 1995 1996
------- ------- ------- ------- ------- ---------
(IN THOUSANDS)
<S> <C> <C> <C> <C> <C> <C>
CONSOLIDATED BALANCE SHEET
DATA:
Working capital............. $ 3,928 $ 5,642 $ 5,002 $18,943 $17,316 $51,033
Total assets................ 10,148 11,563 11,785 26,214 31,910 96,700
Long-term obligations....... 43 268 132 -- -- --
Total stockholders' equity.. 6,148 7,427 6,731 21,331 24,808 86,845
</TABLE>
- -------
(1) In fiscal 1993, includes $217,000 of expenses relating to the
reorganization of the Company's international operations and $300,000 of
expenses accrued for certain intellectual property matters. In fiscal
1994, it was determined that the costs related to the intellectual
property matters would not have to be paid, and, accordingly, such costs
were reversed. See "Management's Discussion and Analysis of Financial
Condition and Results of Operations" and Note 14 of Notes to Consolidated
Financial Statements.
(2) During fiscal 1995, the Company incurred charges totaling $5.4 million,
primarily for acquired in-process research and development and, to a
lesser extent, the loss on the sale of the Company's diode laser product
line. The acquired in-process research and development primarily resulted
from the cash purchase of UTP from United Technologies Corporation for a
total purchase price, including acquisition expenses, of $8.7 million.
Such charges reduced net income per share for fiscal 1995 by $0.33. See
Notes 10 and 11 of Notes to Consolidated Financial Statements.
(3) During fiscal years 1992 and 1993, the Company accrued litigation costs of
$397,000 and $2.4 million, respectively, pertaining primarily to a patent
infringement action brought against the Company, and to a lesser extent in
fiscal 1993, for actions against the Company by certain former employees.
The patent infringement action was settled in fiscal 1993. Due to the
settlement of one of the former employee actions in fiscal 1994 at a cost
less than anticipated and the re-evaluation of the potential liability
with respect to the remaining outstanding lawsuit, the Company reversed
$355,000 of accrued legal expense in fiscal 1994. See Note 14 of Notes to
Consolidated Financial Statements.
16
<PAGE>
UNAUDITED COMBINED PRO FORMA FINANCIAL INFORMATION
The Company has entered into a definitive stock purchase agreement with the
shareholders of FAS and GCA to acquire 100% of the outstanding shares of FAS
and GCA, respectively. The total purchase price is estimated to be
approximately $9.1 million which includes the aggregate consideration of $8.6
million for both GCA and FAS, payable through a combination of cash and notes,
and estimated direct transaction costs of approximately $500,000. The Company
intends to combine GCA and FAS and operate them under the name Uniphase
Fiberoptic Products, Ltd. (UFP).
The Unaudited Pro Forma Combined Financial Information gives effect to the
acquisition of GCA and FAS under the purchase method of accounting using the
assumptions and adjustments described in the accompanying Notes to Pro Forma
Combined Financial Information and should be read in conjunction with the
historical financial statements of the Company and the historical combined
financial statements of GCA and FAS included elsewhere herein. The pro forma
information does not purport to be indicative of the results which would have
been reported if the above transaction had been in effect for the periods
presented or which may result in the future.
The Unaudited Pro Forma Condensed Combined Balance Sheet is presented to
give effect to the acquisition of GCA and FAS as if it had occurred on March
31, 1996 and combines the balance sheet of the Company as of March 31, 1996
with the combined balance sheet of GCA and FAS as of April 30, 1996. The
Unaudited Pro Forma Condensed Combined Statements of Income assumes the
transaction occurred at the beginning of each period presented and combines
the statements of income of the Company for the year ended June 30, 1995 and
the nine months ended March 31, 1996 with the combined statements of income of
GCA and FAS for the twelve months ended July 31, 1995 and the nine months
ended April 30, 1996. See accompanying notes to unaudited pro forma condensed
combined financial statements.
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30, 1995 NINE MONTHS ENDED MARCH 31, 1996
---------------------------------------- ----------------------------------------
PRO PRO
PRO FORMA FORMA PRO FORMA FORMA
UNIPHASE UFP ADJUSTMENTS COMBINED UNIPHASE UFP ADJUSTMENTS COMBINED
-------- ------ ----------- -------- -------- ------ ----------- --------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C> <C> <C> <C> <C> <C>
UNAUDITED PRO FORMA CONDENSED
COMBINED STATEMENTS OF
OPERATIONS:
Net sales............... $42,282 $5,822 $48,104 $47,342 $4,458 $51,800
Cost of sales........... 24,113 3,489 27,602 25,102 3,035 28,137
------- ------ ------- ------- ------ -------
Gross profit............ 18,169 2,333 20,502 22,240 1,423 23,663
Operating expenses:
Research and
development........... 3,710 162 3,872 4,093 119 4,212
Royalty and license.... 1,172 1,172 1,205 -- 1,205
Selling, general and
administrative........ 7,355 1,639 784 (A) 10,528 8,942 1,193 587 (A) 11,162
750 (B) 440 (B)
Acquired in-process
research and
development........... 4,460 -- 4,460 -- -- --
Loss on sale of
product line.......... 891 -- 891 -- -- --
------- ------ ------- ------- ------- ------ ------ -------
Total operating
expenses............ 17,588 1,801 1,534 20,923 14,240 1,312 1,027 16,579
------- ------ ------- ------- ------- ------ ------ -------
Income (loss) on
operations............. 581 532 (1,534) (421) 8,000 111 (1,027) 7,084
Other income (expense),
net.................... 550 (81) (360) (A) 109 887 (66) (270) (A) 551
------- ------ ------- ------- ------- ------ ------ -------
Net income (loss) before
income taxes........... 1,131 451 (1,894) (312) 8,887 45 (1,297) 7,635
Income tax expense
(benefit).............. 396 108 (667) (C) (163) 3,226 25 (451) (C) 2,800
------- ------ ------- ------- ------- ------ ------ -------
Net income (loss)....... $ 735 $ 343 $(1,227) $ (149) $ 5,661 $ 20 $ (846) $ 4,835
======= ====== ======= ======= ======= ====== ====== =======
Net income (loss) per
share.................. $ 0.07 $ (0.01) $ 0.44 $ 0.37
======= ======= ======= =======
Number of weighted
average shares used in
per share amounts...... 10,082 10,082 12,962 12,962
======= ======= ======= =======
</TABLE>
17
<PAGE>
<TABLE>
<CAPTION>
UNIPHASE UFP PRO FORMA PRO FORMA
MARCH 31, 1996 APRIL 30, 1996 ADJUSTMENTS COMBINED
-------------- -------------- ----------- ---------
(IN THOUSANDS)
<S> <C> <C> <C> <C>
UNAUDITED PRO FORMA CON-
DENSED COMBINED BALANCE
SHEET
ASSETS:
Current assets:
Cash and cash
equivalents.......... $18,581 $ 28 $(3,100) (A) $ 15,509
Short-term
investments.......... 18,287 -- 18,287
Accounts receivable,
net.................. 12,824 779 13,603
Inventories........... 8,810 1,064 9,874
Deferred income taxes
and other current
assets............... 2,215 123 2,338
------- ------ ------- --------
Total current
assets............. 60,717 1,994 (3,100) 59,611
Long-term investments... 14,900 -- 14,900
Property, plant and
equipment, net......... 17,019 886 17,905
Intangible assets....... 3,002 -- 5,477 (A) 8,479
Other assets............ 1,062 3 1,065
------- ------ ------- --------
Total assets........ $96,700 $2,883 $ 2,377 $101,960
======= ====== ======= ========
LIABILITIES AND
STOCKHOLDERS' EQUITY:
Current liabilities:
Accounts payable...... $ 3,308 $ 973 $ 4,281
Accrued liabilities... 6,376 355 6,731
Notes payable......... -- 451 451
Current portion of
long-term debt and
lease obligations.... -- 161 161
------- ------ ------- --------
Total current
liabilities........ 9,684 1,940 11,624
Long-term debt, less
current portion........ -- 159 6,000 6,159
Capital lease
obligation, less
current portion........ -- 96 96
Other non-current
liabilities............ 171 -- 171
Deferred income taxes... -- -- 1,565 (A) 1,565
Stockholders' equity:
Common stock.......... 14 3 (3) (A) 14
Other stockholders'
equity............... 86,831 685 (685) (A) 82,331
(4,500) (A)
------- ------ ------- --------
Total stockholders'
equity............. 86,845 688 (5,188) (A) 82,345
------- ------ ------- --------
Total liabilities
and stockholders'
equity........... $96,700 $2,883 $ 2,377 $101,960
======= ====== ======= ========
</TABLE>
NOTES TO UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION
(A) The Company has entered into a definitive stock purchase agreement with
the shareholders of FAS and GCA to acquire 100% of the outstanding shares
of FAS and GCA, respectively. The total purchase price is estimated to be
approximately $9.1 million which includes aggregate consideration of $8.6
million for both GCA and FAS, payable through a combination of cash and
notes, and estimated direct transaction costs of approximately $500,000.
The Company expects that an estimated $4.5 million of the total purchase
price will be allocated to in-process research and development and
immediately charged to expense. This amount is an estimate and is subject
to change based on the completion of an independent valuation which is
currently in process. Since such amount is a non-recurring charge, it has
not been included as a pro forma adjustment to the Unaudited Pro Forma
Condensed Combined Statements of Income. However, this amount has been
included as a pro forma adjustment to the Unaudited Pro Forma Condensed
Combined Balance Sheet.
It is anticipated that the remaining $4.6 million of the total purchase
price will be allocated to specifically identifiable assets acquired and
goodwill. It is estimated that the intangible assets acquired of $3.9
million (net of a deferred tax liability) will be amortized over a weighted
average life of seven years. The related amortization is reflected as a pro
forma adjustment to the Unaudited Pro Forma Condensed Combined Statements
of Income. Such amounts are estimates and are also subject to change
pending completion of the independent valuation.
18
<PAGE>
Interest expense related to the proposed aggregate consideration in the
form of notes has been included in the Unaudited Pro Forma Condensed
Combined Statements of Operations.
(B) The Company intends to combine GCA and FAS and operate them under the name
Uniphase Fiberoptic Products, Ltd. (UFP). UFP will operate as a division
of UTP. In order to operate UFP as a division of UTP, management believes
it was necessary to cancel options to purchase UTP stock previously
granted to UTP employees and to grant replacement options to such
employees to purchase stock of the Company. The Company will incur
compensation expense totaling $4.4 million in connection with such option
grants which were effective on May 15, 1996. Of this total, $3.0 million,
which relates to options which have vested to date, will be charged to
expense during the quarter ending June 30, 1996. This amount has been
included as a pro forma adjustment to the Unaudited Pro Forma Condensed
Combined Balance Sheet but has not been included as a pro forma adjustment
to the Unaudited Pro Forma Condensed Combined Statements of Income because
it is a non-recurring charge. The remaining $1.4 million will be charged
to expense over the remaining vesting period of three years and the
related proportional amounts have been included as a pro forma adjustment
to the Unaudited Pro Forma Condensed Combined Statements of Income.
(C) The pro forma combined provisions for income taxes do not represent the
amounts that would have resulted had Uniphase and GCA and FAS filed
consolidated income tax returns during the periods presented. The pro
forma adjustments have been tax effected at the Company's incremental tax
rate of approximately 40%.
19
<PAGE>
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
INTRODUCTION
The Company designs, develops, manufactures and markets laser subsystems,
laser-based semiconductor wafer defect examination and analysis equipment and
fiber optic telecommunications equipment products. The Company's laser
division designs, develops, manufactures and markets laser subsystems for a
broad range of OEM applications which include biotechnology, industrial
process control and measurement, graphics and printing, and semiconductor
equipment. In 1992, the Company established its Ultrapointe subsidiary, which
designs, develops, manufactures and markets advanced laser-based systems for
semiconductor wafer defect examination and analysis and shipped its first
Ultrapointe System in fiscal 1994.
The Company entered the telecommunications and CATV markets when it acquired
UTP in May 1995. UTP designs, develops, manufactures and markets high-speed
external modulators and transmitters for fiber optic networks in the CATV and
long-haul telecommunications industries. The acquisition was accounted for as
a purchase and, accordingly, historical financial information of the Company
includes the results of UTP from the date of the purchase. In May 1996, the
Company acquired UFP for a total purchase price of $9.1 million which included
a proposed aggregate consideration of $8.6 million payable through a
combination of cash and notes and estimated direct transaction costs of
$500,000. UFP custom packages laser diodes, LEDs and photodetectors for OEMs
for use in fiber optic networks for local telecommunications and data
communications. During the quarter ending June 30, 1996, the Company incurred
a charge of approximately $3.0 million in connection with the cancellation of
certain UTP options and granting of replacement options to purchase Uniphase
Common Stock to UTP employees in order to operate UFP as a division of UTP.
The Company will incur an additional estimated charge of $4.5 million for
acquired in-process research and development in connection with the
acquisition of UFP in the quarter ending June 30, 1996. As a result of this
expected in-process research and development charge and the option grant
related compensation expense, the Company expects to record a net loss for the
quarter ending June 30, 1996. See Note 15 of Notes to Consolidated Financial
Statements.
QUARTERLY RESULTS OF OPERATIONS
The following table sets forth unaudited results for each of the seven
consecutive quarters in the period ended March 31, 1996. This information is
derived from unaudited consolidated financial statements and, in the opinion
of management, includes all adjustments (consisting of normal recurring
adjustments) necessary for a fair presentation when read in conjunction with
the financial statements of the Company included elsewhere in this Prospectus.
<TABLE>
<CAPTION>
FISCAL YEAR ENDED JUNE 30, 1995 NINE MONTHS ENDED MARCH 31, 1996
-------------------------------- --------------------------------
SEPT. 30 DEC. 31 MAR. 31 JUNE 30 SEPT. 30 DEC. 31 MAR. 31
-------- ------- ------- ------- ----------- ---------- ----------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C> <C> <C> <C> <C>
Net sales............... $9,083 $9,941 $11,122 $12,136 $ 12,793 $ 15,673 $ 18,876
Cost of sales........... 5,248 5,846 6,284 6,735 6,974 8,310 9,818
------ ------ ------- ------- ---------- ---------- ----------
Gross profit............ 3,835 4,095 4,838 5,401 5,819 7,363 9,058
Operating expenses:
Research and
development............ 809 896 1,002 1,003 911 1,548 1,634
Royalty and license..... 333 331 331 177 363 387 455
Selling, general and
administrative......... 1,703 1,636 1,837 2,179 2,632 3,033 3,277
Infrequent or unusual
charges:
Acquired in-process
research and
development............ -- -- -- 4,460 (1) -- -- --
Loss on sale of product
line................... -- -- -- 891 (1) -- -- --
------ ------ ------- ------- ---------- ---------- ----------
Total operating
expenses............... 2,845 2,863 3,170 8,710 3,906 4,968 5,366
------ ------ ------- ------- ---------- ---------- ----------
Income (loss) from
operations............. 990 1,232 1,668 (3,309) 1,913 2,395 3,692
Other income, net....... 116 172 116 146 48 390 449
------ ------ ------- ------- ---------- ---------- ----------
Income (loss) before
income taxes........... 1,106 1,404 1,784 (3,163) 1,961 2,785 4,141
Income tax expense
(benefit).............. 409 519 660 (1,192) 745 893 1,588
------ ------ ------- ------- ---------- ---------- ----------
Net income (loss)....... $ 697 $ 885 $ 1,124 $(1,971) $ 1,216 $ 1,892 $ 2,553
====== ====== ======= ======= ========== ========== ==========
OTHER DATA:
Income from operations
before infrequent of
unusual charges (2).... $ 990 $1,232 $ 1,668 $ 2,042 $ 1,913 $ 2,395 $ 3,692
</TABLE>
20
<PAGE>
<TABLE>
<CAPTION>
FISCAL YEAR ENDED JUNE 30, 1995 NINE MONTHS ENDED MARCH 31, 1996
-------------------------------- -------------------------------------
SEPT. 30 DEC. 31 MAR. 31 JUNE 30 SEPT. 30 DEC. 31 MAR. 31
-------- ------- ------- ------- ----------- ---------- ----------
<S> <C> <C> <C> <C> <C> <C> <C>
AS A PERCENTAGE OF NET
SALES:
Net sales............... 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Cost of sales........... 57.8 58.8 56.5 55.5 54.5 53.0 52.0
----- ----- ----- ----- ---------- ---------- ----------
Gross profit........... 42.2 41.2 43.5 44.5 45.5 47.0 48.0
Operating expenses:
Research and
development........... 8.9 9.0 9.0 8.2 7.1 9.9 8.6
Royalty and license.... 3.7 3.3 3.0 1.4 2.8 2.5 2.4
Selling, general and
administrative........ 18.7 16.5 16.5 18.0 20.6 19.3 17.4
Infrequent or unusual
charges:
Acquired in-process
research and
development........... -- -- -- 36.8 (1) -- -- --
Loss on sale of product
line.................. -- -- -- 7.3 (1) -- -- --
Litigation............. -- -- -- -- -- -- --
----- ----- ----- ----- ---------- ---------- ----------
Total operating
expenses............... 31.3 28.8 28.5 71.7 30.5 31.7 28.4
----- ----- ----- ----- ---------- ---------- ----------
Income (loss) from
operations............. 10.9 12.4 15.0 (27.2) 15.0 15.3 19.6
Other income, net...... 1.3 1.7 1.0 1.2 0.3 2.5 2.3
----- ----- ----- ----- ---------- ---------- ----------
Income (loss) before
income taxes........... 12.2 14.1 16.0 (26.0) 15.3 17.8 21.9
Income tax expense
(benefit)............. 4.5 5.2 5.9 (9.8) 5.8 5.7 8.4
----- ----- ----- ----- ---------- ---------- ----------
Net income (loss)....... 7.7% 8.9% 10.1% (16.2)% 9.5% 12.1% 13.5%
===== ===== ===== ===== ========== ========== ==========
OTHER DATA:
Income from operations
before infrequent
or unusual charges
(2)................... 10.9% 12.4% 15.0% 16.8% 15.0% 15.3% 19.6%
</TABLE>
- -------
(1) During fiscal 1995, the Company incurred charges totaling $5.4 million,
primarily for acquired in-process research and development and, to a
lesser extent, for the loss on the sale of the Company's diode laser
product line. The acquired in-process research and development primarily
resulted from the cash purchase of UTP from United Technologies
Corporation for a total purchase price, including acquisition expenses, of
$8.7 million. See Notes 10 and 11 of Notes to Consolidated Financial
Statements.
(2) Other data is presented as supplemental information and should not be
construed as a substitute, or better indicator of, results of operations
than income from operations or net income determined in accordance with
generally accepted accounting principles.
The Company has experienced and expects to continue to experience
significant fluctuations in its quarterly results. The Company believes that
fluctuations in quarterly results may cause the market price of its Common
Stock to fluctuate, perhaps substantially. Factors which have had an influence
on and may continue to influence the Company's operating results in a
particular quarter include the timing of receipt of orders from major
customers, product mix, competitive pricing pressures, the relative
proportions of domestic and international sales, costs associated with the
acquisition or disposition of businesses, products or technologies, the
Company's ability to design, manufacture and ship products on a cost effective
and timely basis, the delay between incurrence of expenses to further develop
marketing and service capabilities and realization of benefits from such
improved capabilities, the announcement and introduction of cost-effective new
products by the Company and by its competitors, and expenses associated with
any intellectual property litigation. In addition, the Company's sales will
often reflect orders shipped in the same quarter that they are received.
Moreover, customers may cancel or reschedule shipments, and production
difficulties could delay shipments. The timing of sales of the Company's
Ultrapointe Systems may result in substantial fluctuations in quarterly
operating results due to the substantially higher per unit price of these
products relative to the Company's other products. In addition, the
semiconductor industry is highly cyclical and historically has experienced
periods of oversupply, resulting in significantly reduced demand for capital
equipment. The semiconductor industry is currently experiencing a downturn
which may materially and adversely affect the Company's business and operating
results.
21
<PAGE>
RESULTS OF OPERATIONS
The following table sets forth for the periods indicated certain financial
data as a percentage of net sales:
<TABLE>
<CAPTION>
NINE MONTHS ENDED
FISCAL YEARS ENDED JUNE 30, MARCH 31,
------------------------------------- --------------------
1993 1994 1995 1995 1996
--------- --------- --------- ------- -------
<S> <C> <C> <C> <C> <C> <C>
Net sales............... 100.0% 100.0% 100.0% 100.0% 100.0%
Cost of sales........... 65.4 61.0 57.0 57.6 53.0
--------- --------- --------- ------ ------
Gross profit........... 34.6 39.0 43.0 42.4 47.0
Operating expenses:
Research and
development........... 7.3 9.3 8.8 9.0 8.6
Royalty and license.... 3.6 3.6 2.8 3.3 2.5
Selling, general and
administrative........ 19.8 (1) 17.3 (1) 17.4 17.2 18.9
Infrequent or unusual
charges:
Acquired in-process
research and
development.......... -- -- 10.5 (2) -- --
Loss on sale of
product line......... -- -- 2.1 (2) -- --
Litigation (3)........ 8.7 (1.1) -- -- --
--------- --------- --------- ------ ------
Total operating
expenses............... 39.4 29.1 41.6 29.5 30.0
--------- --------- --------- ------ ------
Income (loss) from
operations............. (4.8) 9.9 1.4 12.9 17.0
Other income, net...... 0.5 0.6 1.3 1.3 1.8
--------- --------- --------- ------ ------
Income (loss) before
income taxes........... (4.3) 10.5 2.7 14.2 18.8
Income tax expense
(benefit)............. (1.4) 3.7 1.0 5.2 6.8
--------- --------- --------- ------ ------
Net income (loss)....... (2.9)% 6.8% 1.7% 9.0% 12.0%
========= ========= ========= ====== ======
OTHER DATA:
Income from operations
before infrequent or
unusual charges (4)... 3.9% 8.8% 14.0% 12.9% 17.0%
</TABLE>
- --------
(1) In fiscal 1993, includes $217,000 of expenses relating to the
reorganization of the Company's international operations and $300,000 of
expenses accrued for certain intellectual property matters. In fiscal
1994, it was determined that the costs related to the intellectual
property matters would not have to be paid, and, accordingly, such costs
were reversed. See Note 14 of Notes to Consolidated Financial Statements.
(2) During fiscal 1995, the Company incurred charges totaling $5.4 million,
primarily for acquired in-process research and development and, to a
lesser extent, for the loss on the sale of the Company's diode laser
product line. The acquired in-process research and development resulted
primarily from the cash purchase of UTP from United Technologies
Corporation for a total purchase price, including acquisition expenses, of
$8.7 million. Such charges reduced net income per share for fiscal 1995 by
$0.33. See Notes 10 and 11 of Notes to Consolidated Financial Statements.
(3) During fiscal 1993, the Company accrued litigation costs of $2.4 million
pertaining primarily to a patent infringement action brought against the
Company, which was settled in fiscal 1993, and to a lesser extent, to
actions against the Company by certain former employees. Due to the
settlement of one of the former employee actions in fiscal 1994 at a cost
less than anticipated and the re-evaluation of the potential liability
with respect to the remaining outstanding lawsuit, the Company reversed
$355,000 of accrued legal expense in fiscal 1994. See Note 14 of Notes to
Consolidated Financial Statements.
(4) Other data is presented as supplemental information and should not be
construed as a substitute, or better indicator of, results of operations
than income from operations or net income determined in accordance with
generally accepted accounting principles.
22
<PAGE>
Nine Months Ended March 31, 1995 and 1996
Net Sales. For the first nine months of fiscal 1996, net sales were $47.3
million, which represented a $17.2 million or 57.0% increase over net sales of
$30.1 million in the same period of fiscal 1995. The increase was primarily
due to the increased sales of the Company's Ultrapointe Systems which
accounted for $7.4 million of the increase in net sales, and the inclusion of
revenues of $8.8 million from UTP, which was acquired in a purchase
transaction in May 1995. For the first nine months of fiscal 1996, net sales
of laser subsystems increased $945,000 primarily due to an increase in sales
of the Company's argon gas lasers and to a lesser extent solid state lasers,
which together offset the decline in the sales of the Company's mature He-Ne
product line principally in the bar code scanning market, as most customers
are now using semiconductor diode lasers to satisfy bar code scanning
applications.
Gross Profit. For the first nine months of fiscal 1996, gross profit
increased 74.2% to $22.2 million or 47.0% of net sales compared with $12.8
million or 42.4% of net sales in the same period of fiscal 1995. Gross profit
increased in absolute dollars and as a percentage of net sales in the first
nine months of fiscal 1996 primarily due to the increased sales volumes of
Ultrapointe Systems and the addition of the Company's UTP product line, both
of which currently experience higher gross margins than the Company's laser
subsystems. In addition, improved economies of scale resulting from higher
production and purchasing volumes of components in Ultrapointe Systems had a
favorable impact on gross margin. The increasing proportion of higher margin
argon gas laser subsystems relative to lower margin He-Ne subsystems in the
Company's sales mix of its laser products also contributed to the improvement
in gross margin. There can be no assurance that these trends will continue and
that the Company will be able to sustain its gross margin at current levels.
The Company expects that there will continue to be periodic fluctuations in
its gross margin resulting from changes in its sales and product mix,
competitive pricing pressures, manufacturing yields, inefficiencies associated
with new product introductions and a variety of other factors. In addition,
certain of UFP's products provide gross margins below those of the Company's
current telecommunications product lines. As a result, the acquisition of UFP
could have the effect of modestly reducing the Company's overall gross margins
as sales from UFP products grow as a proportion of the Company's total net
sales.
Research and Development Expense. In the first nine months of fiscal 1996,
research and development expense was $4.1 million or 8.6% of net sales which
represented a $1.4 million or 51.2% increase over the same period of fiscal
1995. The increase in research and development expense was primarily due to
the addition of UTP expenses which included increased expenditures associated
with the development of transmitters. For the nine months ended March 31,
1996, laser subsystems experienced a decrease in expenditures primarily due to
the sale of its diode laser product line in June 1995, the redeployment of
certain engineering support and increased reimbursements on expenses from a
certain cooperative agreement with the federal government. This agreement is
scheduled to end on December 31, 1996. The Company is committed to continuing
its significant research and development expenditures and expects that the
absolute dollar amount of research and development expense will increase as it
invests in developing new products and in expanding and enhancing its existing
product lines, although such expenses may vary as a percentage of net sales
from year to year.
Royalty and License Expense. For the first nine months of fiscal 1996,
royalty and license expense increased $210,000 to $1.2 million from $995,000
in the same period of fiscal 1995 and decreased as a percentage of sales to
2.5% from 3.3% in the same period of fiscal 1995. The decrease as a percentage
of net sales was due to the increasing proportion of revenues that the Company
derived from Ultrapointe Systems, which bear a lower royalty rate than laser
subsystems, and from royalty-free UTP products.
The Company continues to develop its solid state laser technology. There are
numerous patents on solid state laser technologies that are held by others,
including academic institutions and competitors of the Company. Such patents
could inhibit the Company's ability to develop, manufacture and sell products
in this area. A number of the patents are conflicting. If there is conflict
between a competitor's patents or products and those of the Company, it could
be very costly for the Company to enforce its rights in an infringement action
or defend
23
<PAGE>
such an action brought by another party. In addition, the Company may need to
obtain license rights to certain patents and may be required to make
substantial payments, including continuing royalties, in exchange for such
license rights. There can be no assurance that licenses to third party
technology, if needed, will be available on commercially reasonable terms.
Selling, General and Administrative Expense. In the first nine months of
fiscal 1996, selling, general and administrative expense was $8.9 million or
18.9% of net sales which represented a $3.8 million or 72.8% increase over
selling, general and administrative expense of $5.2 million or 17.2% of net
sales in the same period of fiscal 1995. The increase was attributable to the
addition of UTP expenditures (which included increased expenditures to support
the transmitter product line and the amortization of acquired intangible
assets), sales commissions on increased sales volume of Ultrapointe Systems,
increased staffing levels and increased selling expenses to support the
Company's product lines. The Company expects the dollar amount of its selling,
general and administrative expenditures to increase in the future, although
such expenses may vary as a percentage of net sales from year to year.
Other Income (Expense), Net. For the first nine months of fiscal 1996,
interest and other income, net increased to $887,000 from $404,000 in the same
period of fiscal 1995. The increase was primarily due to the additional
interest income earned on the net proceeds received from the Company's public
offering of Common Stock in October 1995 and from the sale of Common Stock to
Tencor in November 1995.
Income Tax Expense. As stated in Note 3 of Notes to Consolidated Financial
Statements, the effective tax rate for the nine month period ended March 31,
1996 of fiscal year 1996 was 36% compared to 37% for the same period of fiscal
1995. The decrease in the tax rate is primarily due to non-taxable interest
income from the Company's increased investments.
Years Ended June 30, 1993, 1994 and 1995
Net Sales. Net sales increased 28.4% to $42.3 million in fiscal 1995 from
$32.9 million in fiscal 1994. This increase was primarily attributable to
higher unit volume shipments of the Company's Ultrapointe Systems and its
laser subsystems. Ultrapointe Systems sales increased to approximately $7.4
million or 17.6% of the Company's net sales in fiscal 1995 from $2.4 million
or 7.2% of the Company's net sales in fiscal 1994. Net sales of the Company's
laser subsystems increased $3.3 million year to year due primarily to
increased sales of the Company's argon gas lasers, principally for use in
biotechnology and semiconductor applications. These sales more than offset a
decline in sales of certain of the Company's gas laser subsystems from its
mature He-Ne product line. Use of He-Ne gas lasers has substantially declined
as most customers are now using semiconductor diode lasers to satisfy bar code
scanning applications. Net sales of the Company's telecommunications products
since the acquisition in May 1995 of UTP were approximately $1.0 million or
2.4% of the Company's net sales in fiscal 1995. The Company's international
sales accounted for approximately 30.3%, 28.9% and 31.8% of total net sales
for fiscal years 1995, 1994 and 1993, respectively.
Net sales increased 20.5% to $32.9 million in fiscal 1994 from $27.3 million
in fiscal 1993. The increase in net sales was primarily attributable to
increased sales of argon laser subsystems and sales of Ultrapointe Systems.
The $3.3 million increase in net sales of laser subsystems from year to year
was supported by strong demand for products from both the biotechnology and
semiconductor equipment markets. Several new customer design-ins using the
Company's argon gas lasers also contributed to this growth in laser subsystems
sales. The increased sales of argon gas laser subsystems more than offset the
decline in sales of He-Ne gas laser subsystems in certain markets primarily
because of a shift in technologies used in some customer applications to
semiconductor diode lasers.
Gross Profit. Gross profit increased 41.3% to $18.2 million or 43.0% of net
sales in fiscal 1995 from $12.9 million or 39.0% of net sales in fiscal 1994.
Gross profit increased in absolute dollars and as a percentage of net sales
due to several factors, including the higher sales volume of Ultrapointe
Systems, which carry higher gross margins than the Company's laser subsystems.
In addition, improved economies of scale resulting from higher
24
<PAGE>
production and purchasing volumes of Ultrapointe Systems had a favorable
impact on gross margin. The increasing proportion of higher margin argon gas
laser subsystems relative to lower margin He-Ne gas laser subsystems in the
Company's sales mix of its laser products subsystems also contributed to the
improvement in gross margin. There can be no assurance that these trends will
continue and that the Company will be able to sustain its gross margin at
current levels.
Gross profit increased 36.1% to $12.9 million or 39.0% of net sales in
fiscal 1994 from $9.4 million or 34.6% of net sales in fiscal 1993. Gross
profit increased in absolute dollars and as a percentage of net sales due to
several factors, including a continuing shift in the mix of laser products to
higher margin laser subsystems, first year sales of Ultrapointe Systems,
improved economies of scale, and a reduction of workers' compensation and
health insurance expenses.
Research and Development Expense. Research and development expense in fiscal
1995 was $3.7 million or 8.8% of net sales compared with $3.1 million or 9.3%
of net sales in fiscal 1994. The absolute dollar increase in research and
development expense in fiscal 1995 was primarily attributable to the continued
development of solid state lasers and costs associated with improving and
enhancing the Ultrapointe Systems product line.
Research and development expense in fiscal 1994 was $3.1 million or 9.3% of
net sales compared with $2.0 million or 7.3% of net sales in fiscal 1993. The
increase in research and development expense in fiscal 1994 was primarily due
to the development of solid state lasers and diode lasers, which accounted for
approximately 47.4% of Uniphase's total research and development expenses in
fiscal 1994. The diode laser product line was sold by the Company in fiscal
1995. The dollar amount of research and development expense related to the
further development of Ultrapointe Systems decreased slightly from fiscal 1993
to 1994 as the product transitioned from the laboratory stage to production.
Royalty and License Expense. Royalty and license expense was relatively
constant from fiscal 1994 to 1995 and decreased as a percentage of net sales
to 2.8% in fiscal 1995 from 3.6% in fiscal 1994. Royalty expense decreased as
a percentage of net sales due in part to lower royalty rates applicable to
higher volume sales and international sales of gas laser subsystems. Increased
sales of Ultrapointe Systems, which bear a lower royalty rate than laser
subsystems, also contributed to the decrease.
Royalty and license expense increased to $1.2 million in fiscal 1994 from
$1.0 million in fiscal 1993, and remained relatively constant as a percentage
of net sales. The increase in royalty and license expenses was attributable to
the royalties assessed on the shipments of Ultrapointe Systems and licensing
fees paid to certain universities for patent use rights. Increased fiscal 1994
royalty and license expenses were partially offset by lower royalty rates on
gas laser subsystems that apply to both higher sales volumes and international
sales.
Selling, General and Administrative Expense. Selling, general and
administrative expense in fiscal 1995 was $7.4 million or 17.4% of net sales
compared with $5.7 million or 17.3% of net sales in fiscal 1994. The increase
in selling, general and administrative expense in fiscal 1995 resulted from
increased staffing levels, selling expenses to support the Company's laser
products and new product introductions, sales commissions on higher sales
volume of Ultrapointe Systems, increased business development, investor
relations and stockholder communications activities.
Selling, general and administrative expense increased to $5.7 million in
fiscal 1994 from $5.4 million in fiscal 1993, but decreased as a percentage of
net sales to 17.3% in fiscal 1994 from 19.8% in fiscal 1993. During fiscal
1994, it was determined that certain third party patent costs accrued in
fiscal 1993 would not have to be paid. As a result, the related accrued
expenses of $300,000 were reversed in fiscal 1994. Selling, general and
administrative expenses were also reduced by positive effects from cost
reduction programs. These decreases were primarily offset by higher domestic
distributor commissions, which were recognized as a selling expense.
Infrequent or Unusual Charges. During fiscal years 1993, 1994 and 1995, the
Company incurred certain infrequent or unusual charges. Accordingly, such
charges were set forth as separate line items of operating
25
<PAGE>
expenses. These charges consist of acquired in-process research and
development, loss on sale of product line and litigation expense.
The acquired in-process research and development expense in fiscal 1995 was
$4.5 million or 10.5% of net sales which was primarily attributable to the
Company's purchase of UTP from United Technologies Corporation in May 1995.
See Note 10 of Notes to Consolidated Financial Statements.
The Company incurred a loss of $891,000 on the sale of its diode laser
product line in June 1995. In connection with this sale, the Company also
obtained a limited non-exclusive sublicense to a solid state technology patent
at a reduced royalty rate. The Company sold its diode laser product line due
to the commercial availability of low-cost diode laser component parts from
third party manufacturers and its determination that these external sources
will provide sufficient supply of the components for the foreseeable future.
See Note 11 of Notes to Consolidated Financial Statements.
During fiscal 1993, the Company accrued litigation costs of $2.4 million,
pertaining primarily to a patent infringement action brought against the
Company and, to a lesser extent, to actions against the Company by certain
former employees. The patent infringement action was settled in fiscal 1993.
Due to the settlement of one of the former employee actions in fiscal 1994 at
a cost less than anticipated and the re-evaluation of the potential liability
with respect to the remaining outstanding lawsuit, the Company reversed
$355,000 of accrued legal expenses in fiscal 1994.
Other Income, Net. Other income, net increased to $550,000 in fiscal 1995
from $212,000 in fiscal 1994 and $139,000 in fiscal 1993. The increase in
fiscal 1995 resulted primarily from increased interest income earned on the
Company's short-term investments and, to a lesser extent, net gains on foreign
currency transactions. The increase in fiscal 1994 was primarily attributable
to increased interest income earned on net proceeds from the Company's initial
public offering in November 1993.
Income Tax Expense (Benefit). The Company's effective tax rate was 35.0% in
fiscal 1995 as compared to 35.5% in fiscal 1994. A substantial portion of the
Company's net deferred tax assets of $2.2 million related to the charge for
acquired in-process research and development. A valuation allowance has not
been provided for such net deferred tax assets since the Company believes that
it is more likely than not that such net deferred tax assets will be realized
from the Company's ongoing operations.
The Company's effective tax rate was 35.5% in fiscal 1994 compared to a tax
benefit equal to 32.8% of the pretax loss in fiscal 1993.
LIQUIDITY AND CAPITAL RESOURCES
At March 31, 1996, the Company's combined balance of cash, cash equivalents
and investments was $51.8 million. The Company has met its liquidity needs to
date primarily through cash generated from operations and sales of its equity
securities.
Cash generated from operations was $2.6 million in the first nine months of
fiscal year 1996, compared with $1.4 million in the first nine months of
fiscal 1995. Cash generated from operations for the first nine month period of
fiscal 1996 resulted primarily from increases in income before depreciation
and amortization expense and in accounts payable which together offset
increases in inventories and accounts receivable. This increase in inventory
levels reflected increased purchases of components associated with higher
sales.
Cash used in investing activities was $43.4 million in the first nine months
of fiscal 1996 compared with $1.7 million in the first nine months of fiscal
1995. The Company's cash used in investing activities increased primarily due
to the investment of excess cash from the proceeds of sales of common stock.
The Company also made capital expenditures to acquire certain properties in
San Jose, California totaling 109,000 square feet, which included land,
building and improvements for an aggregate purchase price of approximately
$11.0 million. The
26
<PAGE>
remaining increase was primarily due to expenditures associated with
constructing a clean room and adding a second lithium niobate wafer processing
line to the Company's current fabrication facility in Connecticut and
expanding the Pennsylvania optical transmitter facility in order to support
the current demand for UTP's products. The Company continued to invest in
property, plant and equipment needed for its business requirements, including
manufacturing capacities throughout the Company. In July 1995, the Company
also acquired the remaining outstanding shares of I.E. Optomech, Ltd. In May
1996, the Company acquired UFP and expended $9.1 million, which included a
proposed aggregate consideration of $8.6 million for both GCA and FAS and
estimated direct transaction costs of $500,000.
In October 1995, the Company completed an underwritten public offering of
shares of Common Stock for net proceeds of approximately $40.5 million. In
November 1995, Tencor agreed to become the exclusive OEM reseller of the
Ultrapointe Systems and the Identifier, the Company's ADC software product,
and in connection therewith acquired 665,568 shares of the Company's Common
Stock for a net purchase price of approximately $12.3 million.
The Company has a $5.0 million revolving line of credit with a bank. There
were no borrowings under the line of credit at March 31, 1996. Advances under
the line of credit bear interest at the bank's prime rate (8.25% at March 31,
1996) and are secured by inventories and accounts receivable. Under the terms
of the line of credit agreement, the Company is required to maintain certain
minimum working capital, net worth, profitability levels and other specific
financial ratios. In addition, the agreement prohibits the payment of cash
dividends and contains certain restrictions on the Company's ability to borrow
money or purchase assets or interests in other entities without the prior
written consent of the bank. The line of credit expires on November 1, 1996.
See Note 4 of Notes to Consolidated Financial Statements.
The Company intends to use the net proceeds from this offering and available
lines of credit, together with cash flows from operations, to finance its
future operations. The Company believes that its existing cash balances and
investments, together with cash flow from operations, available lines of
credit and the proceeds realized on the sale of the shares offered hereby by
the Company, will be sufficient to meet its liquidity and capital spending
requirements at least through the end of calendar year 1997. However, possible
acquisitions of complementary businesses, products or technologies may require
additional financing prior to such time. There can be no assurance that
additional financing will be available when required or, if available, will be
on terms satisfactory to the Company. The Company has no present plans,
agreements or commitments, and is not currently engaged in any negotiation
with respect to any such acquisition.
27
<PAGE>
BUSINESS
GENERAL
Uniphase is an optoelectronics company that designs, develops, manufactures
and markets laser subsystems, laser-based semiconductor wafer defect
examination and analysis equipment and fiber optic telecommunications
equipment products. Optoelectronics is a technology that extends the speed and
capacity of conventional electronic solutions by addressing many of the
constraints of the electron with the particle of light, the photon. Since its
founding, Uniphase has shipped over one million lasers and has become a
leading supplier of laser subsystems for OEMs in the biotechnology, industrial
process control, semiconductor wafer inspection, and graphics and printing
markets.
The Company's strategy is to leverage its core competencies in laser
technology to develop highly focused and differentiated applications where
there is a convergence of market need and optoelectronic technology. The
Company's knowledge of laser technology enabled it to introduce an
optoelectronics application for the semiconductor capital equipment industry,
the Ultrapointe System, in June 1993. The Ultrapointe System works in
conjunction with automated inspection systems from vendors such as Tencor and
KLA to enable semiconductor manufacturers to more accurately identify and
classify defects. This defect examination and analysis procedure enables
semiconductor manufacturers to improve yields by identifying and containing
process problems. In November 1995, Tencor became the exclusive OEM reseller
of the Ultrapointe System. In May 1996, the Company introduced its Identifier
software product, an optional feature that provides ADC capability for
Ultrapointe Systems. Working in conjunction with the Ultrapointe System, the
Identifier software automates the defect classification process, thereby
improving the precision and repeatability of defect classification.
The Company extended its optoelectronic product offerings into the
telecommunications equipment market by acquiring UTP in May 1995. UTP designs,
develops, manufactures and markets high-speed external modulators and
transmitters for fiber optic networks in the long-haul telecommunications and
CATV industries. In November 1995, UTP established a facility to develop and
manufacture turn-key CATV transmitters. In May 1996, the Company acquired UFP.
The acquisition of UFP expands the Company's presence in the optoelectronic
communications market. UFP custom packages laser diodes, LEDs and
photodetectors for OEMs for use in fiber optic networks for local
telecommunications and data communications.
COMPANY STRATEGY
The Company seeks to leverage its expertise in optoelectronics to develop
highly focused and differentiated applications where there is a convergence of
market need and optoelectronic technology. Uniphase seeks to integrate its
strengths in photonics, electronics and software development to provide
innovative and cost effective solutions to its customers. The key elements of
Uniphase's business strategy are as follows:
. Capitalize on Expertise in Laser Technology and Laser Manufacturing. Since
its inception in 1979, Uniphase has sold over one million lasers to OEM
customers and has become a leader in certain market segments. The Company
is currently developing solid state lasers for its existing OEM customers
and new applications. In this regard, Uniphase has commercially introduced
a series of green wavelength solid state microlasers and a series of
continuous wave and pulsed infrared solid state lasers. In addition, the
Company is in the late stage of development of blue wavelength solid state
microlasers. The Company believes that it is well positioned to continue
development of and penetrate the market for solid state lasers, which the
Company believes will be the primary commercial laser technology in the
future.
. Offer Applications Differentiated by Optoelectronic Technologies. The
Company's expertise in laser technology has enabled it to successfully
introduce and market applications products in the semiconductor capital
equipment and telecommunications equipment markets. The Company's
Ultrapointe Systems utilize high resolution laser imaging systems for the
examination and analysis of wafer defects that are as small as 0.1 micron.
The Company also develops and produces optical external modulators and
associated transmitters for fiberoptic CATV transmission systems as well as
modulators for long haul fiber optic digital
28
<PAGE>
transmission. In May 1996, the Company acquired UFP as a continuation of its
strategy to pursue selected opportunities where optoelectronic technology
converges on specific market needs. Through UFP, the Company will offer
custom packaged laser diodes and photodetectors for the efficient
transmission of voice, data and video across local fiber optic systems.
. Provide Cost-Effective, Demand-Driven Solutions to its OEM Customers. The
Company seeks, through close relationships, to understand its customers'
needs at an early stage in the customers' product development cycles and to
design its laser subsystems and telecommunications equipment products to
meet these specific needs. The Company focuses on selling its subsystems to
customers at the design-in phase of a product, creating the potential for
recurring sales throughout a product's life. Following design-in of its
products, the Company shifts its focus to obtaining manufacturing
efficiencies, quality enhancements and cost reductions during the product
life.
. Maintain Industry and Customer Diversity. Uniphase sells its laser
subsystems to numerous OEMs in the biotechnology, measurement systems,
semiconductor equipment and graphics and printing system industries, which
reduces the Company's vulnerability to a downturn in any specific industry
or company. The Company has also increased the diversity of its industry
and customer base by leveraging its expertise in laser technology to
develop products for the semiconductor capital equipment and
telecommunications equipment markets.
PRODUCTS AND MARKETS
The Company offers optoelectronic products in three principal product
families: laser subsystems, semiconductor capital equipment and fiber optic
telecommunications equipment products. The Company's laser subsystems were the
Company's initial product offering and these operations have enabled the
Company to invest in the further development of its laser technology and to
offer new applications products. In fiscal 1994, the Company first shipped its
Ultrapointe System for defect examination and analysis of semiconductor
wafers. In May 1995, the Company acquired UTP to provide high-speed external
modulators and transmitters for the fiber optic networks in the long-haul
telecommunications and CATV industries. In May 1996, the Company acquired UFP,
which custom packages laser diodes, LEDs and photodetectors for OEMs for use
in fiber optic networks for local telecommunications and data communications.
The following table sets forth the Company's net sales by product family in
fiscal years 1994 and 1995 and for the nine months ended March 31, 1995 and
1996.
<TABLE>
<CAPTION>
NET SALES
-----------------------------------
FISCAL YEAR ENDED NINE MONTHS ENDED
JUNE 30, MARCH 31,
----------------- -----------------
PRODUCT CATEGORY 1994 1995 1995 1996
- ---------------- -------- -------- -------- --------
(IN THOUSANDS)
<S> <C> <C> <C> <C>
Laser Subsystems........................... $ 30,558 $ 33,837 $ 25,026 $ 25,972
Semiconductor Capital Equipment............ 2,364 7,428 5,120 12,536
Telecommunications Equipment (1)........... -- 1,017 -- 8,834
-------- -------- -------- --------
$ 32,922 $ 42,282 $ 30,146 $ 47,342
</TABLE>
- --------
(1) The Company first entered the telecommunications equipment market through
the acquisition of UTP in a transaction accounted for as a purchase on May
15, 1995. As a result, telecommunications equipment net sales for fiscal
1995 reflect the inclusion of UTP operations from May 15, 1995 through
June 30, 1995.
LASER PRODUCTS
Background
Today, lasers are used in a variety of applications in the biotechnology,
semiconductor, consumer electronics, graphic arts and industrial process
control and measurement industries. For example, in the biotechnology field,
lasers are incorporated in flow cytometers, which identify and analyze
biological cells, in
29
<PAGE>
DNA sequencers, which measure and identify DNA patterns, and in certain
surgical instruments. In the semiconductor field, lasers are used to perform
automated test and measurement functions. In consumer electronics markets,
lasers are an enabling technology in laser printers and compact disc players.
In the industrial process control and measurement field, lasers are used for
bar code scanning.
The principal factors that distinguish different types of lasers and
determine the particular laser suitable for a specific application are
wavelength (color), cost, operating life and output power, which is measured
in terms of watts ("W") or milliwatts ("mW"). Lasers are capable of emitting
light from low frequency, long wavelength (greater than 700 nm) infrared light
through the visible spectrum to high frequency, short wavelength (less than
400 nm) ultraviolet light. For example, the wavelength of the laser is of key
importance in causing the fluorescence of dyes in biotechnology applications.
In addition, laser light at shorter green and blue wavelengths is capable of
being focused to smaller, more intense points of light, enabling higher
resolution optoelectronic applications, such as semiconductor wafer
inspection.
Four types of lasers commonly available today are gas, liquid, semiconductor
diode and solid state, each of which derives its classification from the
lasing material it uses. Examples of gas lasers include argon lasers used for
biotechnology applications and carbon dioxide lasers used for industrial
welding applications. Liquid dye lasers are sold primarily in research
markets. Semiconductor diode lasers are used in CD players and in
telecommunications equipment.
The Company believes that solid state lasers will ultimately address all of
the applications currently served by gas lasers and that new applications for
lasers, such as marking and micromachining, will be made possible by solid
state technology. Solid state lasers use a solid material such as crystal,
glass or certain fibers as their lasing medium and, in some cases, use a
semiconductor diode laser as the energy source to stimulate their lasing
medium. While infrared solid state lasers are commercially available, shorter
wavelength green and blue solid state lasers have been commercialized on a
very limited basis to date due to cost and performance issues. The Company
believes that further development of green and blue solid state lasers may
lead to significant market opportunities for these shorter wavelength laser
subsystems. In order to provide its customers with the benefits of the smaller
size and the improved efficiency of solid state lasers, the Company is
developing microlaser products.
Laser Subsystems Markets and Products
Uniphase's principal laser subsystem products consist of air-cooled argon
gas laser subsystems, which generally emit blue or green light, Helium Neon
("He-Ne") laser subsystems, which generally emit red or green light and solid
state lasers, which generally emit infrared, blue or green light. These
systems consist of a combination of a laser head containing the lasing medium,
power supply, cabling and packaging, including heat dissipation elements.
Uniphase's principal laser subsystem products and representative applications
include:
<TABLE>
<CAPTION>
LASER TYPE WAVELENGTH POWER PRICE RANGE (1) PRINCIPAL APPLICATIONS
---------- ----------- ---------------- --------------- ------------------------------
<S> <C> <C> <C> <C>
Gas:
He-Ne 633 nm 1-25 mW $50-$1,500 CAE Photoplotting
Argon 458-515 nm 3-75 mW $2,500-$12,000 Capillary Electrophoresis
Color Separation
Solid State:
Microlaser 473-1064 nm 5-50 mW $4,000-$9,000 Direct-to-Plate Printing
DNA Sequencing
Flow Cytometry
Particle Counting
Semiconductor Wafer Inspection
Stablelight 1064 nm Up to 4W $15,000-$20,000 Spectrometry
Daylight 349-1064 nm Up to 1mJ pulsed $30,000-$40,000 Micromachining
Marking
</TABLE>
- --------
(1) Product prices vary depending on order volume, power output and other
customer requirements and configurations.
30
<PAGE>
The overall market for gas lasers is mature and is expected to decline as
technology transitions from conventional lasers, including gas and liquid, to
solid state lasers, which the Company expects to be the primary laser
technology in the future. In comparison to gas lasers, solid state lasers are
smaller and use less power. Sales of the Company's argon gas lasers have
increased in recent years primarily as a result of increased sales of such
products for use in biotechnology and semiconductor applications. Use of He-Ne
gas lasers has substantially declined as most customers are now using
semiconductor diode lasers to satisfy bar code scanning applications.
Uniphase introduced a series of green wavelength solid state microlasers in
May 1994. The Company is in the late stage of development of blue wavelength
solid state lasers and, in fiscal 1996, the Company has shipped such lasers to
certain customers for evaluation purposes. These products consist of a power
supply and an infrared diode laser coupled to a proprietary crystal structure
contained in a temperature controlled housing. The Company believes that these
products will ultimately address the principal markets currently served by
Uniphase's argon laser products. The Company also believes that the reduced
size and power requirements of these microlasers will permit new applications
for these products, although no assurance can be given that these microlasers
will achieve commercial acceptance for use in existing or any new
applications.
Uniphase introduced a series of continuous wave and pulsed infrared solid
state laser systems at the Conference on Laser and Electro-Optics in May 1995.
These products consist of a power supply and a number of high power diodes or
diode arrays coupled to a proprietary crystal structure in a stable mechanical
structure. The continuous wave product, Stablelight, produces up to 4W of
infrared power and is principally used by customers in industrial process
control and measurement applications. The Daylight product produces pulses up
to 1 milli-Joule ("mJ") and is designed for customers with micromachining or
marking requirements.
SEMICONDUCTOR CAPITAL EQUIPMENT PRODUCTS
Background
Technological advances and demands for increasing levels of performance have
led the semiconductor industry to develop more complicated devices with
increasingly smaller geometries. A current state-of-the-art microprocessor may
have four million transistors per square centimeter, four or five "wiring"
levels and require 400 process steps during its manufacture, providing ample
opportunities for particle contamination to occur on the wafer and cause
defects. As semiconductor feature sizes decrease, devices become increasingly
susceptible to smaller defects during their manufacture. It has been estimated
that 80% of the loss of manufacturing yield is caused by particle
contamination that occurs on the wafer during the manufacturing process.
One of the semiconductor industry's responses to the increasing
vulnerability of semiconductor devices to smaller defects has been to employ
defect detection and inspection that is closely linked to the manufacturing
process. Semiconductor process engineers monitor their processes more closely,
identifying defects and their origins in order to reduce their recurrence and
maintain and improve process yields. Presently, automated inspection systems
such as those manufactured by Tencor and KLA are used on-line to detect and
locate defects as small as 0.1 micron. A single wafer may be inspected
numerous times during its progression through manufacturing. These on-line
detection systems use advanced image processing and innovative laser scanning
technologies to achieve high sensitivity and speed.
Detecting the presence of defects is only the first step in preventing their
recurrence. After detection, the defects must be examined in order to identify
their size, shape and the process step in which the defect occurred. This
examination is called "defect classification." The resulting description of
the defects is then added to a computer database. This database is used to
monitor defect trends and to pinpoint the sources of defects and contaminating
particles to specific process steps or pieces of equipment. Identification of
the sources of defects in the lengthy and complex semiconductor manufacturing
process has become essential for maintaining high yield production.
While automated inspection systems have progressed to being able to detect
submicron defects, the conventional optical microscopes that have
traditionally been used for defect classification are not capable of
31
<PAGE>
examining such defects. With a state-of-the-art, conventional optical
microscope, a 0.3 micron defect, which is nearly the entire minimum feature
size of today's microprocessor, appears only as a dark speck. Further, certain
types of defects that are embedded in or under films created during gas phase
semiconductor manufacturing processes are not currently observable by such
microscopes. Other very shallow defects, which are often only 0.1 micron high
and which may occur during the chemical mechanical polishing ("CMP") process,
are also not observable by conventional microscopes.
The Ultrapointe System Solution
The Company established its Ultrapointe subsidiary in fiscal 1992 and began
shipping Ultrapointe Systems in fiscal 1994. The Ultrapointe System is a laser
imaging system ("LIS") that is capable of examining microscopic defects with
the ease and speed of conventional microscopes while also offering increased
resolution and the ability to provide three-dimensional ("3-D") images. This
system combines state-of-the-art high speed laser scanning technology, real-
time confocal imaging and digital image reconstruction to allow for 3-D
imaging of semiconductor defects as small as 0.1 micron. The Ultrapointe
System works in conjunction with automated inspection systems from vendors
such as Tencor and KLA to enable semiconductor manufacturers to more
accurately identify and classify defects. This defect examination and analysis
procedure enables semiconductor manufacturers to improve yields by identifying
and containing process problems. Ultrapointe Systems operate in the
manufacturing clean room, adjacent to automated inspection systems, and can in
seconds produce detailed images of defects even when they are very small or
embedded or buried in films. The Company believes that its Ultrapointe System
is the only currently available, non-destructive wafer inspection tool with
increased resolution and 3-D imaging capabilities that is capable of both
examining certain sub-surface wafer defects and accurately analyzing the
sources of defects.
The following diagram illustrates the stages in the wafer manufacturing
process in which the Company's Ultrapointe Systems are designed to function in
an on-line capacity:
The diagram appearing on page 32 of the Prospectus depicts a semiconductor
wafer prior to defect examination, analysis and classification by the Company's
Ultrapointe System. Next to the wafer is a drawing of an Ultrapointe System
unit; there is a drawing of a finished wafer underneath, having undergone defect
examination by the Ultrapointe System.
32
<PAGE>
The Ultrapointe System utilizes an optical technique called scanning laser
confocal microscopy. This technique uses, through high power microscopic
optics, an argon laser as an intense light source to scan a wafer's surface
numerous times. The return signal from the laser is processed by the system's
computer workstation, which provides a complete topological image of the
wafer's surface at the system's console and can display in a high resolution
format defects as small as 0.1 micron. Typical magnifications afforded by
Ultrapointe Systems approximate 35,000x, as compared with conventional white
light microscopes upper magnification limits of approximately 6,000x. Through
software developed by the Company, the system's workstation can also evaluate
and classify defects, communicate with automated inspection systems and store
images and other data.
The Company currently offers two versions of its Ultrapointe System, the
Ultrapointe LIS 500, which has a base list price of $275,000, and the
Ultrapointe LIS 1010, which has a base list price of $368,000. These products
differ primarily in the degree of software image manipulation available to the
operator. The systems can also be tailored, through software, to interface
with various automated inspection systems and local area networks. The
Ultrapointe LIS 500 includes full wafer automation and handling and a Silicon
Graphics workstation. The images available include a conventional, real time
white light microscopy image, real time laser confocal "slices" and a multiple
slice top view of the wafer surface and defect. The full resolving power of
the laser images is available and surface, embedded and buried defects can be
viewed. This product can be upgraded at any time with advanced two dimensional
("2-D") and 3-D imaging accessories. The Ultrapointe LIS 1010 incorporates all
of the features of the Ultrapointe LIS 500 while using a more advanced version
of the Silicon Graphics workstation.
The Ultrapointe System currently requires a human operator to classify
defects. In May 1996, the Company introduced its Identifier software product,
an optional feature that provides automatic defect classification capability
for Ultrapointe Systems. Working in conjunction with the Ultrapointe System,
the Identifier software automates the defect classification process, thereby
improving the precision and repeatability of defect classification. The
ability to review defects using ADC software is becoming increasingly
important to semiconductor manufacturers as it facilitates defect
classification without direct operator evaluation at each defect site. This
automation can improve reliability and consistency by eliminating operator-
induced variations. In addition, such automation helps speed analysis of the
vast amounts of defect data and classifications necessary for yield
enhancement programs. The Company developed the Identifier software using
technology licensed from ISOA, Inc. and in cooperation with the semiconductor
industry consortium, SEMATECH. The Identifier has a base list price of
$150,000.
In November 1995, the Company entered into a three-year agreement with
Tencor under which Tencor became the exclusive OEM reseller for the Company's
Ultrapointe Systems and the Identifier, the Company's ADC software product.
Under the Agreement, Tencor will distribute the Ultrapointe System under its
own label worldwide and has the responsibility for installation and service of
the systems it sells. The Company retains the right to distribute its products
through its own channels. The Agreement includes a license providing Tencor
with certain ADC technology and payments to the Company to accelerate ADC
development.
TELECOMMUNICATIONS EQUIPMENT PRODUCTS
UTP Background
Fiber optic cable is gaining widespread acceptance in upgrades and new
installations of CATV and telecommunications systems worldwide. The use of
fiber optic cable results in vastly improved performance, flexibility,
reliability and lower installation and operating costs when compared to
traditional copper and coaxial cable. Moreover, technological innovation and
market forces are creating increased demand for communication transmission
systems with multiple delivery capability and higher performance and
reliability features. Further, telecommunications interexchange carriers are
being required to provide higher speed data transmission over longer lengths
of installed optical fiber between electronic repeater stations. Due to the
high cost of new fiber installations, interexchange carriers seek to utilize
the installed fiber base to the greatest extent possible. In the CATV
industry, consolidation has resulted in a smaller number of multiple system
operators controlling larger networks. These operators, who compete with other
technologies such as direct broadcast satellite television, are upgrading
their systems and seek economical solutions that will increase their network
flexibility and reliability.
33
<PAGE>
The flexibility and performance of fiber optic systems has been enhanced
through the use of two types of signal encoding techniques: direct modulation
and external modulation. In direct modulation, the light output from a diode
laser is switched on and off to generate a signal, similar to the operation of
a flashlight. This frequent switching, however, causes wavelength instability,
which limits the distance of transmission before signal regeneration is
required. Further, the diode lasers used in direct modulation have limited
power and modulation rate, thereby constraining the performance of the signal
transmission system. In external modulation, the light output of a
continuously powered laser is switched in a separate crystal of lithium
niobate. Light from the laser travels along waveguides patterned into lithium
niobate crystals and electrical signals applied to electrodes alongside the
waveguides encode the signal onto a light beam for transmission in the optical
fiber. As compared to direct modulation, external modulation has the following
advantages:
. Longer Distances in Telecommunications. External modulators enable signal
transmission over longer distances in telecommunications systems before
signal regeneration is required. External modulation thereby reduces the
required number of expensive repeaters or amplifiers, which are a
significant cost in transmission systems.
. Higher Capacity in Telecommunications. External modulation is being used
by equipment suppliers that are developing transmission hardware
incorporating wavelength division multiplexing ("WDM"). WDM is capable of
increasing the capacity of a fiber route up to 16 times without upgrading
to more expensive electronic multiplexing/demultiplexing equipment. WDM
is compatible with the large installed base of fiber optic networks and
can be used to increase significantly the data carrying capacity of such
networks. External modulators also enable higher data rates (e.g. OC-192
or 10 Gbps) to be effectively transmitted over long distances.
. Longer Distances and Higher Fidelity in CATV. External modulators operate
at higher laser power and therefore allow signals to be transmitted over
longer distances without detection and retransmission. In addition,
external modulation provides inherently higher fidelity because of lower
laser noise and low noise susceptibility to optical system reflections,
such as those arising from existing fiber optic connections. External
modulators are fully compatible with CATV distribution systems that
utilize fiber optical amplifiers.
UTP Products and Markets
In May 1995, the Company purchased UTP, which designs, develops,
manufactures and markets high-speed external modulators and transmitters for
fiber optic networks in the CATV and telecommunications industries. The
Company acquired UTP as part of its strategy to pursue selected opportunities
where optoelectronic technology converges on specific market needs which have
not been adequately addressed by conventional electronic solutions.
The Company produces lithium niobate integrated optic modulators by using
its proprietary Annealed Proton Exchange (APE(R)) fabrication process. The
Company believes that this process produces modulators which have higher
optical power handling, and inherently better fidelity as compared with
competing external modulators. The Company also sells customized external
modulators for a variety of customer applications.
The Company's principal modulator products include:
<TABLE>
<CAPTION>
TYPE WAVELENGTH APPLICATION
- ---- ---------------- ------------------------------
<S> <C> <C>
CATV Modulators................ 1300 nm, 1550 nm CATV Super Trunk Transmitter
2.5 Gbps Digital Modulators.... 1300 nm, 1550 nm OC-48 Telecommunications
Microwave and Radio Frequency
Modulators.................... 1300 nm, 1550 nm Antenna Links, Radar, Cellular
</TABLE>
34
<PAGE>
UTP began to supply turn-key externally modulated CATV transmitters to CATV
OEMs in September 1995. These transmitters incorporate a continuous-wave diode
laser, a lithium niobate modulator and patented electronic linearity and
control circuitry. The Company routinely customizes its transmitter to the
specifications of the OEM customer. The Company also resells optical fiber
amplifiers as part of providing complete optical transmission functionality to
OEMs.
The principal applications addressed by the Company's telecommunications
equipment products are as follows:
. Cable. The principal cable television applications addressed by the
Company are externally modulated transmitters for trunk-line
applications. These transmitters operate at the preferred optical
wavelength of 1550 nm. They incorporate high power (>20 mw) diode lasers
and the Company's modulators to provide high optical powers for the
transmission of broadcast television signals over long distances. In
addition, they are compatible with existing optical amplifier technology,
which allows the transmission distance or the subscriber area to be
increased. The Company's modulated transmitters are designed for use in
broadband systems, are operational over bandwidths of up to 1 Ghz and are
compatible with hybrid fiber coax ("HFC") systems being developed by
certain telecommunications equipment providers for the transmission of
voice, data and video.
. Long-Haul Telecommunications. The principal long-haul telecommunications
application addressed by the Company is a 2.5 Gbps transmission system
for long distance telephone interexchange carriers. The Company's
external modulators are used in these systems to significantly increase
the space between repeaters in such systems. The Company's modulators
allow the transmission of up to 32,000 phone conversations over a single
fiber to switching sites across distances of up to 350 miles. In
addition, the Company's external modulators are well suited for WDM
applications at 2.5 Gbps. In such applications, multiple wavelength
telecommunications signals are transmitted over the same fiber, thereby
multiplying the capacity of the fiber cable system. Telecommunications
customers are presently deploying systems with four and eight separate
wavelengths in order to accommodate 10 Gbps and 20 Gbps, respectively,
using UTP's OC-48 modulators. The Company is also developing a higher
speed modulator to provide similar capability at 10 Gbps (OC-192 data
rate).
. Wireless Antenna Links. The rapid growth of wireless communication
systems is producing many deployment situations where the antenna must be
located a significant distance from the telephone base station. The
Company's modulators are well suited for fiber optic transmitter systems
to carry RF signals from the antenna in cellular systems to base
stations.
. Specialty Products and Markets. In May 1996, UTP entered into an
agreement with Sanders, a Lockheed Martin Company, to develop and produce
fiber optic transmitters for the United States government to be installed
on high performance aircraft. Additional applications for the Company's
integrated optic modulators include fiber optic gyroscopes ("FOGs"),
analog RF fiber optic systems and laboratory and research and development
activities. The Company is a leading commercial supplier of multi-
function integrated optic signal processing chips for FOGs. FOGs are
intended for use in commercial aviation, military/aerospace and
industrial applications. The Company also offers a variety of integrated
optic modulators and switches for use at frequencies up to 20 Ghz that
are being used in a large variety of industrial, government and
university research and development programs.
UFP Products and Markets
In May 1996, the Company acquired UFP which custom packages laser diodes,
LEDs and photodetectors for OEMs for use in fiber optic networks. UFP uses its
proprietary technologies of epoxy-based attachment and laser welding to attach
fiber ("pigtailing") to these optoelectronic components in a variety of
configurations to meet the specific needs of its OEM customers.
35
<PAGE>
The principal applications addressed by UFP are as follows:
. Data communications. The ever-increasing use of computer networks is
fueling a growth in fiber data communications systems. Fiber offers
advantages over copper-wire links that include longer distance
transmission, higher data rates, ease of multiplexing, and immunity from
electromagnetic interference. UFP offers custom packaged optical sources
and detectors for a variety of fiber-based data communications
applications such as single-fiber Ethernet and Token Ring.
. Local telecommunications. Low-cost laser diodes are used in the feeder
and loop portions of the local telephone network to accommodate various
data rates. The Company supplies custom packaged components to
telecommunications equipment manufacturers. For example, UFP supplies
custom laser-diode submodules for use as optical sources and detectors in
SONET OC-3 (155 Mbps) networks.
. Specialty Markets. UFP products are well suited for several specialty
markets such as fiber optic test and measurement equipment, fiber optic
sensors and military and aerospace data communications applications. For
example, the Company pigtails red diode lasers for use in hand-held fiber
optic fault locators.
SALES AND MARKETING
Uniphase markets its laser subsystem products principally to OEMs through
its own sales force in the United States, United Kingdom and Germany and
through a worldwide network of representatives and distributors to service
smaller domestic accounts, including those in the research and education
markets. The Company's sales and marketing strategy for its laser subsystem
products is to establish long term relationships with its OEM customers at the
early design-in phase of its laser subsystems into customers applications and
through high levels of customer service and support. The following chart sets
forth the Company's principal OEM customers for laser subsystems by
application:
<TABLE>
<CAPTION>
INDUSTRIAL PROCESS
CONTROL AND WAFER INSPECTION
BIOTECHNOLOGY INSTRUMENTS MEASUREMENT INSTRUMENTS SYSTEMS GRAPHICS AND PRINTING SYSTEMS
- ------------------------- ----------------------- ------------------ -----------------------------------------------
<S> <C> <C> <C>
Applied Biosystems Allen-Bradley Co. ADE Corporation Crosfield Electronics Ltd.
Beckman Instruments ASM Lithography, B.V. Nikon Corporation Gerber Systems Corporation
Coulter Corporation Canon Tencor Instruments Optronics, a division of Intergraph Corporation
Molecular Dynamics ICL Plc Purup Pre-Press A/S
Ortho Diagnostic Systems Scitex Corporation Ltd.
</TABLE>
One laser subsystems customer, the Applied Biosystems Division of Perkin-
Elmer Corporation, accounted for approximately 11%, 12%, 12% and 13% of the
Company's net sales for fiscal years 1993, 1994, 1995, and the nine months
ended March 31, 1996, respectively. In addition, in the nine months ended
March 31, 1996, Tencor accounted for 11% of the Company's sales through the
purchase of both laser subsystems and Ultrapointe Systems. A reduction or
delay in orders from these customers could adversely affect the Company's
results of operations. In addition, another laser subsystem customer accounted
for 10% of net sales in both fiscal years 1993 and 1994. See Note 12 of Notes
to Consolidated Financial Statements.
Uniphase markets its Ultrapointe Systems through Tencor's worldwide
distribution channels and a network of four independent sales representatives
in the United States and Canada. In Japan, the Company has a distribution
agreement with Tencor and Innotech Corporation for sales to Japan's
semiconductor industry. In Europe and the Pacific Rim, the Company distributes
its products through Tencor; however, the Company has the right to market its
products through its own distribution channels.
36
<PAGE>
As of March 31, 1996, the Company had sold 63 Ultrapointe Systems in the
United States, Japan and Korea. Customers for the Company's Ultrapointe System
include:
American Microsystems Micron Technology*
Analog Devices Microunity
Applied Materials Motorola*
Digital Equipment Corporation* Philips Semiconductors*
Fujitsu, Ltd.* Samsung*
IBM Corporation* SEMATECH
Intel* Sony Corporation
LSI Logic Corporation* Toshiba*
Lucent Technologies* (formerly AT&T) VLSI Technology*
L.G. Semicon VTC
Matsushita Electric* Yamaha Corporation
--------
* Indicates customers that have purchased multiple Ultrapointe Systems.
UTP markets its telecommunications equipment products to OEMs through its
own direct sales force and is in the process of establishing a sales office in
Chalfont, Pennsylvania. In addition, UTP sells such products through
distributors in Europe, Australia, Japan and Taiwan. Customers for the
Company's telecommunications equipment products include Ericsson Raynet and
Harmonic Lightwaves.
CUSTOMER SUPPORT AND SERVICE
The Company believes that a high level of customer support is necessary to
successfully develop and maintain long term relationships with its OEM
customers in its laser subsystems and telecommunications equipment businesses.
This close relationship begins at the design-in phase and is maintained as
customer needs change and evolve. The Company provides direct service and
support to its OEM customers through its offices in the United States. The
Company's European laser subsystem customers are serviced through its sales
and support offices in the United Kingdom and Germany. In Japan, the Company's
laser subsystems distributor, Autex, assists in performing support and service
functions. The Company provides support through both on-site customer service
and telephone support from its various facilities that perform sales and
service functions. The Company generally warrants all of its laser products
for a period of one year from the date of shipment. Certain argon lasers carry
warranties based on hours of use.
A high level of customer support is also necessary when providing production
instrumentation for the semiconductor industry. Tencor and all distributors of
Ultrapointe Systems are responsible for sales, installation, warranty and
post-warranty support. Ultrapointe Systems generally carry a one-year warranty
from the date of installation or fifteen months from shipment, whichever
occurs first. Service contracts are available for system support after the
warranty period.
RESEARCH AND DEVELOPMENT
During fiscal years 1993, 1994, 1995 and the nine months ended March 31,
1996, Uniphase spent $2.0 million, $3.1 million, $3.7 million, and $4.1
million, respectively, on research and development. In fiscal 1995, Uniphase
incurred charges totaling $4.5 million for acquired in-process research and
development, most of which were incurred in connection with the acquisition of
UTP. The Company expects to incur an estimated charge of $4.5 million for
acquired in-process research and development in connection with the
acquisition of UFP in the quarter ending June 30, 1996. In fiscal 1996, the
Company's laser research and development efforts will focus primarily on the
continued development of solid state lasers. These programs are supported up
to $1.4 million by an award from the Advanced Technologies Program of the
Department of Commerce which expires in
37
<PAGE>
December 1996. The Company also has development and licensing agreements with
Stanford University and the University of St. Andrews, Scotland which give the
Company the right to manufacture and sell certain next generation laser
products being developed by these universities. If the Company manufactures
such products, it will be required to pay the universities certain royalties
based on sales of the products.
The Company continues to devote substantial research and development
resources to its Ultrapointe Systems product line. These efforts focus on the
Company's Identifier software product and the enhancement of laser images. In
addition to the Identifier, the Company is also exploring a number of methods
to improve the resolution of the scanning laser confocal microscopy technique
used in the Ultrapointe System and, in particular, the Company is currently
working with a leading semiconductor manufacturer to enable the Ultrapointe
System to examine semiconductor masks.
The Company is developing new and enhanced telecommunications equipment
products and enhancing its manufacturing capability for telecommunications
equipment products. For example, higher performance modulators and
transmitters are under development, as are advanced multi-gigabit modulators.
In manufacturing, the Company is developing improved CAD design tools and
advanced modulator packages. The Company also participates in two national
consortia: the Analog Optoelectronics Module Consortium, which seeks to
develop new and cost-effective RF and microwave transmitters and receivers,
and the National Transparent Optical Network Consortium, which is involved in
advanced high capacity WDM fiber optic communications components and networks.
MANUFACTURING
The Company manufactures its argon laser subsystems and related power
supplies at its San Jose, California facility and its He-Ne lasers at its
Manteca, California facility. The Company assembles and tests its Ultrapointe
Systems and manufactures initial systems of its microlasers at its San Jose,
California facility. The Company's modulator products are manufactured at its
facility in Bloomfield, Connecticut (where it is expanding a clean room) and
its transmitters are manufactured in Chalfont, Pennsylvania. UFP products are
manufactured at the Company's facilities in Witney, United Kingdom and
Batavia, Illinois. The Company manufactures its Stablelight and Daylight solid
state laser subsystems products at its I.E. Optomech Ltd. subsidiary located
in the United Kingdom. The Company has purchasing, materials management,
assembly, final testing and quality assurance functions at each location for
the products that are manufactured at that facility.
The manufacture of the Company's laser subsystems, Ultrapointe Systems and
telecommunications equipment products is a highly complex and precise process,
requiring production in a highly controlled environment. The Company maintains
a newly expanded 2,000 square foot class 100 clean room in which all
Ultrapointe System assembly takes place. Systems are tested and then packaged
for direct shipment into a customer's clean room. Changes in the Company's or
its suppliers' manufacturing processes or the inadvertent use of defective or
contaminated materials by the Company or its suppliers could adversely affect
the Company's ability to achieve acceptable manufacturing yields and product
reliability. To the extent the Company does not achieve such yields or product
reliability, its operating results and customer relationships would be
adversely affected.
The raw materials and sub-components which the Company requires for the
manufacture of its products are generally available from several sources. The
Company purchases some raw materials and components from single sources, but
has no reason to believe it could not purchase such materials and components
from alternative sources of supply on comparable terms. The Company obtains
all the robotics, workstations, and many optical components used in its
Ultrapointe Systems from Equipe Technologies, Silicon Graphics, Inc., and
Olympus Corporation, respectively. The Company currently utilizes a sole
source for the crystal semiconductor chip sets incorporated in its solid state
microlaser products and acquires its pump diodes for use in its solid state
laser products from SDL Inc., Opto Power Corporation and GEC. Certain of these
companies also manufacture products that compete with those of the Company.
The Company obtains lithium niobate wafers and specialized fiber components
used in its telecommunications products from primarily Crystal Technology,
Inc. and Fujikura
38
<PAGE>
Ltd., respectively. From time to time, the Company has experienced delays in
obtaining raw materials and components. However, to date such delays have not
materially affected its operations. The Company does not have long-term volume
purchase agreements with any of these suppliers, and no assurance can be given
that these components will be available in the quantities required by the
Company, if at all.
COMPETITION
The industries in which the Company sells its products are highly
competitive. Uniphase's overall competitive position depends upon a number of
factors, including the price and performance of its products, the level of
customer service and quality of its manufacturing processes, the compatibility
of its products with existing laser systems and Uniphase's ability to
participate in the growth of emerging technologies, such as solid state
lasers. In the argon laser market, Uniphase primarily competes with American
Laser, Coherent, Ion Laser Technology, NEC, Omnichrome, Spectra-Physics,
Toshiba and Carl Zeiss. In the He-Ne laser market, Uniphase considers Melles-
Griot, NEC and Carl Zeiss to be its primary competitors. In the solid state
laser markets, Uniphase's competitors include Coherent, Hitachi, IBM,
Lightwave, Opto Power Corporation, Philips, SDL, Inc., Siemens and Sony.
Significant competitive factors in the market for Ultrapointe Systems
include specific system performance, cost of ownership, support and
infrastructure and the ability to interface to existing automated inspection
systems and local area networks. Ultrapointe Systems compete with the
following three types of devices: scanning electron microscopes, conventional
white light microscopes and laser confocal microscopes. The Company believes
that its principal competitors include Amray, Hitachi, JEOL, Kinetek,
Kensington, Lasertech, Leica, Nidek, Nikon, Stahl Research and Carl Zeiss.
Competitive factors in the market for the Company's telecommunications
equipment products include price, product performance and reliability, the
capability to provide strong customer support and service, customer
relationships and the breadth of product line. In this market, the Company
faces competition from companies that have substantially greater financial,
engineering, research, development, manufacturing, marketing, service and
support resources, greater name recognition than the Company and long-standing
customer relationships. With respect to modulator products for CATV and
telecommunications equipment suppliers, the Company's competitors include AT&T
Micro Electronics, Crystal Technology, Inc., Fujitsu, Integrated Optical
Components, Ltd. and Sumitomo Cement Opto Electronics Group. With respect to
CATV 1550 nm transmitters for supply to OEMs, the Company's competitors
include AEL, Harmonic Lightwave, Kablerhydt, Ortel, Synchronous Communications
and PAi. Other CATV equipment suppliers may also enter this market. With
respect to laser diode products for data communications and local
telecommunications equipment suppliers, the Company's competitors include Oz
Optics and SDL-Optics as well as larger optoelectronic suppliers such as AMP
and Hewlett-Packard. Potential new technologies may also emerge to compete
with the Company's products, such as electro-absorption modulators that are
being introduced for long-haul telecommunications.
PATENTS AND PROPRIETARY RIGHTS
The Company holds 30 United States patents and certain corresponding foreign
patents on the technologies related to its products and processes. The United
States patents expire on dates ranging from 1999 to 2014. The Company has
applied for additional patents related to its solid state laser products, its
Ultrapointe Systems (three of which were recently issued) and its
telecommunications products. The Company has also acquired several patent
licenses involving areas such as end-pumped solid state lasers, diode-pumped
blue light lasers and waveguides.
The laser, semiconductor equipment, CATV and telecommunications industries
in which the Company sells its products are characterized by frequent
litigation regarding patent and other intellectual property rights. Numerous
patents in these industries are held by others, including academic
institutions and competitors of the Company. Such patents could inhibit the
Company's ability to develop new products for such markets. From time to time,
the Company has received notices claiming that it has infringed third-party
patents or other
39
<PAGE>
intellectual property rights. While in the past licenses generally have been
available to the Company where third-party technology was necessary or useful
for the development or production of the Company's products, there can be no
assurance that licenses to third-party technology will be available on
commercially reasonable terms, if at all. Generally, a license, if granted,
would include payments by the Company of up-front fees, ongoing royalties or a
combination thereof. There can be no assurance that such royalty or other
terms would not have a significant adverse impact on the Company's operating
results. The Company is a licensee of a number of third party technologies and
intellectual property rights and is required to pay royalties to these third
party licensors on certain of its products, including its Ultrapointe Systems
and its solid state lasers. In fiscal 1995 and in the nine months ended March
31, 1996, the Company expensed $1.2 million and $1.2 million, respectively, in
license and royalty fees primarily in connection with its gas laser
subsystems. In addition, there can be no assurance that third parties will not
assert claims against the Company with respect to its existing products or
with respect to future products under development by the Company. In the event
of litigation to determine the validity of any third-party claims, such
litigation could result in significant expense to the Company and divert the
efforts of the Company's technical and management personnel, whether or not
such litigation is determined in favor of the Company. In the event of an
adverse result in any such litigation, the Company could be required to expend
significant resources to develop non-infringing technology or to obtain
licenses to the technology which is the subject of the litigation. There can
be no assurance that the Company would be successful in such development or
that any such licenses would be available to the Company. In the absence of
such a license, the Company could be enjoined from future sales of the
infringing product or products. In fiscal years 1992 and 1993, the Company
incurred substantial legal expenses in connection with a patent infringement
action relating to the Company's current gas laser subsystems brought by
Spectra-Physics Lasers, Inc. ("Spectra-Physics"). While the Spectra-Physics
case has since been settled, no assurance can be given that, in the future,
the Company will be able to avoid similar actions by competitors or others or
not be forced to initiate its own actions to protect its proprietary position.
BACKLOG
Backlog consists of written purchase orders for products for which the
Company has assigned shipment dates within the following 12 months. As of
March 31, 1996 the Company's backlog was approximately $15.7 million, as
compared with a backlog of approximately $6.1 million at March 31, 1995.
Orders in backlog are firm, but are subject to cancellation or rescheduling by
the customer. Because of possible changes in product delivery schedules and
cancellation of product orders and because the Company's sales will often
reflect orders shipped in the same quarter that they are received, the
Company's backlog at any particular date is not necessarily indicative of
actual sales for any succeeding period. Certain of the Company's laser
subsystems customers are adopting "just in time" techniques with respect to
ordering the Company's products, which will cause the Company to have shorter
lead times for providing products. Such shorter lead times are likely to
result in lower backlog.
EMPLOYEES
At March 31, 1996, the Company had a total of 328 full-time employees,
including 61 in research, development and engineering, 39 in sales, marketing
and services, 189 in manufacturing, and 39 in general management,
administration and finance. The Company intends to hire additional personnel
during the next 12 months in each of these areas. The Company's future success
will depend in part on its ability to attract, train, retain and motivate
highly qualified employees, who are in great demand. There can be no assurance
that the Company will be successful in attracting and retaining such
personnel. The Company's employees are not represented by any collective
bargaining organization, and the Company has never experienced a work
stoppage, slowdown or strike. The Company considers its employee relations to
be good.
40
<PAGE>
FACILITIES
On February 8, 1996, the Company acquired two properties in San Jose,
California, totaling 109,000 square feet, which includes land, buildings and
improvements, for an aggregate purchase price of approximately $11.0 million.
One of the properties is the Company's current principal facility occupied
under an operating lease which would have expired in August 1998. The Company
plans to expand into the additional building. The Company's principal sales,
marketing, technical support, administration, and research and development
operations as well as manufacturing operations for the argon laser and
Ultrapointe products will occupy these facilities. The Company plans to lease
any unused space.
The Company's manufacturing facilities for its He-Ne laser products occupy a
20,000 square foot building in Manteca, California. The building is leased
through September 1997. The Company's facilities for its telecommunications
equipment products occupy a 33,000 square foot leased building in Bloomfield,
Connecticut, where its modulator operations are manufactured and a 18,000
square foot leased building in Chalfont, Pennsylvania where its transmitter
operations are manufactured. UFP products are manufactured at the Company's
7,000 square foot facility in Witney, United Kingdom and its 5,000 square foot
facility in Batavia, Illinois. Leases for the Bloomfield, Chalfont, Witney and
Batavia facilities expire in July 2002 (with a lease extension available
through 2007), February 2001, December 2013, and July 1999, respectively. The
Company also maintains sales and service offices in both the United Kingdom
and Germany to support its European operations.
The Company anticipates capital expenditures for fiscal 1997 of
approximately $4.0 million to support expansion of its current operations,
including the expansion into additional facilities.
41
<PAGE>
MANAGEMENT
EXECUTIVE OFFICERS AND DIRECTORS
The executive officers and directors of the Company and their respective
ages as of the date of this Prospectus are as follows:
<TABLE>
<CAPTION>
NAME AGE POSITION
---- --- --------
<S> <C> <C>
Kevin N. Kalkhoven.................... 52 President, Chief Executive Officer
and Chairman of the Board
R. Clark Harris....................... 59 President of UTP
Dan E. Pettit......................... 49 Vice President, Finance and Chief
Financial Officer
John M. Scott......................... 52 President of Ultrapointe
Ian T. Jenks.......................... 42 President of the Laser Division
William B. Bridges, Ph.D. (1)......... 61 Director
Robert C. Fink (2).................... 61 Director
Catherine P. Goodrich (1)............. 39 Director
Stephen C. Johnson (2)................ 53 Director
Anthony R. Muller (1)(2).............. 53 Director
Wilson Sibbett, Ph.D.................. 48 Director
</TABLE>
- --------
(1) Member of Audit Committee
(2) Member of Compensation Committee
Mr. Kalkhoven has been President and Chief Executive Officer of the Company
since January 1992, a member of the Board of Directors of the Company since
February 1992, and Chairman of the Board since April 1994. From September 1988
to January 1992, Mr. Kalkhoven was President of Demax Software, a systems
software company. From 1986 to August 1988, Mr. Kalkhoven was President and
Chief Executive Officer of AIDA Corporation, a computer aided engineering
company that was acquired in October of 1987 by Teradyne Corporation. Mr.
Kalkhoven is a member of the Board of Directors of Network Express, a
manufacturer of telecommunications equipment.
Mr. Harris joined the Company in May 1995, as President of UTP. Prior to
joining the Company, Mr. Harris held several executive positions with United
Technologies Corporation, most recently as General Manager of United
Technologies Technology Center from 1990 to March 1995. From 1987 to 1989, Mr.
Harris served as Senior Vice President of Sikorsky Aircraft Division.
Mr. Pettit joined the Company as Corporate Controller in March 1986 and has
been Vice President of Finance since November 1986. In June 1994, he became
the Company's Chief Financial Officer. Prior to joining the Company, Mr.
Pettit held the positions of Group Controller and Division Controller at
Burroughs Corporation, where he was employed from 1983 to 1986.
Mr. Scott joined the Company as President of Ultrapointe in April 1994.
Before joining the Company, Mr. Scott held numerous executive positions at
companies in the semiconductor equipment industry, most recently as Vice
President of Sales and Service at Tencor Instruments, a manufacturer of wafer
defect inspection systems, where he was employed from 1987 to 1994.
Mr. Jenks joined the Company as President of the Laser Division in August
1995. Before joining the Company, Mr. Jenks had been serving as a consultant
to the Company since February 1995. Mr. Jenks was the founder and Chief
Executive Officer of I.E. Optomech Ltd., a solid state laser company, until
its acquisition by Uniphase in July 1995. Prior to founding I.E. Optomech, he
was the Chief Executive Officer of the International Projects Division of the
management consulting firm Ingersol Engineers, Inc.
42
<PAGE>
Dr. Bridges has been a member of the Company's Board of Directors since May
1986. He has been a Professor of Electrical Engineering and Applied Physics at
the California Institute of Technology since June 1977 and the Carl F. Braun
Professor of Engineering since 1983. Dr. Bridges served as President of the
Optical Society of America, a nonprofit professional society, in 1988.
Mr. Fink has been a member of the Company's Board of Directors since April
1995. Mr. Fink has served as Senior Vice President of Lam Research since
October 1995. From July 1993 to October 1995, Mr. Fink served as Chief
Operating Officer of Lam Research, following its acquisition of Drytek, Inc.,
where he had served as President since 1988. From 1984 to 1988, Mr. Fink
served as Director of VLSI Operations for ITT Corporation's Semiconductor
Division. Mr. Fink also currently serves on the board of directors of
Consilium Corporation, a publicly held software manufacturer for the
pharmaceutical and semiconductor industries.
Ms. Goodrich has been a member of the Company's Board of Directors since
January 1994. Ms. Goodrich is President of Goodrich Ventures, Inc., a
consulting firm specializing in business development of early stage
electronics companies since June 1992. Prior to establishing her own firm, Ms.
Goodrich was a general partner in Oak Investment Partners, a venture capital
group, from 1981 to 1992. Ms. Goodrich also serves on the board of directors
of Etec Corporation, San Disk Corporation and Zitel Corporation, all publicly
held companies, as well as on the board of directors of several privately held
companies.
Mr. Johnson has been a member of the Company's Board of Directors since
April 1984. He has been President and Chief Executive Officer of Komag
Incorporated, a publicly held supplier of high density computer disks, since
1983. Mr. Johnson also is a director of 3Com Corporation, a local area network
company.
Mr. Muller has been a member of the Company's Board of Directors since
September 1984. Since November 1990, Mr. Muller has served as Senior Vice
President of Operations and Administration and Chief Financial Officer of
Centigram Communications Corporation, a supplier of telecommunications
systems. From March 1985 to July 1990, Mr. Muller was Vice President of
Finance and Chief Financial Officer of Silicon Valley Group, Inc., a
manufacturer of production processing systems for the semiconductor industry.
Professor Sibbett has been a member of the Company's Board of Directors
since February 1995. Professor Sibbett has been Director of Research for the
School of Physics and Astronomy at the University of St. Andrews in Scotland
since 1994. Since 1985, Professor Sibbett has been the head of the School of
Physics and Astronomy at the University of St. Andrews. Professor Sibbett has
been a member of the Science and Engineering Research Council ("SERC") of the
Department of Trade and Industry since 1986 and served as chairman of the SERC
Laser Committee from 1992 to 1994.
All directors hold office until the next annual meeting of shareholders or
until their successors have been elected and qualified. Officers serve at the
discretion of the Board of Directors. There are no family relationships
between any of the directors or executive officers of the Company.
43
<PAGE>
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information known to the Company with
respect to the beneficial ownership of the Company's Common Stock as of May
20, 1996, and as adjusted to reflect the Stock Split and the sale of the
2,000,000 shares of Common Stock offered hereby by the Company, by (i) all
persons who are beneficial owners of five percent (5%) or more of the
Company's Common Stock, (ii) each director of the Company, (iii) the Company's
Chief Executive Officer and each of the other executive officers with annual
compensation in excess of $100,000 for fiscal year 1995, and (iv) all current
directors and executive officers as a group. Unless otherwise indicated, each
of the stockholders has sole voting and investment power with respect to the
shares beneficially owned, subject to community property laws, where
applicable.
<TABLE>
<CAPTION>
PERCENTAGE
NUMBER OF BENEFICIALLY OWNED (2)
SHARES ---------------------------
BENEFICIALLY BEFORE AFTER
BENEFICIAL OWNER OWNED (1) OFFERING OFFERING
- ---------------- ------------ ----------- -----------
<S> <C> <C> <C>
Kopp Investment Advisors, Inc. ..... 1,162,064 8.4% 7.3%
6600 France Avenue South
Suite 672
Edina, MN 55435
The Prudential Insurance Company of 1,012,600 7.3 6.4
America............................
Prudential Plaza
Newark, New Jersey 07102-3777
Kevin N. Kalkhoven (3).............. 437,750 3.1 2.7
Dan E. Pettit (4)................... 120,408 * *
John M. Scott (5)................... 65,131 * *
Ian T. Jenks........................ 60,000 * *
Stephen C. Johnson (6).............. 51,636 * *
Anthony R. Muller (7)............... 49,708 * *
William B. Bridges (8).............. 40,684 * *
Catherine P. Goodrich (9)........... 25,312 * *
R. Clark Harris (10)................ 20,380 * *
Wilson Sibbett (11)................. 6,250 * *
Robert Fink......................... -- -- --
All officers and directors as a 877,259 6.1 5.3
group (11 persons) (12)............
</TABLE>
- --------
* Less than 1% of the outstanding Common Stock.
(1) Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission. In computing the number of shares
beneficially owned by a person and the percentage ownership of that
person, shares of Common Stock subject to options held by that person
that are currently exercisable or exercisable within 60 days of May 20,
1996 are deemed outstanding. Such shares, however, are not deemed
outstanding for the purposes of computing the percentage ownership of
each other person. To the Company's knowledge, except as set forth in the
footnotes to this table and subject to applicable community property
laws, each person named in the table has sole voting and investment power
with respect to the shares set forth opposite such person's name.
(2) Percentage of ownership is based on 13,814,264 shares of Common Stock
outstanding on May 20, 1996.
(3) Includes 427,500 shares subject to stock options exercisable as of July
19, 1996.
(4) Includes 115,032 shares subject to stock options exercisable as of July
19, 1996.
(5) Includes 59,375 shares subject to stock options exercisable as of July
19, 1996.
(6) Includes 5,312 shares subject to stock options exercisable as of July 19,
1996.
(7) Includes 3,312 shares subject to stock options exercisable as of July 19,
1996 and 4,380 shares held by Lesley Muller, Mr. Muller's daughter.
(8) Includes 5,312 shares subject to stock options exercisable as of July 19,
1996.
(9) Includes 25,312 shares subject to stock options exercisable as of July
19, 1996.
(10) Includes 20,380 shares subject to stock options exercisable as of July
19, 1996.
(11) Includes 6,250 shares subject to stock options exercisable as of July 19,
1996.
(12) Includes an aggregate of 667,785 shares subject to stock options
exercisable as of July 19, 1996.
44
<PAGE>
UNDERWRITING
Montgomery Securities, Alex. Brown & Sons Incorporated, Unterberg Harris and
Josephthal Lyon & Ross Incorporated (the "Underwriters") have agreed, subject
to the terms and conditions contained in the Underwriting Agreement, to
purchase from the Company the number of shares of Common Stock indicated below
opposite their respective names at the public offering price less the
underwriting discount set forth on the cover page of this Prospectus. The
Underwriting Agreement provides that the obligations of the Underwriters are
subject to certain conditions precedent, and that the Underwriters are
committed to purchase all of such shares if any are purchased.
<TABLE>
<CAPTION>
NUMBER
UNDERWRITERS OF SHARES
------------ ---------
<S> <C>
Montgomery Securities..............................................
Alex. Brown & Sons Incorporated....................................
Unterberg Harris...................................................
Josephthal Lyon & Ross Incorporated................................
---------
Total.......................................................... 2,000,000
=========
</TABLE>
The Underwriters have advised the Company that they propose initially to
offer the Common Stock to the public on the terms set forth on the cover page
of this Prospectus. The Underwriters may allow selected dealers a concession
of not more than $ per share; and the Underwriters may allow, and such
dealers may reallow, a concession of not more than $ per share to certain
other dealers. After the public offering, the offering price and other selling
terms may be changed by the Underwriters. The Common Stock is offered subject
to receipt and acceptance by the Underwriters, and to certain other
conditions, including the right to reject orders in whole or in part.
The Company has granted an option to the Underwriters, exercisable during
the 30-day period after the date of this Prospectus, to purchase up to a
maximum of 300,000 additional shares of Common Stock to cover over-allotments,
if any, at the same price per share as the initial 2,000,000 shares to be
purchased by the Underwriters. To the extent that the Underwriters exercise
this option, the Underwriters will be committed, subject to certain
conditions, to purchase such additional shares in approximately the same
proportion as set forth in the above table. The Underwriters may purchase such
shares only to cover over-allotments made in connection with this offering.
The Underwriting Agreement provides that the Company will indemnify the
Underwriters against certain liabilities, including civil liabilities under
the Securities Act, or will contribute to payments the Underwriters may be
required to make in respect thereof.
All of the directors and executive officers of the Company holding an
aggregate of 877,259 shares of Common Stock (plus an additional approximately
86,658 shares of Common Stock exercisable under stock options vested as of 90
days from the date of this Prospectus) have agreed that they will not, without
the prior written consent of Montgomery Securities, directly or indirectly,
(1) offer, pledge, sell, contract to sell (including, without limitation, any
short sale), sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, establish an
open "put equivalent position" within the meaning of Rule 16a-1(h) under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
transfer or dispose of, directly or indirectly, any shares of Common Stock or
any securities convertible into or exercisable or exchangeable for Common
Stock owned directly by such party or with respect to which such party has or
acquires beneficial ownership or (2) enter into any swap or similar agreement
that transfers, in whole or in part, the economic risk of ownership of the
Common Stock, whether any such transaction described in clause (1) or (2)
above is to be settled by delivery of Common Stock or such other securities,
in cash or otherwise or publicly announce the intention to do any of the
foregoing, for a period of 90 days after the date of this Prospectus.
Montgomery Securities may, in its sole discretion, at any time without prior
notice, release all
45
<PAGE>
or any portion of the securities held by the Company's directors and executive
officers from the aforementioned restrictions. The Company has agreed in the
Underwriting Agreement that, without the prior written consent of Montgomery
Securities (which consent may be withheld at the sole discretion of Montgomery
Securities), it will not (other than pursuant to the Company's 1993 Employee
Stock Purchase Plan or pursuant to options under the Company's Amended and
Restated 1993 Flexible Stock Incentive Plan) issue, offer, sell, grant options
to purchase or otherwise dispose of any of the Company's equity securities or
any other securities convertible into or exchangeable with the Company's
Common Stock or other equity securities for a period of 90 days after the
first date that any shares of Common Stock are released for sale in this
offering.
In connection with this offering, the Underwriters and selling group
members, if any, may engage in passive market making transactions in the
Common Stock on the Nasdaq National Market in accordance with Rule 10b-6A
under the Exchange Act. Passive marketing making consists of displaying bids
on the Nasdaq National Market that are limited by the bid prices of
independent market makers and completing purchases in response to order flow
at prices limited by such bids. Net purchases by a passive market maker on
each day are limited to a specified percentage of the passive market maker's
average daily trading volume in the Common Stock during a specified prior
period. Purchases by the passive market maker must be discontinued for any day
on which such limit is reached. Passive market making may stabilize the market
price for the Common Stock at a level above that which might otherwise prevail
and, if commenced, may be discontinued at any time.
LEGAL MATTERS
The validity of the Common Stock offered hereby will be passed upon for the
Company by Morrison & Foerster LLP, Palo Alto, California. Certain legal
matters in connection with the offering will be passed on for the Underwriters
by Wilson Sonsini Goodrich & Rosati, Professional Corporation, Palo Alto,
California.
EXPERTS
The consolidated financial statements of the Company as of June 30, 1995 and
1994 and for each of the three years in the period ended June 30, 1995 and the
combined financial statements of GCA Fibreoptics Ltd. and Fiberoptic Alignment
Solutions, Inc. as of October 31, 1995 and 1994 and for the years then ended,
appearing in this Prospectus and in the Registration Statement have been
audited by Ernst & Young LLP, independent auditors, as set forth in their
reports thereon appearing elsewhere herein and in the Registration Statement
and are included in reliance upon such reports given upon the authority of
such firm as experts in accounting and auditing.
46
<PAGE>
INDEX TO FINANCIAL STATEMENTS
UNIPHASE CORPORATION
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
Report of Ernst & Young LLP, Independent Auditors.......................... F-2
Consolidated Balance Sheets.............................................. F-3
Consolidated Statements of Operations.................................... F-4
Consolidated Statements of Stockholders' Equity.......................... F-5
Consolidated Statements of Cash Flows.................................... F-6
Notes to Consolidated Financial Statements............................... F-7
</TABLE>
GCA FIBREOPTICS LTD. & FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
<TABLE>
<S> <C>
Report of Ernst & Young LLP, Independent Auditors......................... F-18
Combined Balance Sheets................................................. F-19
Combined Statements of Operations....................................... F-20
Combined Statements of Cash Flows....................................... F-21
Notes to Combined Financial Statements.................................. F-22
Unaudited Interim Condensed Combined Balance Sheets....................... F-27
Unaudited Interim Condensed Combined Statements of Operations and Retained
Earnings................................................................. F-28
Unaudited Interim Condensed Combined Statements of Cash Flows............. F-29
Notes to Unaudited Interim Condensed Combined Financial Statements........ F-30
</TABLE>
F-1
<PAGE>
REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
The Board of Directors and Stockholders
Uniphase Corporation
We have audited the accompanying consolidated balance sheets of Uniphase
Corporation as of June 30, 1994 and 1995, and the related consolidated
statements of operations, stockholders' equity, and cash flows for each of the
three years in the period ended June 30, 1995. These financial statements are
the responsibility of the Company's management. Our responsibility is to
express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the consolidated financial position of Uniphase
Corporation at June 30, 1994 and 1995, and the consolidated results of its
operations and its cash flows for each of the three years in the period ended
June 30, 1995, in conformity with generally accepted accounting principles.
ERNST & YOUNG LLP
San Jose, California
July 31, 1995
F-2
<PAGE>
UNIPHASE CORPORATION
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<TABLE>
<CAPTION>
JUNE 30, MARCH 31,
---------------- -----------
1994 1995 1996
------- ------- -----------
(UNAUDITED)
<S> <C> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents....................... $ 3,048 $ 2,880 $18,581
Short-term investments.......................... 11,167 4,679 18,287
Accounts receivable, less allowances for
doubtful accounts of $100 at June 30, 1994,
$164 at June 30, 1995 and $234 at March 31,
1996........................................... 4,314 8,793 12,824
Inventories..................................... 3,359 5,478 8,810
Deferred income taxes and other current assets.. 1,377 2,367 2,215
------- ------- -------
Total current assets.......................... 23,265 24,197 60,717
Long-term investments............................. -- -- 14,900
Property, plant, and equipment, net............... 2,260 3,452 17,019
Intangible assets................................. 605 3,178 3,002
Other assets...................................... 84 1,083 1,062
------- ------- -------
Total assets.................................. $26,214 $31,910 $96,700
======= ======= =======
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable................................ $ 1,228 $ 2,249 $ 3,308
Accrued payroll and related expenses............ 1,770 1,965 2,722
Other accrued expenses.......................... 1,192 2,667 3,654
Current portion of capital lease obligations.... 132 -- --
------- ------- -------
Total current liabilities..................... 4,322 6,881 9,684
Deferred income taxes............................. 561 -- --
Other non-current liabilities..................... -- 221 171
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value:
1,000,000 shares authorized, none issued and
outstanding................................... -- -- --
Common stock, $0.001 par value:
Authorized shares--20,000,000 Issued and
outstanding shares-- 8,812,908 at June 30,
1994, 9,515,604 at June 30, 1995 and 13,694,138
at March 31, 1996.............................. 8 10 14
Additional paid-in capital...................... 13,093 15,751 72,188
Stock purchase notes receivable................. (18) -- --
Retained earnings............................... 8,223 8,958 14,619
Net unrealized gain (loss) on securities avail-
able-for-sale.................................. 11 -- (11)
Foreign currency translation adjustment......... 14 89 35
------- ------- -------
Total stockholders' equity.................... 21,331 24,808 86,845
------- ------- -------
Total liabilities and stockholders' equity.... $26,214 $31,910 $96,700
======= ======= =======
</TABLE>
See accompanying notes to consolidated financial statements
F-3
<PAGE>
UNIPHASE CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
NINE MONTHS ENDED
YEARS ENDED JUNE 30, MARCH 31,
------------------------- ------------------
1993 1994 1995 1995 1996
------- ------- ------- -------- --------
(UNAUDITED)
<S> <C> <C> <C> <C> <C>
Net sales....................... $27,314 $32,922 $42,282 $ 30,146 $ 47,342
Cost of sales................... 17,870 20,067 24,113 17,378 25,102
------- ------- ------- -------- --------
Gross profit.................. 9,444 12,855 18,169 12,768 22,240
Operating expenses:
Research and development...... 1,986 3,058 3,710 2,707 4,093
Royalty and license........... 986 1,212 1,172 995 1,205
Selling, general, and
administrative............... 5,417 5,693 7,355 5,176 8,942
Infrequent or unusual charges:
Acquired in-process research
and development............. -- -- 4,460 -- --
Loss on sale of product line. -- -- 891 -- --
Litigation................... 2,381 (355) -- -- --
------- ------- ------- -------- --------
Total operating expenses........ 10,770 9,608 17,588 8,878 14,240
------- ------- ------- -------- --------
Income (loss) from operations. (1,326) 3,247 581 3,890 8,000
Interest income................. 84 274 487 385 1,014
Interest expense................ (60) (37) (25) (24) (20)
Other income (expense), net..... 115 (25) 88 43 (107)
------- ------- ------- -------- --------
Income (loss) before income
taxes........................ (1,187) 3,459 1,131 4,294 8,887
Income tax expense (benefit).... (389) 1,228 396 1,588 3,226
------- ------- ------- -------- --------
Net income (loss)............... $ (798) $ 2,231 $ 735 $ 2,706 $ 5,661
======= ======= ======= ======== ========
Net income (loss) per share..... $ (0.14) $ 0.27 $ 0.07 $ 0.27 $ 0.44
======= ======= ======= ======== ========
Shares used in per share
calculation.................... 5,510 8,274 10,082 9,966 12,962
======= ======= ======= ======== ========
</TABLE>
See accompanying notes to consolidated financial statements.
F-4
<PAGE>
UNIPHASE CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(IN THOUSANDS)
<TABLE>
<CAPTION>
STOCK NET FOREIGN
COMMON STOCK ADDITIONAL PURCHASE UNREALIZED CURRENCY
-------------- PAID-IN NOTE RETAINED GAIN ON TRANSLATION
SHARES AMOUNT CAPITAL RECEIVABLE EARNINGS SECURITIES ADJUSTMENT TOTAL
------ ------ ---------- ---------- -------- ---------- ----------- -------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Balance at July 1, 1992. 5,076 $ 6 $ 749 $(166) $ 6,789 $-- $ 49 $ 7,427
Repurchase of common
stock................. (4) -- (8) -- -- -- -- (8)
Issuance of common
stock for minority
interest in
Ultrapointe........... 86 -- 207 -- -- -- -- 207
Net loss............... -- -- -- -- (797) -- -- (797)
Foreign currency
translation
adjustment............ -- -- -- -- -- -- (98) (98)
------ --- ------- ----- ------- ---- ---- -------
Balance at June 30,
1993................... 5,158 6 948 (166) 5,992 -- (49) 6,731
Repurchase of common
stock................. (6) -- (8) -- -- -- -- (8)
Exercise of stock
options and related
tax benefits.......... 352 -- 695 -- -- -- -- 695
Common stock issued
upon initial public
offering, net of
issuance costs........ 3,308 2 11,458 -- -- -- -- 11,460
Repayment of stock
purchase note......... -- -- -- 148 -- -- -- 148
Net income............. -- -- -- -- 2,231 -- -- 2,231
Net unrealized gain on
securities available-
for-sale.............. -- -- -- -- -- 11 -- 11
Foreign currency
translation
adjustment............ -- -- -- -- -- -- 63 63
------ --- ------- ----- ------- ---- ---- -------
Balance at June 30,
1994................... 8,812 8 13,093 (18) 8,223 11 14 21,331
Exercise of stock
options and related
tax benefits.......... 704 2 2,658 -- -- -- -- 2,660
Repayment of stock
purchase note......... -- -- -- 18 -- -- -- 18
Net income............. -- -- -- -- 735 -- -- 735
Net realized gain on
securities available-
for-sale.............. -- -- -- -- -- (11) -- (11)
Foreign currency
translation
adjustment............ -- -- -- -- -- -- 75 75
------ --- ------- ----- ------- ---- ---- -------
Balance at June 30,
1995................... 9,516 10 15,751 -- 8,958 -- 89 24,808
Exercise of stock
options and related
tax benefits
(unaudited)........... 522 -- 3,629 -- -- -- -- 3,629
Common stock issued
upon public offering,
net of issuance costs
(unaudited)........... 2,990 3 40,526 -- -- -- -- 40,529
Common stock issued to
Tencor net of issuance
costs (unaudited)..... 666 1 12,282 -- -- -- -- 12,283
Net income (unaudited). -- -- -- -- 5,661 -- -- 5,661
Net unrealized gain on
securities available-
for-sale (unaudited) -- -- -- -- -- (11) -- (11)
Foreign currency
translation adjustment
(unaudited)........... -- -- -- -- -- -- (54) (54)
------ --- ------- ----- ------- ---- ---- -------
Balance at March 31,
1996 (unaudited)....... 13,694 $14 $72,188 $ -- $14,619 $(11) $ 35 $86,845
====== === ======= ===== ======= ==== ==== =======
</TABLE>
See accompanying notes to consolidated financial statements.
F-5
<PAGE>
UNIPHASE CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
<TABLE>
<CAPTION>
NINE MONTHS ENDED
YEARS ENDED JUNE 30, MARCH 31,
-------------------------- -------------------
1993 1994 1995 1995 1996
------ -------- -------- -------- ---------
(UNAUDITED)
<S> <C> <C> <C> <C> <C>
OPERATING ACTIVITIES
Net income (loss)............ $ (798) $ 2,231 $ 735 $ 2,706 $ 5,661
Adjustments to reconcile net
income (loss) to net cash
provided by operating
activities:
Depreciation and
amortization............... 872 941 1,154 819 1,435
(Gain) loss on disposal of
fixed assets............... 43 5 (18) -- --
Acquired in-process research
and development............ -- -- 4,460 -- --
Undistributed earnings of
affiliate.................. -- -- (114) -- --
Change in deferred income
taxes, net................. (360) 179 (2,188) -- --
Loss on sale of product
line....................... -- -- 891 -- --
Change in operating assets
and liabilities:
Accounts receivable......... (306) (754) (3,286) (2,623) (4,031)
Inventories................. (238) (788) (1,244) (760) (3,332)
Other current assets........ 5 (259) (391) (442) 152
Accounts payable, accrued
liabilities, income tax
payable and other.......... 923 286 3,221 1,729 2,717
------ -------- -------- -------- ---------
Net cash provided by
operating activities..... 141 1,841 3,220 1,429 2,602
------ -------- -------- -------- ---------
INVESTING ACTIVITIES
Notes receivable from related
parties..................... -- 133 -- -- --
Purchase of available-for-
sale investments............ -- (11,156) (10,604) (9,582) (36,731)
Sale of available-for-sale
investments................. -- -- 17,081 9,440 8,212
Investment in I.E. Optomech
Ltd......................... -- (528) (12) (109) (238)
Acquisition of net assets of
United Technologies
Photonics, Inc.............. -- -- (8,747) -- --
Acquisition of licenses...... -- -- (600) -- --
Proceeds from sale of product
line........................ -- -- 375 -- --
Purchase of property, plant
and equipment............... (650) (1,065) (1,808) (1,481) (14,665)
Decrease (increase) in other
assets...................... 79 (3) 17 4 21
------ -------- -------- -------- ---------
Net cash used in investing
activities............... (571) (12,619) (4,298) (1,728) (43,401)
------ -------- -------- -------- ---------
FINANCING ACTIVITIES
Repurchase of common stock... (8) (8) -- -- --
Repayment of stock purchase
note........................ -- 148 18 -- --
Proceeds from issuance of
common stock................ -- 11,759 1,024 1,797 56,500
Principal payments on capital
lease obligations........... (160) (107) (132) (98) --
------ -------- -------- -------- ---------
Net cash provided by (used
in) financing activities. (168) 11,792 910 1,699 56,500
------ -------- -------- -------- ---------
Increase (decrease) in cash
and cash equivalents......... (598) 1,014 (168) 1,400 15,701
Cash and cash equivalents at
beginning of period.......... 2,632 2,034 3,048 3,048 2,880
------ -------- -------- -------- ---------
Cash and cash equivalents at
end of period................ $2,034 $ 3,048 $ 2,880 $ 4,448 $ 18,581
====== ======== ======== ======== =========
</TABLE>
See accompanying notes to consolidated financial statements.
F-6
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
NOTE 1. BUSINESS ACTIVITIES AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business Activities.
Uniphase Corporation (the "Company" or "Uniphase") designs, develops,
manufactures and markets laser subsystems, laser-based semiconductor wafer
defect examination and analysis equipment and fiber optic telecommunications
equipment products. Uniphase operates three manufacturing facilities in the
United States (in San Jose and Manteca, California, and Bloomfield,
Connecticut). The Company's laser division designs, develops, manufactures and
markets laser subsystems for a broad range of OEM applications, which include
biotechnology, industrial process control and measurement, graphics and
printing and semiconductor equipment. Uniphase's domestic wholly-owned
subsidiary, Ultrapointe Corporation, designs, develops, manufactures and
markets advanced laser-based systems for semiconductor wafer defect
examination and analysis. In May 1994, the Company acquired a 49% equity
position in I.E. Optomech, an optoelectronics company located in the United
Kingdom. The Company increased its ownership percentage on May 1, 1995 to
51.5% through an additional equity investment and on July 1, 1995, purchased
the remaining equity interest. In May 1995, Uniphase acquired United
Technologies Photonics, Inc., which designs, develops, manufactures and
markets high-speed external modulators and transmitters for fiber optic
networks in the CATV and long-haul telecommunications industries, and which is
being operated as a Uniphase subsidiary, Uniphase Telecommunications Products,
Inc. ("UTP"). At the end of fiscal 1995, the Company sold the net assets of
its diode laser product line, which was previously operated in a Los Angeles
facility. Uniphase also has wholly-owned subsidiaries in Germany and the
United Kingdom to market and service its products in Europe.
Basis of Presentation.
The consolidated financial statements include Uniphase, its wholly-owned
subsidiaries, I.E. Optomech subsequent to obtaining controlling interest on
May 1, 1995 and UTP subsequent to its purchase by the Company on May 15, 1995.
All significant intercompany accounts and transactions have been eliminated.
Amounts applicable to the minority interest of I.E. Optomech are
insignificant.
Cash, Cash Equivalents, and Short-term Investments.
Uniphase considers all liquid investments with maturities of ninety days or
less when purchased to be cash equivalents. The Company's short-term
investments have maturities of one year or less. The Company's securities are
classified as available-for-sale and are recorded at fair value. Fair value is
based upon quoted market prices on the last day of the fiscal year. The cost
of debt securities sold is based on the specific identification method.
Unrealized gains and losses are reported as a separate component of
stockholders' equity. Gross realized gains and losses are included in interest
income and have not been material. The Company's investments consist of the
following:
F-7
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
<TABLE>
<CAPTION>
JUNE 30, 1994
---------------------------------------
GROSS GROSS ESTIMATED
UNREALIZED UNREALIZED FAIR
COST GAINS LOSSES VALUE
------- ---------- ---------- ---------
(IN THOUSANDS)
<S> <C> <C> <C> <C>
Municipal bonds......................... $ 7,156 $-- $-- $ 7,156
Auction instruments..................... 4,000 11 -- 4,011
Money market instruments................ 1,439 -- -- 1,439
Certificate of deposits................. 503 -- -- 503
------- --- --- -------
$13,098 $11 $-- $13,109
======= === === =======
Included in cash and cash equivalents... $ 1,942 $-- $-- $ 1,942
Included in short-term investments...... 11,156 11 -- 11,167
------- --- --- -------
$13,098 $11 $-- $13,109
======= === === =======
<CAPTION>
JUNE 30, 1995
---------------------------------------
GROSS GROSS ESTIMATED
UNREALIZED UNREALIZED FAIR
COST GAINS LOSSES VALUE
------- ---------- ---------- ---------
(IN THOUSANDS)
<S> <C> <C> <C> <C>
Auction instruments..................... $ 3,000 $-- $-- $ 3,000
Municipal bonds......................... 1,679 -- -- 1,679
Certificate of deposits................. 1,003 -- -- 1,003
Money market instruments................ 549 -- -- 549
------- --- --- -------
$ 6,231 $-- $-- $ 6,231
======= === === =======
Included in cash and cash equivalents... $ 1,552 $-- $-- $ 1,552
Included in short-term investments...... 4,679 -- -- 4,679
------- --- --- -------
$ 6,231 $-- $-- $ 6,231
======= === === =======
</TABLE>
Inventories.
Inventories are valued at the lower of cost (first-in, first-out method) or
market. The components of inventory consist of the following:
<TABLE>
<CAPTION>
JUNE 30,
------------- MARCH 31,
1994 1995 1996
------ ------ ---------
(IN THOUSANDS)
<S> <C> <C> <C>
Finished goods.......................................... $ 948 $2,043 $1,818
Work in process......................................... 969 1,072 2,992
Raw materials and purchased parts....................... 1,442 2,363 4,000
------ ------ ------
$3,359 $5,478 $8,810
====== ====== ======
</TABLE>
Property, Plant and Equipment.
Property, plant and equipment are stated at cost. Depreciation is computed
by the straight-line method over the estimated useful lives of the assets,
which range from two to five years. Leasehold improvements are amortized by
the straight-line method over the shorter of the estimated useful lives of the
assets or the term of the lease. The components of property, plant and
equipment are as follows:
F-8
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
<TABLE>
<CAPTION>
JUNE 30,
------------- MARCH 31
1994 1995 1996
------ ------ --------
(IN THOUSANDS)
<S> <C> <C> <C>
Land..................................................... $ -- $ -- $ 3,816
Building and improvements................................ -- -- 7,728
Manufacturing equipment.................................. 3,823 4,944 9,726
Furniture, fixtures and office equipment................. 2,243 2,887 3,277
Leasehold improvements................................... 371 556 364
------ ------ -------
6,437 8,387 24,911
Less: accumulated depreciation and amortization.......... 4,177 4,935 7,892
------ ------ -------
$2,260 $3,452 $17,019
====== ====== =======
</TABLE>
Concentration of Credit Risk.
Financial instruments that potentially subject the Company to concentrations
of credit risk consist primarily of cash equivalents, short-term investments
and trade receivables. The Company places its cash equivalents and short-term
investments with high credit-quality financial institutions. The Company
invests its excess cash primarily in auction instruments, municipal bonds and
certificates of deposits. The Company has established guidelines relative to
credit ratings, diversification and maturities that seek to maintain safety
and liquidity. The Company sells primarily to customers involved in the
application of laser technology or the manufacture of semiconductors. The
Company performs ongoing credit evaluations of its customers and does not
require collateral. The Company provides reserves for potential credit losses,
and such losses and yearly provisions have not been significant and have been
within management's expectations.
Foreign Currency Translation.
Assets and liabilities denominated in foreign currencies are translated
using the exchange rate on the balance sheet dates. Revenues and expenses are
translated using average rates of exchange prevailing during the year. The
translation adjustment resulting from this process is shown separately as a
component of stockholders' equity. Foreign currency transaction gains and
losses are not material and are included in the determination of net income.
Revenue Recognition.
Revenue from the sale of products is generally recognized upon shipment.
Revenue on the shipment of Ultrapointe Systems on evaluation is deferred until
customer acceptance. The Company provides for the estimated cost to repair
products under warranty at the time of sale.
Revenues from UTP's research contracts are recognized on the percentage-of-
completion method, measured by costs incurred to date to estimated total costs
for each contract. Under this method, revenues are recognized as various
stages of research contracts are completed. Provisions for estimated losses on
uncompleted contracts are made in the period in which such losses are
determined.
The Company is party to certain research and development contracts with
third parties whereby the Company is obligated to spend certain specified
amounts over periods ranging from two to three years on certain research and
development activities and will be reimbursed by the third party participants
for a portion of such expenditures. During fiscal 1995, the Company earned
reimbursements of $245,000 in connection with these contracts which were
recorded as credits to research and development expense. The corresponding
amounts during fiscal 1994 were insignificant. At June 30, 1995, a total of
approximately $4.6 million remains to be
F-9
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
expended under these contracts for which the Company will receive
reimbursements of approximately $2.2 million. The research activities covered
by the contracts are complementary to the Company's own research and
development activities. At the end of the contracts, the Company will own or
have access to the technology developed in connection with the contracts.
Income Taxes
Income taxes are calculated under the provisions of Statement of Financial
Accounting Standards No. 109 (FAS 109), "Accounting for Income Taxes." Under
FAS 109, the liability method is used in accounting for income taxes which
includes the effects of temporary differences between financial and taxable
amounts of assets and liabilities.
Net Income (Loss) Per Share.
Net income (loss) per share is computed using the weighted average number of
shares of common stock and dilutive common equivalent shares from stock
options using the treasury stock method. Since fully diluted earnings per
share differs from primary earnings per share by less than 3%, only primary
earnings per share is shown below. Shares and net income used in the per share
computations are as follows:
<TABLE>
<CAPTION>
NINE MONTHS ENDED
YEAR ENDED JUNE 30, MARCH 31,
--------------------- -----------------
1993 1994 1995 1995 1996
------ ------ ------ -------- --------
(IN THOUSANDS)
<S> <C> <C> <C> <C> <C>
Weighted average common shares.......... 5,076 7,276 9,108 9,004 11,854
SAB 83 shares........................... 434 -- -- -- --
Stock options........................... -- 998 974 962 1,108
------ ------ ------ -------- --------
Total................................. 5,510 8,274 10,082 9,966 12,962
====== ====== ====== ======== ========
Net income.............................. $ (798) $2,231 $ 735 $ 2,706 $ 5,661
====== ====== ====== ======== ========
Net income per share.................... $(0.14) $ 0.27 $ 0.07 $ 0.27 $ 0.44
====== ====== ====== ======== ========
</TABLE>
Pursuant to the Securities and Exchange Commission Staff Accounting
Bulletins, common equivalent shares issued by the Company at prices below the
initial public offering price during the 12-month period prior to the offering
have been included in the fiscal 1993 calculation (using the treasury stock
method and the initial public offering price of $4.00 per share).
Reclassifications.
Certain reclassifications, relating to geographic sales information, have
been made to the fiscal 1994 and fiscal 1993 presentation to conform to the
fiscal 1995 presentation.
NOTE 2. OTHER ACCRUED EXPENSES
The components of other accrued expenses are as follows:
<TABLE>
<CAPTION>
JUNE 30,
---------------
MARCH 31,
1994 1995 1996
------- ------- ---------
(IN THOUSANDS)
<S> <C> <C> <C>
Royalties payable..................................... $ 442 $ 435 $ 830
Warranty reserve...................................... 172 385 510
Other accrued liabilities............................. 578 1,847 2,314
------- ------- ------
$ 1,192 $ 2,667 $3,654
======= ======= ======
</TABLE>
F-10
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
NOTE 3. INCOME TAXES
The expense (benefit) for income taxes consists of the following:
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
--------------------
1993 1994 1995
----- ------ ------
(IN THOUSANDS)
<S> <C> <C> <C>
Federal:
Current................................................. $ (60) $ 806 $1,967
Deferred................................................ (285) 173 (1,688)
----- ------ ------
(345) 979 279
State:
Current................................................. 13 196 550
Deferred................................................ (75) 6 (500)
----- ------ ------
(62) 202 50
Foreign:
Current................................................. 18 47 67
----- ------ ------
Income tax expense (benefit).......................... $(389) $1,228 $ 396
===== ====== ======
</TABLE>
A reconciliation of the income tax expense (benefit) at the federal statutory
rate to the income tax expense (benefit) at the effective tax rate is as
follows:
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
-----------------------
1993 1994 1995
------ ------- ------
(IN THOUSANDS)
<S> <C> <C> <C>
Income taxes (benefit) computed at federal statutory
rate.................................................. $ (404) $ 1,176 $ 385
State taxes, net of federal benefit.................... (41) 133 33
Foreign taxes on income................................ 18 47 (7)
Research, development, and foreign tax credits......... -- (132) (15)
Other.................................................. 38 4 --
------ ------- -----
$ (389) $ 1,228 $ 396
====== ======= =====
</TABLE>
The components of deferred taxes consist of the following:
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
----------------------
1994 1995
--------- -----------
(IN THOUSANDS)
<S> <C> <C>
Deferred tax assets:
State taxes............................................ $ 64 $ 186
Accrued legal expenses................................. 69 36
Inventory reserve...................................... 188 234
Vacation accruals...................................... 120 128
Intangibles and acquired in-process research and
development........................................... -- 1,760
Warranty reserve....................................... 69 139
Diode laser product line write-off..................... -- 257
Other accruals not deductible for tax.................. 45 74
-------- -----------
Total deferred tax assets............................ 555 2,814
Deferred tax liabilities:
Tax over book depreciation............................. 88 19
Interest charge DISC commission........................ 473 613
-------- -----------
Total deferred tax liabilities....................... 561 632
-------- -----------
Total net deferred tax assets (liabilities).......... $ (6) $ 2,182
======== ===========
</TABLE>
F-11
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
The Company believes that net deferred tax assets are more likely than not
to be realized from the Company's ongoing operations. Thus, no valuation
allowance is deemed necessary. Cumulative undistributed earnings of Uniphase's
foreign subsidiaries were approximately $110,000, $99,000 and $282,000 at June
30, 1993, 1994 and 1995, respectively. These amounts have been permanently
reinvested, and accordingly, no provision for federal and state income taxes
has been provided thereon. The tax benefit associated with exercises of stock
options reduced taxes currently payable by $346,000 and $1,636,000 for the
years ended June 30, 1994 and 1995, respectively. Such benefits are credited
to additional paid-in capital when realized. For the nine-month periods ended
March 31, 1995 and 1996, income taxes were provided based on the estimated
annual effective tax rates for such years which were 37% and 36%,
respectively.
NOTE 4. LINE OF CREDIT
The Company has a $5.0 million revolving bank line of credit that expires on
November 1, 1996. Advances under the line of credit bear interest at the
bank's prime rate (9% at June 30, 1995 and 8.25% at March 31, 1996) and are
secured by inventories and accounts receivable. Under the terms of the line of
credit agreement, the Company is required to maintain certain minimum working
capital, net worth, profitability levels and other specific financial ratios.
In addition, the agreement prohibits the payment of cash dividends and
contains certain restrictions on the Company's ability to borrow money or
purchase assets or interests in other entities without the prior written
consent of the bank. There were no borrowings under the line of credit at June
30, 1995 or March 31, 1996.
NOTE 5. LEASE COMMITMENTS
Uniphase leases manufacturing and office space primarily in San Jose and
Manteca, California and Bloomfield, Connecticut under noncancelable operating
leases expiring at various dates through August 1998 and containing certain
renewal options ranging from one to four years. Future minimum commitments for
noncancelable operating leases are as follows which excludes $221,000 accrued
at June 30, 1995 for vacated space upon sale of a product line:
<TABLE>
<CAPTION>
OPERATING
LEASES
--------------
(IN THOUSANDS)
<S> <C>
1996.......................................................... $ 833
1997.......................................................... 678
1998.......................................................... 351
1999.......................................................... 55
------
Total minimum lease payments.................................. $1,917
======
</TABLE>
Rental expense for operating leases for the years ended June 30, 1993, 1994
and 1995 amounted to approximately $539,000, $530,000 and $605,000,
respectively.
NOTE 6. EMPLOYEE BENEFIT PLAN
Uniphase has an employee 401(k) salary deferral plan, covering all domestic
employees. Employees may make contributions by withholding a percentage of
their salary up to $9,240 per year. Company contributions consist of $.25 per
dollar contributed by the employees with at least six months of service.
Company contributions were approximately $85,000, $100,000 and $131,000 for
the years ended June 30, 1993, 1994, and 1995, respectively.
F-12
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
NOTE 7. STOCK OPTION PLANS
As of June 30, 1995, Uniphase has reserved 3,044,000 shares of common stock
for future issuance to employees, directors and consultants under its 1984
Amended and Restated Stock Option Plan (the "1984 Option Plan") and 1993
Flexible Stock Incentive Plan (the "1993 Option Plan"). The existing reserve
includes an additional 700,000 shares, approved by the Board of Directors
during fiscal 1995, that have been reserved for issuance under the 1993 Option
Plan pending stockholder approval. The Board of Directors has the authority to
determine the type of option and the number of shares subject to option. The
exercise price cannot be less than the fair value at the date of grant.
Options generally become exercisable over a four-year period and, if not
exercised, expire from five to ten years from the date of grant. The following
table summarizes option activity through June 30, 1995:
<TABLE>
<CAPTION>
OPTIONS OUTSTANDING
------------------------------------------
SHARES AGGREGATE
AVAILABLE NUMBER PRICE EXERCISE
FOR GRANT OF SHARES PER SHARE PRICE
--------- --------- ------------ ---------
(IN THOUSANDS, EXCEPT PRICE PER SHARE)
<S> <C> <C> <C> <C>
Balance at June 30, 1992............ 586 1,598 $ 0.62-$1.80 $ 1,976
Granted........................... (258) 258 $ 1.60-$2.40 466
Exchanged......................... (54) 54 $ 0.46 25
Canceled.......................... 204 (204) $ 0.62-$1.80 (280)
------ ----- ------------ -------
Balance at June 30, 1993............ 478 1,706 $ 0.46-$2.40 2,187
Increase in authorized shares..... 1,254 -- -- --
Granted........................... (1,184) 1,184 $ 2.40-$4.63 3,404
Canceled.......................... 52 (52) $ 0.46-$4.63 (119)
Exercised......................... -- (352) $ 0.46-$2.40 (349)
------ ----- ------------ -------
Balance at June 30, 1994............ 600 2,486 $ 0.46-$4.63 5,123
Increase in authorized shares,
pending shareholder approval..... 700 -- -- --
Granted........................... (874) 874 $3.88-$11.57 7,354
Canceled.......................... 32 (128) $ 1.30-$9.88 (373)
Exercised......................... -- (646) $ 0.46-$4.63 (827)
------ ----- ------------ -------
Balance at June 30, 1995............ 458 2,586 $0.46-$11.57 $11,277
====== ===== ============ =======
</TABLE>
Options for 934,000 shares are exercisable as of June 30, 1995.
Certain employees of UTP have been granted tandem stock options whereby such
employees receive options to purchase shares of either Common Stock of UTP
(the "UTP Options") under the UTP 1995 Flexible Stock Incentive Plan (the
"1995 Option Plan") or Common Stock of Uniphase (the "Uniphase Options") under
Uniphase's 1993 Option Plan. Under the tandem option plan structure, the
aggregate value of the UTP Options and the Uniphase Options that are granted
to each optionee are equal. The optionees can exercise either their UTP
Options or Uniphase Options, but not both. When the optionees exercise their
options as to UTP Common Stock, their corresponding Uniphase Options
automatically terminate, and vice versa. The total number of Uniphase Options
granted in tandem with UTP options is 82,454 shares, at an exercise price of
$11.563 per share, which was the fair market value of Uniphase Common Stock on
the date of grant. The total number of UTP Options granted as of June 30, 1995
is 953,500 shares, at an exercise price of $1.00 per share which was the fair
value of UTP stock at that date. UTP has reserved 246,500 shares of Common
Stock for future issuance. Both the Uniphase Options and the UTP Options will
be exercisable in accordance with the standard vesting schedules under the
1993 Option Plan and the 1995 Option Plan, over a four-year period.
F-13
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
NOTE 8. EMPLOYEE STOCK PURCHASE PLAN
The Uniphase 1993 Employee Stock Purchase Plan (the "Purchase Plan") was
adopted in October 1993 and amended during fiscal 1994. The Company has
reserved 400,000 shares of common stock for issuance under the Purchase Plan.
The Purchase Plan, effective February 1, 1994, provides eligible employees
with the opportunity to acquire an ownership interest in Uniphase through
participation in a program of periodic payroll deductions applied at specific
intervals to the purchase of common stock. The Purchase Plan is structured as
a qualified employee stock purchase plan under Section 423 of the amended
Internal Revenue Code of 1986. However, the Purchase Plan is not intended to
be a qualified pension, profit sharing or stock bonus plan under Section
401(a) of the 1986 Code and is not subject to the provisions of the Employee
Retirement Income Security Act of 1974. The Purchase Plan will terminate upon
the earlier of December 31, 1998 or the date on which all shares available for
issuance under the Purchase Plan have been sold. During fiscal 1995, employees
purchased 57,850 shares of common stock under the Purchase Plan and 342,150
shares are available for future issuance.
NOTE 9. INVESTMENT IN I.E. OPTOMECH LTD.
In May 1994, Uniphase purchased 49% of the outstanding common stock of I.E.
Optomech Ltd., a privately held optoelectronics company located in the United
Kingdom for $528,000 in cash, which included intellectual properties related
to solid state lasers and the right to manufacture and sell certain I.E.
Optomech Ltd. products. In May of 1995, the Company acquired an additional
2.5% of the outstanding common stock of I.E. Optomech, Ltd. for approximately
$12,000 in cash. As of June 30, 1995, the Company owned 51.5% of I.E. Optomech
and the acquisition has been accounted for by the purchase method of
accounting. The fair market value of the net assets less minority interests at
the date of acquisition was $109,000. The excess of the investment in
I.E. Optomech over the fair value of the net assets acquired is being
amortized over its estimated useful life of 10 years. Accumulated amortization
is approximately $54,000 as of June 30, 1995. In July 1995, the Company
acquired the remaining 48.5% of I.E. Optomech for $238,000 in cash. I.E.
Optomech will operate as a wholly-owned subsidiary of the Company.
NOTE 10. ACQUISITION OF UNIPHASE TELECOMMUNICATIONS PRODUCTS, INC.
On May 15, 1995, the Company acquired all the outstanding capital stock of
UTP, from United Technologies Corporation. UTP is a global supplier of
integrated optical components used in transmitters for fiber-based networks in
the cable television and telecommunications industries, as well as in optical
antenna links and navigation systems. The total purchase price of $8,747,000
included a cash payment of $8,050,000 to United Technologies Corporation and
$697,000 for related acquisition expenses. The acquisition has been accounted
for by the purchase method of accounting and accordingly, the accompanying
financial statements include the results of operations of UTP subsequent to
the acquisition date. The fair value of the net assets and acquired in-process
research and development purchased was $7,975,000. The excess of $772,000 of
the acquisition price over such fair value and the purchased intangible assets
are being amortized over estimated useful lives ranging from 5 to 10 years.
Accumulated amortization is approximately $47,000 at June 30, 1995.
The following unaudited pro forma summary presents the consolidated results
of operations of the Company as if the acquisition of UTP had occurred at the
beginning of fiscal 1994 and does not purport to be indicative of what would
have occurred had the acquisition been made as of the beginning of fiscal 1994
or of results which may occur in the future.
F-14
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
---------------------
1994 1995
---------- ----------
(IN THOUSANDS, EXCEPT
PER SHARE DATA)
<S> <C> <C>
Net sales.............................................. $39,967 $46,512
Net income............................................. $ 2,756 $ 222
Net income per share................................... $ 0.34 $ 0.02
</TABLE>
The effects of the UTP acquisition on the 1995 consolidated statement of
cash flows were as follows (in thousands):
<TABLE>
<S> <C>
Working capital acquired............................................. $1,215
Property, plant and equipment........................................ 1,260
Intangibles and goodwill............................................. 2,072
In-process research and development.................................. 4,200
------
Total purchase price................................................. $8,747
======
</TABLE>
NOTE 11. SALE OF DIODE LASER PRODUCT LINE
The Company sold its diode laser product line for $375,000 in cash on June
30, 1995. The loss on sale of the product line was $891,000. In conjunction
with the sale, the Company also obtained a limited non-exclusive sublicense to
a solid state technology patent at a reduced royalty rate.
NOTE 12. GEOGRAPHIC AND INDUSTRY SEGMENT INFORMATION
Uniphase operates in two geographic regions: the United States and Europe.
The Company operates in a single industry segment, the design, manufacture and
sale of laser subsystems and laser based products. The following table shows
sales, operating income (loss) and other financial information by geographic
region:
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
-------------------------
1993 1994 1995
------- ------- -------
(IN THOUSANDS)
<S> <C> <C> <C>
Net Sales:
United States--domestic............................ $18,639 $23,403 $29,456
United States--export.............................. 1,915 2,771 5,726
Europe............................................. 6,760 6,748 7,100
Intercompany (primarily to Europe)................. 5,516 5,370 5,466
Eliminations....................................... (5,516) (5,370) (5,466)
------- ------- -------
Total net sales.................................. $27,314 $32,922 $42,282
======= ======= =======
Operating Income (Loss):
United States...................................... $(1,072) $ 3,115 $ 276
Europe............................................. (193) 107 299
Eliminations....................................... (61) 25 6
------- ------- -------
Total operating income (loss).................... $(1,326) $ 3,247 $ 581
======= ======= =======
Identifiable Assets:
United States...................................... $ 9,277 $24,219 $28,785
Europe............................................. 2,508 1,995 3,125
------- ------- -------
Total assets..................................... $11,785 $26,214 $31,910
======= ======= =======
</TABLE>
F-15
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
Intercompany transfers represent products that are transferred between
geographic areas on a basis intended to reflect as nearly as possible the
market value of the products. Identifiable assets are those assets of the
Company that are identified with the operations of the corresponding
geographic area.
One laser subsystem customer accounted for 11%, 12% and 12% of the Company's
consolidated net sales in years ended June 30, 1993, 1994, and 1995,
respectively. In addition, another laser subsystem customer accounted for 10%
of the Company's consolidated net sales in both years ended June 30, 1993 and
1994.
NOTE 13. SUPPLEMENTAL CASH FLOW INFORMATION
<TABLE>
<CAPTION>
YEAR ENDED JUNE 30,
-------------------
1993 1994 1995
---- ---- ----
(IN THOUSANDS)
<S> <C> <C> <C>
Cash paid for interest.................................. $ 60 $ 28 $ 11
Cash paid for income taxes.............................. $ 12 $965 $1,213
Issuance of common stock for minority interest in
Ultrapointe............................................ $207 $ -- $ --
</TABLE>
NOTE 14. LITIGATION AND CONTINGENCIES
During fiscal 1994, the Company settled one of two remaining lawsuits
against the Company which had been filed by certain former employees. Due to
the settlement of this lawsuit at a cost which was less than anticipated and
the re-evaluation of the potential liability with respect to the remaining
outstanding lawsuit, the Company reversed $355,000 of accrued legal expense.
In addition, during fiscal 1994, it was determined that certain costs accrued
for in fiscal 1993, with respect to certain third party patents, would not
have to be paid. As a result of this determination, accrued expenses of
$300,000 were reversed in fiscal 1994 as a credit to selling, general and
administrative expenses.
In the ordinary course of business, various lawsuits and claims are filed
against the Company. While the outcome of these matters is currently not
determinable, management believes that the ultimate resolution of these
matters will not have a material adverse effect on the Company's financial
statements.
NOTE 15. EVENTS SUBSEQUENT TO JUNE 30, 1995 (UNAUDITED)
In October 1995, the Company received proceeds, net of related expenses, of
approximately $40,529,000 from a public offering of 2,990,000 shares of common
stock. In November 1995, the company issued an additional 665,568 shares of
common stock for a net purchase price of approximately $12,283,000 to Tencor
in a private placement in connection with the licensing arrangement entered
into with Tencor.
During fiscal 1996, two former employees commenced wrongful termination
actions against the Company. The Company believes these claims are without
merit and is vigorously defending them. Even if these claims are adjudicated
in favor of the plaintiffs, the Company does not believe that the ultimate
resolution of these matters will have a material adverse impact on the Company
or its operations.
On February 8, 1996, the Company acquired two properties in San Jose,
California, totaling 109,000 square feet, which includes land, buildings and
improvements, for an aggregate purchase price of approximately $11.0 million.
One of the properties is the Company's current principal facility occupied
under an operating lease which would have expired in August 1998. The Company
plans to expand into the additional building. The Company's principal sales,
marketing, technical support, administration, and research and development
operations as well as manufacturing operations for the argon laser and
Ultrapointe products will occupy these facilities. The Company plans to lease
any unused space.
F-16
<PAGE>
UNIPHASE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS--(CONTINUED)
(INFORMATION AS OF MARCH 31, 1996 AND RELATING FOR THE
NINE-MONTH PERIODS ENDED MARCH 31, 1995 AND 1996 IS UNAUDITED)
On April 27, 1996, the Company's Board of Directors approved a two-for-one
split of its Common Stock (the "Stock Split") to be effected in the form of a
100% stock dividend, payable on June 3, 1996 to Stockholders of record on May
20, 1996. All prior period common stock and per share data in these financial
statements and the notes thereto have been adjusted to reflect the pending
Stock Split.
The Company has entered into a definitive stock purchase agreement with the
shareholders of FAS and GCA to acquire 100% of the outstanding shares of FAS
and GCA, respectively. The total purchase price is estimated to be
approximately $9.1 million which includes the aggregate consideration of $8.6
million for both GCA and FAS, payable through a combination of cash and notes,
and estimated direct transaction costs of approximately $500,000.
The Company expects that an estimated $4.5 million of the estimated total
purchase price will be allocated to in-process research and development and
immediately charged to expense. This amount is an estimate and is subject to
change based on the completion of an independent valuation which is currently
in process. It is anticipated that the remaining $4.6 million of the estimated
total purchase price will be allocated to specifically identifiable assets
acquired and goodwill. It is estimated that intangible assets acquired of $3.9
million (net of deferred tax liability) will be amortized over a weighted
average life of seven years.
In addition, in order to operate UFP as a division of UTP, management
believes it was necessary to cancel options to purchase UTP stock previously
granted to UTP employees and to grant replacement options to such employees to
purchase stock of the Company. The Company will incur compensation expense
totaling $4.4 million in connection with such option grants which were
effective on May 15, 1996. Of this total, $3.0 million, related to options
which have vested to date, will be charged to expense during the quarter
ending June 30, 1996 and the remaining $1.4 million will be charged to
expense over the remaining vesting period of three years.
F-17
<PAGE>
REPORT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
The Board of Directors
Uniphase Corporation
We have audited the accompanying combined balance sheets of GCA Fibreoptics
Ltd. and Fiberoptics Alignment Solutions, Inc. as of October 31, 1994 and
1995, and the related combined statements of operations and cash flows for the
years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the combined financial position of GCA Fibreoptics
Ltd. and Fiberoptics Alignment Solutions, Inc. at October 31, 1994 and 1995,
and the combined results of their operations and their cash flows for the
years then ended, in conformity with generally accepted accounting principles.
ERNST & YOUNG LLP
San Jose, California
May 28, 1996
F-18
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
COMBINED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<TABLE>
<CAPTION>
OCTOBER 31,
--------------
1994 1995
------ ------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents.................................... $ 81 $ 15
Accounts receivable, less allowance for doubtful accounts of
$26 at
October 31, 1994 and 1995................................... 897 676
Inventories.................................................. 570 815
Deferred income taxes........................................ 45 49
Other current assets......................................... 17 76
------ ------
Total current assets....................................... 1,610 1,631
Property, plant, and equipment, net............................ 405 942
Other assets................................................... 6 6
------ ------
Total assets............................................... $2,021 $2,579
====== ======
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Notes payable to bank........................................ $ 324 $ 232
Accounts payable............................................. 575 792
Income taxes payable......................................... 66 93
Other accrued expenses....................................... 182 211
Current portion of long-term debt............................ 83 82
Current portion of capital lease obligations................. 10 80
------ ------
Total current liabilities.................................. 1,240 1,490
Long-term debt, less current portion........................... 277 190
Capital lease obligations, less current portion................ 22 146
Commitments
Shareholders' equity:
Common stock, FAS--$1.00 par value:
Authorized shares--10,000
Issued and outstanding shares--1,000 as of July 31, 1994 and
1995........................................................ 1 1
GCA--$0.0162 par value
Authorized shares--250,000
Issued and outstanding shares--101,000 as of October 31,
1994 and 1995............................................... 2 2
Additional paid-in capital................................... 253 303
Shareholder note receivable.................................. (1) (1)
Foreign currency translation adjustment...................... 3 (4)
Retained earnings............................................ 224 452
------ ------
Total shareholders' equity................................. 482 753
------ ------
Total liabilities and shareholders' equity................. $2,021 $2,579
====== ======
</TABLE>
See accompanying notes to combined financial statements
F-19
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
COMBINED STATEMENTS OF OPERATIONS AND RETAINED EARNINGS
(IN THOUSANDS)
<TABLE>
<CAPTION>
YEARS ENDED
OCTOBER 31,
--------------
1994 1995
------ ------
<S> <C> <C>
Net sales....................................................... $3,468 $5,690
Cost of sales................................................... 1,961 3,471
------ ------
Gross profit.................................................. 1,507 2,219
Operating expenses:
Research and development...................................... 143 142
Selling, general, and administrative.......................... 1,164 1,680
------ ------
Total operating expenses........................................ 1,307 1,822
------ ------
Income from operations........................................ 200 397
Interest expense................................................ (42) (84)
------ ------
Net income before income taxes................................ 158 313
Income tax expense.............................................. 35 85
------ ------
Net income...................................................... 123 228
Beginning retained earnings..................................... 101 224
------ ------
Ending retained earnings........................................ $224 $452
====== ======
</TABLE>
See accompanying notes to combined financial statements.
F-20
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
COMBINED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
<TABLE>
<CAPTION>
YEARS ENDED
OCTOBER 31,
------------
1994 1995
----- -----
<S> <C> <C>
OPERATING ACTIVITIES
Net income...................................................... $ 123 $ 228
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization.................................. 123 311
Change in deferred income taxes, net........................... (31) (4)
Change in operating assets and liabilities:
Accounts receivable............................................ (273) 221
Inventories.................................................... (102) (245)
Other current assets........................................... -- (59)
Accounts payable, income taxes payable and other accrued
expenses...................................................... 183 273
----- -----
Net cash provided by operating activities.................... 23 725
INVESTING ACTIVITIES
Increase in other assets........................................ (6) --
Purchase of property, plant and equipment....................... (290) (573)
----- -----
Net cash used in investing activities........................ (296) (573)
FINANCING ACTIVITIES
Net payments under line of credit agreement..................... 61 (92)
Payments on long-term debt...................................... (78) (88)
Proceeds from issuance of long-term debt........................ 394 --
Principal payments on capital lease obligations................. (24) (31)
----- -----
Net cash provided by (used in) financing activities.......... 353 (211)
Effect of exchange rates on cash................................. (11) (7)
----- -----
Increase (decrease) in cash and cash equivalents................. 69 (66)
Cash and cash equivalents at beginning of period................. 12 81
----- -----
Cash and cash equivalents at end of period....................... $ 81 $ 15
===== =====
</TABLE>
See accompanying notes to combined financial statements.
F-21
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS
NOTE 1. SIGNIFICANT ACCOUNTING POLICIES
Business Activities.
GCA Fibreoptics Ltd. ("GCA"), is a manufacturer of fiberoptic devices and
distributor of circuit projection components based in Witney, United Kingdom.
Fiberoptics Alignment Solutions, Inc. ("FAS") is a manufacturer and assembler
of fiberoptic components and provides services for a world-wide installed-base
of automated alignment and laser welding systems based in Batavia, Illinois.
Both GCA and FAS as a combined entity will be referred hereafter as "the
Company." Uniphase has entered into a definitive stock purchase agreement with
the shareholders of FAS and GCA to acquire 100% of the outstanding shares of
FAS and GCA, respectively.
Basis of Presentation.
The same individual is the majority shareholder of both GCA and FAS.
Therefore the presentation of the combined financial statements is similar to
the pooling-of-interests method of accounting. Accordingly the financial
statements of FAS as of July 31, 1994 and 1995 and its fiscal years then ended
have been combined with the financial statements of GCA as of October 31, 1994
and 1995 and for its fiscal years then ended. There were no significant events
for FAS in the periods from August 1, 1994 and 1995 to October 31, 1994 and
1995. All intercompany transactions have been eliminated from the combined
financial statements.
Cash and Cash Equivalents.
The Company considers all liquid investments with maturities of ninety days
or less when purchased to be cash equivalents.
Inventories.
Inventories are valued at the lower of cost (first-in, first-out method) or
market. The components of inventory consist of the following:
<TABLE>
<CAPTION>
OCTOBER 31,
---------------
1994 1995
------- -------
(IN THOUSANDS)
<S> <C> <C>
Finished goods................................................. $ 59 $ 62
Work in process................................................ 32 31
Raw materials and purchased parts.............................. 479 722
------- -------
$570 $815
======= =======
</TABLE>
Property, Plant and Equipment.
Property, plant and equipment are stated at cost. Depreciation is computed
under the straight-line method of accounting over the estimated useful lives
of the assets, which range from three to five years. Leasehold improvements
are amortized over the shorter of the estimated useful lives of the assets or
the term of the lease. The components of property, plant and equipment are as
follows:
F-22
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS--(CONTINUED)
<TABLE>
<CAPTION>
OCTOBER 31,
--------------
1994 1995
--------------
(IN THOUSANDS)
<S> <C> <C>
Manufacturing equipment...................................... $ 309 $ 971
Furniture.................................................... 505 619
Leasehold improvements....................................... 32 38
------ -------
846 1,628
Less: accumulated depreciation and amortization.............. 441 686
------ -------
$405 $942
====== =======
</TABLE>
Concentration of Credit Risk.
The Company performs ongoing credit evaluations of its customers and does
not require collateral. The Company provides reserves for potential credit
losses, and such losses and yearly provisions have not been significant and
have been within management's expectations.
Foreign Currency Translation.
Assets and liabilities denominated in foreign currencies are translated
using the exchange rate on the balance sheet dates. Revenues and expenses are
translated using average rates of exchange prevailing during the year. The
translation adjustment resulting from this process is shown separately as a
component of shareholders' equity. Foreign currency transaction gains and
losses are not material and are included in the determination of net income.
Revenue Recognition.
Revenue from the sale of products is generally recognized upon shipment.
Income Taxes.
Income taxes are calculated under the provisions of Statement of Financial
Accounting Standards No. 109 (FAS 109), "Accounting for Income Taxes". Under
FAS 109, the liability method is used in accounting for income taxes which
includes the effects of temporary differences between financial and taxable
amounts of assets and liabilities.
Earnings per Share
Earnings per share information has been omitted because it will not provide
meaningful information of the combined company.
Impact of Recently Issued Accounting Standards.
In March 1995, the FASB issued Statement No. 121, "Accounting for the
Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed of,"
which requires impairment losses to be recorded on long-lived assets used in
operations when indicators of impairment are present and the undiscounted cash
flows estimated to be generated by those assets are less than the assets'
carrying amount. Statement 121 also addresses the accounting for long-lived
assets that are expected to be disposed of. The Company will adopt Statement
121 in the first quarter of the fiscal year 1996 and, based on current
circumstances, does not believe the effect of adoption will be material.
F-23
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS--(CONTINUED)
NOTE 2. COMMITMENTS
The Company's manufacturing and office space in the United Kingdom and the
United States are under leases expiring at various dates from July 1999 to
December 2013. The Company has the option of terminating one of the lease
agreements on December 25, 2003 upon six months written notification. The
Company also
leases office equipment under noncancelable operating leases expiring at
various dates from October 1996 to February 2000. The Company leases certain
equipment under capital leases. Total capitalized costs included in property,
plant and equipment was $29,000 and $311,000 as of October 31, 1994 and 1995,
respectively. The related accumulated depreciation as of October 31, 1994 and
1995 was $8,000 and $55,000, respectively.
The future minimum commitments under capital and operating leases are as
follows:
<TABLE>
<CAPTION>
CAPITAL OPERATING
LEASES LEASES
------- ---------
(IN THOUSANDS)
<S> <C> <C>
1996.......................................................... $96 $114
1997.......................................................... 92 110
1998.......................................................... 63 108
1999.......................................................... 19 106
2000.......................................................... -- 73
Thereafter.................................................... -- 229
---- ----
Total minimum lease payments.................................. 270 $740
====
Less: amounts representing interest........................... 44
----
$226
====
</TABLE>
Rental expense for the years ended October 31, 1994 and 1995 was $74,000 and
$94,000, respectively.
NOTE 3. LINE OF CREDIT.
GCA maintains approximately $1,500,000 revolving line of credit agreement.
Advances under the line of credit bear interest at 2% above the bank's prime
rate (8.75% at October 31, 1995) and are secured by all UK accounts receivable.
As of October 31, 1995 the outstanding balance was $232,000.
NOTE 4. LONG-TERM DEBT.
In March 1994, GCA entered into a Small Firm Guaranteed Loan ("SFG Loan").
The loan is repayable in 60 equal monthly installments and is guaranteed by
substantially all the assets of GCA, totaling $2,266,000 at April 31, 1996.
Interest payable on the loan is prime plus 2%. The balance outstanding as of
October 31, 1994 and 1995 was $345,000 and $262,000, respectively.
Future principal payments on long-term debt, consisting primarily of the SFG
Loan are as follows:
<TABLE>
<CAPTION>
(IN THOUSANDS)
<S> <C>
1996............................................................. $ 82
1997............................................................. 82
1998............................................................. 76
1999............................................................. 32
----
$272
====
</TABLE>
F-24
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS--(CONTINUED)
NOTE 5. INCOME TAXES
The provision for income taxes consists of the following:
<TABLE>
<CAPTION>
YEAR ENDED
OCTOBER 31,
-----------------
1994 1995
------- -------
(IN THOUSANDS)
<S> <C> <C>
Federal:
Current..................................................... $ -- $ 9
State:
Current..................................................... -- 4
Foreign:
Current..................................................... 66 76
Deferred.................................................... (31) (4)
------- -------
Income tax expense $ 35 $ 85
======= =======
</TABLE>
A reconciliation of the income tax expense at the federal statutory rate to
the income tax expense at the effective tax rate is as follows:
<TABLE>
<CAPTION>
YEAR ENDED
OCTOBER 31,
----------------
1994 1995
------- -------
(IN THOUSANDS)
<S> <C> <C>
Income taxes computed at federal statutory rate................ $ 59 $ 112
Foreign income taxes at a rate less than the federal rate...... (26) (18)
Other.......................................................... 2 (9)
------ -------
Total.......................................................... $ 35 $ 85
====== =======
</TABLE>
The components of deferred taxes consist of the following:
<TABLE>
<CAPTION>
YEAR ENDED
OCTOBER 31,
----------------
1994 1995
------- -------
(IN THOUSANDS)
<S> <C> <C>
Deferred tax assets:
Inventory reserve............................................ $ 17 $ 28
Depreciation................................................. 11 4
Accrued rent................................................. 17 17
------- -------
Total deferred tax assets..................................... $ 45 $ 49
======= =======
</TABLE>
The Company believes that deferred tax assets are more likely than not to be
realized from the Company's ongoing operations.
F-25
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO COMBINED FINANCIAL STATEMENTS--(CONTINUED)
NOTE 6. GEOGRAPHICAL AND INDUSTRY SEGMENT INFORMATION
The Company operates in two geographical regions: the United States and
Europe. The Company operates in a single industry segment, the design,
manufacture and sale of fiberoptic components. The following table shows
sales, operating income, and identifiable assets.
<TABLE>
<CAPTION>
YEARS ENDED
OCTOBER 31,
----------------
1994 1995
------- -------
(IN THOUSANDS)
<S> <C> <C>
Net Sales:
United States--domestic...................................... $ -- $ 710
United States--exports....................................... -- 277
Europe....................................................... 3,468 4,922
Eliminations................................................. -- (219)
------- -------
Total net sales............................................. $ 3,468 $ 5,690
======= =======
Operating Income (loss):
United States................................................ $ (5) $ 64
Europe....................................................... 205 333
Eliminations................................................. -- --
------- -------
Total operating income...................................... $ 200 $ 397
======= =======
Identifiable Assets:
United States................................................ $ 71 $ 313
Europe....................................................... 1,950 2,266
------- -------
Total assets................................................ $ 2,021 $ 2,579
======= =======
</TABLE>
Intercompany transfers represent products that are transferred between
geographic areas on a basis intended to reflect as nearly as possible the
market value of the products. Identifiable assets are those assets of the
Company that are identified with the operations of the corresponding
geographic area.
One customer accounted for 11% of combined net sales in the year ended
October 31, 1995. No customers accounted for more than 10% of combined net
sales in the year ended October 31, 1994.
NOTE 7. SUPPLEMENTAL CASH FLOW INFORMATION
<TABLE>
<CAPTION>
YEAR ENDED
JUNE 30,
-----------
1994 1995
----- -----
<S> <C> <C>
Interest paid during the year...................................... $ 43 $ 84
Non-cash transactions
Assets acquired through capital leases............................ $ 27 $ 225
Stocks issued in exchange for assets contributed.................. $ -- $ 50
</TABLE>
NOTE 8. STOCK OPTION AGREEMENT
As of October 31, 1994, Company has reserved 50,000 shares of common stock
for future issuance to a minority shareholder. As of October 31, 1994 10,000
options were granted at an exercise price of $3.60. No options had been
exercised and the outstanding options expired in March 1995.
F-26
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
CONDENSED COMBINED BALANCE SHEETS (UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)
<TABLE>
<CAPTION>
APRIL 30,
1996
---------
<S> <C>
ASSETS
Current assets:
Cash and cash equivalents.......................................... $ 28
Accounts receivable, less allowance for doubtful accounts of $26 at
April 30, 1996.................................................... 779
Inventories........................................................ 1,064
Other current assets............................................... 123
------
Total current assets............................................. 1,994
Property, plant and equipment, net................................... 886
Other assets......................................................... 3
------
Total assets..................................................... $2,883
======
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Notes payable to bank.............................................. $ 451
Accounts payable................................................... 973
Income taxes payable............................................... 109
Other accrued expenses............................................. 246
Current portion of long-term debt and lease obligations............ 82
Current portion of lease obligations............................... 79
------
Total current liabilities........................................ 1,940
Long-term debt, less current portion................................. 159
Capital lease obligations, less current portion...................... 96
Shareholders' equity:
Common stock....................................................... 3
Additional paid-in capital......................................... 304
Notes receivable from shareholders................................. (1)
Retained earnings.................................................. 382
------
Total shareholders' equity....................................... 688
------
Total liabilities and shareholders' equity....................... $2,883
======
</TABLE>
See accompanying notes to condensed combined financial statements.
F-27
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
CONDENSED COMBINED STATEMENTS OF OPERATIONS (UNAUDITED)
(IN THOUSANDS)
<TABLE>
<CAPTION>
SIX MONTHS ENDED
APRIL 30,
------------------
1995 1996
-------- --------
<S> <C> <C>
Net sales.................................................. $3,078 $ 2,909
Cost of sales.............................................. 1,790 2,048
-------- --------
Gross profit............................................. 1,288 861
Operating expenses:
Research and development................................. 84 80
Selling, general, and administrative..................... 859 753
-------- --------
Total operating expenses............................... 943 833
-------- --------
Income from operations..................................... 345 28
Interest expense........................................... (44) (42)
-------- --------
Net income (loss) before income taxes...................... 301 (14)
Income tax expense....................................... 70 28
-------- --------
Net income (loss).......................................... $ 231 $ (42)
======== ========
</TABLE>
See accompanying notes to condensed combined financial statements.
F-28
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
CONDENSED COMBINED STATEMENTS OF CASH FLOWS (UNAUDITED)
(IN THOUSANDS)
<TABLE>
<CAPTION>
SIX MONTHS ENDED
APRIL 30,
------------------
1995 1996
-------- --------
<S> <C> <C>
OPERATING ACTIVITIES
Net income............................................... 231 (42)
Adjustments to reconcile net income to cash provided by
operating activities:
Depreciation and amortization.......................... 146 162
Change in deferred taxes, net.......................... 3 7
Change in operating assets and liabilities:
Accounts receivable.................................... (403) (103)
Inventories............................................ (112) (249)
Other current assets................................... (113) (2)
Accounts payable, income taxes payable and other
accrued expenses...................................... 314 232
-------- --------
Net cash provided by operating activities............ 66 5
INVESTING ACTIVITIES
Purchase of property, plant and equipment................ (495) (106)
-------- --------
Net cash used in investing activities................ (495) (106)
FINANCING ACTIVITIES
Net borrowings under line of credit agreement............ 404 219
Payments on long-term debt............................... (31) (31)
Principal payments on capital lease obligations.......... (3) (51)
-------- --------
Net cash provided by financing activities............ 370 137
Effect of exchange rates on cash........................... 4 (23)
-------- --------
Increase (decrease) in cash and cash equivalents........... (55) 13
Cash and cash equivalents at beginning of period........... 81 15
-------- --------
Cash and cash equivalents at end of period................. 26 28
======== ========
Supplemental disclosures of noncash activities
Assets acquired through capital leases................... 80 --
Stock issued in exchange for assets contributed.......... 50 --
</TABLE>
See accompanying notes to condensed combined financial statements.
F-29
<PAGE>
GCA FIBREOPTICS LTD. AND FIBEROPTICS ALIGNMENT SOLUTIONS, INC.
NOTES TO INTERIM CONDENSED COMBINED FINANCIAL STATEMENTS (UNAUDITED)
FOR THE SIX MONTHS ENDED APRIL 30, 1996 AND 1995
NOTE 1.
BASIS OF PRESENTATION.
The accompanying financial statements have been prepared in accordance with
generally accepted accounting principles for interim financial information and
with rules 10-01 of Regulation S-X. Accordingly, they do not include all of
the footnote information required by generally accepted accounting principles
for annual financial statements. In the opinion of management, all adjustments
(consisting of normal recurring adjustments) necessary for a fair presentation
of financial condition and results of operations have been included. Detailed
footnote information for the periods are not presented. The results of
operations for the six months ended April 30, 1996 are not necessarily
indicative of the results of operations to be expected for the full year
ending July 31, 1996.
Prior to the Company's acquisition of GCA and FAS, the same individual had
been the majority shareholder of both GCA and FAS. Therefore, the presentation
of the combined financial statements is in a similar manner to the pooling-of-
interests method of accounting. Accordingly the financial statements of FAS as
of January 31, 1996 and the six month periods then ended, have been combined
with the financial statements of GCA as of April 30, 1996 and the six month
periods then ended. All intercompany transactions have been eliminated from
the combined financial statements.
NOTE 2.
INVENTORIES.
Inventory consists of the following:
<TABLE>
<CAPTION>
APRIL 30, 1996
--------------
(IN THOUSANDS)
<S> <C>
Finished goods............................................. $ 71
Work in process............................................ 36
Raw materials and purchased parts.......................... 957
------
$1,064
======
</TABLE>
NOTE 3.
LINE OF CREDIT.
In November 1995, FAS agreed to a $150,000 revolving line of credit
agreement. Advances under the line of credit bear interest at 2% above the
bank's prime rate (10.25% at April 30, 1996) and are secured by all
receivables, inventory, property, plant and equipment, and any cash and non-
cash proceeds of any of the foregoing items. Under the terms of the agreement,
the Company is required to maintain certain debt to tangible net worth ratios
and net cash flow related to the long-term debt. The agreement has been
guaranteed by two significant shareholders of the Company. As of April 30,
1996 the outstanding balance was $140,000.
F-30
<PAGE>
================================================================================
No dealer, sales representative, or any other person has been authorized to
give any information or to make any representations in connection with this
offering other than those contained in this Prospectus, and, if given or made,
such information or representations must not be relied upon as having been
authorized by the Company or the Underwriters. This Prospectus does not
constitute an offer to sell or a solicitation of any offer to buy any
securities other than the shares of Common Stock to which it relates or an
offer to, or a solicitation of, any person in any jurisdiction where such an
offer or solicitation would be unlawful. Neither the delivery of this
Prospectus nor any sale made hereunder shall, under any circumstances create an
implication that there has been no change in the affairs of the Company or that
information contained herein is correct as of any time subsequent to the date
hereof.
-------------------
TABLE OF CONTENTS
-------------------
<TABLE>
<CAPTION>
Page
----
<S> <C>
Available Information..................................................... 2
Incorporation of Certain Documents by Reference........................... 2
Prospectus Summary........................................................ 3
Risk Factors.............................................................. 5
Recent Developments....................................................... 13
Use of Proceeds........................................................... 13
Price Range of Common Stock............................................... 14
Dividend Policy........................................................... 14
Capitalization............................................................ 15
Selected Consolidated Financial Data...................................... 16
Unaudited Combined Pro Forma
Financial Information.................................................... 17
Management's Discussion and Analysis of Financial Condition and Results of
Operations............................................................... 20
Business.................................................................. 28
Management................................................................ 42
Principal Stockholders.................................................... 44
Underwriting.............................................................. 45
Legal Matters............................................................. 46
Experts................................................................... 46
Index to Financial Statements............................................. F-1
</TABLE>
===============================================================================
===============================================================================
2,000,000 SHARES
[UNIPHASE LOGO]
COMMON STOCK
----------------
PROSPECTUS
----------------
MONTGOMERY SECURITIES
ALEX. BROWN & SONS
INCORPORATED
UNTERBERG HARRIS
JOSEPHTHAL LYON & ROSS
INCORPORATED
June , 1996
================================================================================
<PAGE>
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth the costs and expenses, other than
underwriting discounts and commissions, payable by the Company in connection
with the sale of Common Stock being registered. All amounts are estimates
except the SEC registration fee, NASD filing fee and Nasdaq listing fee.
<TABLE>
<CAPTION>
AMOUNT TO BE PAID
-----------------
<S> <C>
SEC registration fee.................................... $ 24,884
NASD filing fee......................................... 7,716
Nasdaq listing fee...................................... 17,500
Printing expenses....................................... 100,000
Legal fees and expenses................................. 100,000
Accounting fees and expenses............................ 180,000
Blue Sky fees and expenses.............................. 10,000
Transfer agent fees..................................... 10,000
Miscellaneous expenses.................................. 99,900
--------
Total................................................. $550,000
========
</TABLE>
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
The indemnification and liability of the Company's directors and officers
are governed by Delaware law.
Under Section 145 of the General Corporation Law of the State of Delaware,
the Registrant has broad powers to indemnify its directors and officers
against liabilities that may incur in such capacities, including liabilities
under the Securities Act of 1933, as amended (the "Securities Act"). The
Registrant's Bylaws also provide for mandatory indemnification of its
directors and executive officers, and permissive indemnification of its
employees and agents, to the fullest extent permissible under Delaware law.
The Registrant's Certificate of Incorporation provides that the liability of
its directors for monetary damages shall be eliminated to the fullest extent
permissible under Delaware law. Pursuant to Delaware law, this includes
elimination of liability for monetary damages for breach of the directors'
fiduciary duty of care to the Registrant and its stockholders. These
provisions do not eliminate the directors' duty of care and, in appropriate
circumstances, equitable remedies such as injunctive or other forms of non-
monetary relief will remain available under Delaware law. In addition, each
director will continue to be subject to liability for breach of the director's
duty of loyalty to the Registrant, for acts of omissions not in good faith or
involving intentional misconduct, for knowing violations of law, for any
transaction from which the director derived an improper personal benefit, and
for payment of dividends or approval of stock repurchases or redemptions that
are unlawful under Delaware law. The provision also does not affect a
director's responsibilities under any other laws, such as the federal
securities laws or state or federal environmental laws.
The Registrant has entered into agreements with its directors and certain of
its executive officers that require the Registrant to indemnify such persons
against expenses, judgments, fines, settlements and other amounts actually and
reasonably incurred (including expenses of a derivative action) in connection
with any proceeding, whether actual or threatened, to which any such person
may be made a party by reason of the fact that such person is or was a
director or officer of the Registrant or any of its affiliated enterprises,
provided such person acted in good faith and in a manner such person
reasonably believed to be in or not opposed to the best interests of the
Registrant and, with respect to any criminal proceeding, had no reasonable
cause to believe his or her conduct was unlawful. The indemnification
agreement also sets forth certain procedures that will apply in the event of a
claim for indemnification thereunder.
II-1
<PAGE>
The Registrant has obtained a policy of directors' and officers' liability
insurance that insures the Company's directors and officers against the cost
of defense, settlement or payment of a judgment under certain circumstances.
The Underwriting Agreement provides for cross-indemnification of the
Underwriters and the Registrant and its officers and directors for certain
liabilities arising under the Securities Act or otherwise.
ITEM 16. EXHIBITS
(a) Exhibits
<TABLE>
<CAPTION>
NO. DESCRIPTION
--- -----------
<C> <S>
1.1+ Form of Underwriting Agreement
2.1+ Purchase and Sale Agreement between Registrant and Tasman-Sterling
Associates, a California general partnership, dated January 30, 1996
(incorporated by reference to the indicated exhibit to the Company's
Current Report on Form 8-K filed February 22, 1996)
2.2 Form of Stock Purchase Agreement between Registrant, Fiberoptic
Alignment Solutions, Inc., an Illinois corporation ("FAS"), Uniphase
Telecommunications Products, Inc., a Delaware corporation, and the
shareholders of FAS named therein, and Amendment No. 1 thereto dated
as of May 31, 1996
2.3++ Form of Agreement between Registrant and GCA Fibreoptics Limited for
the Sale and Purchase of the Entire Issued Share Capital of GCA
Fibreoptics Limited
5.1+ Opinion of Morrison & Foerster LLP
23.1 Consent of Ernst & Young LLP, Independent Auditors
23.2+ Consent of Counsel (included in Exhibit 5.1)
24.1+ Power of Attorney (see page II-3)
27 Financial Data Schedule
</TABLE>
- -------
+ Previously filed.
++Filed pursuant to Rule 202 of Regulation S-T of the Securities and Exchange
Act of 1934, as amended.
ITEM 17. UNDERTAKINGS
Insofar as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the foregoing provisions, or otherwise, the Registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities
Act, and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer or controlling
person of the Registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question of
whether such indemnification by it is against public policy as expressed in
the Securities Act and will be governed by the final adjudication of such
issue.
The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act,
the information omitted from the form of Prospectus filed as part of this
Registration Statement in reliance upon Rule 430A and contained in a form
of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4), or
497(h) under the Securities Act shall be deemed to be part of this
Registration Statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act, each post-effective amendment that contains a form of Prospectus shall
be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
(3) For the purpose of determining liability under the Securities Act,
each filing of the Registrant's annual report pursuant to Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan's annual report
pursuant to Section 15(d) of the Exchange Act) that is incorporated by
reference in the Registration Statement shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
II-2
<PAGE>
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED, THE
REGISTRANT CERTIFIES THAT IT HAS REASONABLE GROUNDS TO BELIEVE THAT IT MEETS
ALL OF THE REQUIREMENTS FOR FILING ON FORM S-3 AND HAS DULY CAUSED THIS
AMENDMENT NO. 1 TO THE REGISTRATION STATEMENT TO BE SIGNED ON ITS BEHALF BY
THE UNDERSIGNED, THEREUNTO DULY AUTHORIZED, IN THE CITY OF SAN JOSE, STATE OF
CALIFORNIA, ON THE 6TH DAY OF JUNE, 1996.
Uniphase Corporation
/s/ Kevin N. Kalkhoven
By: _________________________________
KEVIN N. KALKHOVEN
PRESIDENT, CHIEF EXECUTIVE OFFICER
AND CHAIRMAN OF THE BOARD OF
DIRECTORS
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, AS AMENDED, THIS
AMENDMENT NO. 1 TO THE REGISTRATION STATEMENT HAS BEEN SIGNED BY THE FOLLOWING
PERSONS IN THE CAPACITIES AND ON THE DATES INDICATED:
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
<S> <C> <C>
/s/ Kevin Kalkhoven President, Chief June 6, 1996
- ------------------------------------- Executive Officer
KEVIN N. KALKHOVEN and Chairman of the
Board of Directors
(Principal
Executive Officer)
/s/ Dan E. Pettit* Vice President, June 6, 1996
- ------------------------------------- Finance, Chief
DAN E. PETTIT Financial Officer
and Secretary
(Principal
Financial and
Accounting Officer)
- ------------------------------------- Director
WILLIAM B. BRIDGES, PH.D.
/s/ Robert C. Fink* Director June 6, 1996
- -------------------------------------
ROBERT C. FINK
/s/ Catherine P. Goodrich* Director June 6, 1996
- -------------------------------------
CATHERINE P. GOODRICH
/s/ Stephen C. Johnson* Director June 6, 1996
- -------------------------------------
STEPHEN C. JOHNSON
/s/ Anthony R. Muller* Director June 6, 1996
- -------------------------------------
ANTHONY R. MULLER
Director
- -------------------------------------
WILSON SIBBETT, PH.D.
*By: /s/ Kevin N. Kalkhoven
- ----------------------------------
KEVIN N. KALKHOVEN
Attorney-in-fact
</TABLE>
II-3
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
SEQUENTIALLY
EXHIBIT NUMBERED
NUMBER EXHIBITS PAGE
------- -------- ------------
<C> <S> <C>
1.1+ Form of Underwriting Agreement
2.1+ Purchase and Sale Agreement between Registrant and
Tasman-Sterling Associates, a California general
partnership, dated January 30, 1996 (incorporated by
reference to the indicated exhibit to the Company's
Current Report on Form 8-K filed February 22, 1996)
2.2 Form of Stock Purchase Agreement between Registrant,
Fiberoptic Alignment Solutions, Inc., an Illinois
corporation ("FAS"), Uniphase Telecommunications
Products, Inc., a Delaware corporation, and the
shareholders of FAS named therein, and Amendment No. 1
thereto dated as of May 31, 1996
2.3++ Form of Agreement between Registrant and GCA
Fibreoptics Limited for the Sale and Purchase of the
entire issued share capital of GCA Fibreoptics Limited
as of May 24, 1996
5.1+ Opinion of Morrison & Foerster LLP
23.1 Consent of Ernst & Young LLP, Independent Auditors
23.2+ Consent of Counsel (included in Exhibit 5.1)
24.1+ Power of Attorney (see page II-3)
27 Financial Data Schedule
</TABLE>
- --------
+ Previously filed.
++Filed pursuant to Rule 202 of Regulation S-T of the Securities and Exchange
Act of 1934, as amended.
<PAGE>
EXHIBIT 2.2
STOCK PURCHASE AGREEMENT
among
UNIPHASE CORPORATION
FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
and
THE SHAREHOLDERS OF FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
Dated as of May 24, 1996
<PAGE>
STOCK PURCHASE AGREEMENT
STOCK PURCHASE AGREEMENT (the "Agreement"), dated and effective as of
May 24, 1996, by and among Fiberoptic Alignment Solutions, Inc., a corporation
organized and existing under the laws of the State of Illinois ("FAS" or "Target
Corporation"), Uniphase Telecommunications Products, Inc., a corporation
organized and existing under the laws of the State of Delaware ("UTP" or
"Acquiring Corporation"), and each and every shareholder of FAS identified on
the signature pages hereto (individually, a "Shareholder", collectively, the
"Shareholders"). Certain capitalized terms in this Agreement are defined in
Section 10.12.
RECITALS
--------
A. The Shareholders are the record owners of all of the 1,000 outstanding
shares at no par value of the common stock of the Target Corporation (the
"Shares"). The Acquiring Corporation wishes to purchase all of the outstanding
Shares of the Target Corporation from the Shareholders upon the terms herein
provided.
B. To induce Acquiring Corporation to enter into this transaction, the
Shareholders are willing to make the representations and warranties set forth
herein.
NOW THEREFORE, in consideration of the foregoing and the mutual promises
contained herein, the parties agree as follows:
AGREEMENT
---------
ARTICLE 1
PURCHASE AND SALE OF SHARES
1.1 Purchase and Sale. Subject to the terms and conditions set forth in
this Agreement, and in accordance with the Business Corporation Act of 1983 of
the State of Illinois (the "IBCA"), at the Closing (as defined below),
each Shareholder agrees to sell and transfer to the Acquiring Corporation, and
the Acquiring Corporation agrees to purchase from each Shareholder, all of the
Shares owned by such Shareholder. The obligations of each of the Shareholders to
sell the Shares held by him shall be several and not joint.
1.2 Purchase Price. In consideration of the sale of the Shares by the
Shareholders, and in consideration of the representations, warranties and
covenants of the Target Corporation and the Shareholders, the
Acquiring Corporation agrees to pay to the Shareholders the amount of $6,197.03
per Share (except as provided in Exhibit B attached hereto) for an aggregate
consideration of $6,197,030 (the "Purchase Price"). The Purchase Price shall be
paid by Uniphase to the Shareholders at the Closing by way of a certified or
bank cashier's check or wire transfer ("Same Day Funds") or pursuant to an
unsecured promissory note delivered to the Shareholders at Closing in
substantially the form attached hereto as Exhibit A-1 and, in the case of the
promissory note deliverable to J. Timothy Greaves, Exhibit A-2 (the "Note(s)").
The allocation of the Purchase Price between cash and Notes to each Shareholder
is set forth in Exhibit B attached hereto.
1.3 The Closing. Within three business days after the execution of this
Agreement (or such later date as the parties may agree), a closing (the
"Closing") will be held at the offices of Morrison & Foerster, 755 Page Mill
Road, Palo Alto, California 94306 (or such other place as the parties may agree)
for the purpose of confirming satisfaction or waiver of all conditions contained
herein as of the Closing Date (as defined below) and for the purpose of
delivering the Shares and payment of the Purchase Price. Subject to the
satisfaction or waiver of each of the conditions specified in Articles 7 and 8
hereof as of the Closing Date, the following shall occur:
(a) Each Shareholder shall deliver or cause to deliver to the
Acquiring Corporation certificates representing all of the Shares owned by such
Shareholder duly endorsed in favor of Uniphase.
(b) The Acquiring Corporation shall pay the Purchase Price by
delivery of Same Day Funds or Notes to the Shareholders in accordance with
Exhibit B attached hereto.
The date on which the Closing occurs is referred herein as the
"Closing Date".
1.4 Guarantee of Existing Loans of Target Corporation. Uniphase shall use
its reasonable commercial best efforts to cause those Shareholders and their
respective spouses who have guaranteed those certain loans of Target Corporation
in the approximate aggregate principal amount of $175,000 (the "Guaranteed
Loans") with First National Bank of Chicago ("First National Bank") to be
released from such guarantees within thirty (30) days following the Closing
Date. Uniphase agrees to defend, indemnify and hold harmless each of such
Shareholders and their spouses from any liability or expenses paid or incurred
by such persons after the Closing Date pursuant to such guarantees.
2
<PAGE>
ARTICLE 2
REPRESENTATIONS AND WARRANTIES OF TARGET
CORPORATION AND SHAREHOLDERS
Target Corporation and the Shareholders hereby jointly and
severally represent and warrant to Acquiring Corporation as follows:
2.1 Corporate Organization; Etc.
(a) Target Corporation is a corporation duly organized, validly
existing and in good standing under the law of Illinois; has full power and
authority (corporate and otherwise) to carry on its business as it is now being
conducted and to own, lease or operate its properties and assets; and is duly
qualified or licensed to do business as a foreign corporation in good standing
in every jurisdiction in which the character or location of the properties and
assets owned, leased or operated by it or the conduct of its business requires
such licensing or qualification, except in those jurisdictions where the failure
to be so duly qualified or licensed in good standing will not have a material
adverse effect on the business, operation, properties, assets or condition
(financial or otherwise) of the Target Corporation (the "Business"). A schedule
initialed and delivered by Target Corporation to Acquiring Corporation prior to
the execution and delivery of this Agreement (the "Disclosure Schedule") lists
all such jurisdictions in which Target Corporation is qualified or licensed to
do business.
(b) Target Corporation has delivered to Acquiring Corporation complete
and correct copies of (i) its Articles of Incorporation, as amended to date,
certified by the appropriate official of the Target Corporation's jurisdiction
of incorporation; and (ii) its Bylaws, as amended to date, certified by the
Secretary of the Target Corporation. The Target Corporation's Certificate of
Incorporation and Bylaws are in full force and effect, and the Target
Corporation is in full compliance with the provisions thereof.
2.2 Capitalization. As of the date of this Agreement, the authorized
capital stock of Target Corporation consists of 10,000 shares of FAS Stock, no
par value per share. At the date hereof, 1,000 shares of FAS Stock were issued
and outstanding. All issued and outstanding shares of FAS Stock are duly
authorized, validly issued, fully paid, nonassessable and free of preemptive
rights. Except as set forth above, as of the date of this Agreement, there are
no shares of capital stock or other securities of Target Corporation
outstanding; there are no outstanding options, warrants, conversion or exchange
privileges or other rights to purchase or obtain any capital stock of Target
Corporation and there are no contracts, commitments, understandings,
arrangements or restrictions relating to the issuance, sale, transfer or
purchase by Target Corporation of any shares of its capital stock.
2.3 Subsidiaries. At the date hereof, Target Corporation does not have any
Subsidiaries (as defined below) and does not own any equity interest (or have
the right to acquire any equity interest) in any other corporation, partnership,
joint venture or other business entity.
2.4 Authorization. Target Corporation has full corporate power and
authority to enter into this Agreement and to carry out the transactions
contemplated hereby. The Board of Directors of Target Corporation has taken all
action required by law, its Articles of Incorporation, its Bylaws or otherwise
to authorize the execution, delivery and performance of this Agreement and the
consummation of the transactions contemplated hereby. This Agreement has been
duly and validly authorized, executed and delivered and no other corporate
action is necessary except Target Corporation shareholders' approval of the
Exchange. Subject to obtaining the necessary approval by shareholders of Target
Corporation, this Agreement is a valid and binding obligation of Target
Corporation enforceable in accordance with its terms.
3
<PAGE>
2.5 No Violation. Except as set forth in the Disclosure Schedule, neither
the execution and delivery of this Agreement nor its performance and the
consummation of the transactions contemplated hereby will (a) violate any
provision of the Articles of Incorporation or Bylaws of Target Corporation, (b)
violate, or be in conflict with, or constitute a default (or an event which,
with or without due notice or lapse of time, or both, would constitute a
default) under, or result in the modification or termination of, or cause or
permit the acceleration of the maturity of any debt, obligation, contract,
commitment or other agreement to which Target Corporation is a party or by which
it or its property may be bound, (c) result in the creation or imposition of any
mortgage, pledge, lien, security interest, encumbrance, restriction, charge or
limitation of any kind, upon any property or assets of Target Corporation, or
(d) violate any statute or law or any judgment, decree, order, regulation or
rule of any court or governmental authority.
2.6 Consents and Approvals of Government Authorities. Except as set forth
in the Disclosure Schedule and for filing and recordation of the Articles of
Exchange as required by the laws of the States of Illinois, no consent, approval
or authorization of, or declaration, filing or registration with, any
governmental or regulatory authority is required in connection with the
execution, delivery and performance of this Agreement by Target Corporation and
the consummation of the transactions contemplated thereby.
2.7 Financial Statements. Target Corporation has furnished to Acquiring
Corporation an unaudited, internal balance sheet of Target Corporation as of
July 31, 1995 and a statement of income for the year then ended. Target
Corporation also has furnished to Acquiring Corporation the unaudited, internal
balance sheet of Target Corporation as of April 30, 1996 and a statement of
income for the nine (9) month period then ended. All of such financial
statements are in accordance with the books and records of Target Corporation.
The above balance sheets and the notes thereto are complete and correct and
fully and fairly present the assets, Liabilities and financial condition of
Target Corporation as at the respective dates thereof, and the statements of
income are complete and correct and fully and fairly present the results of the
operations for the periods therein referred to.
2.8 No Undisclosed Liabilities; Etc. Target Corporation has no Liabilities
of the type required to be reflected or disclosed in a balance sheet (or the
notes thereto) prepared in accordance with generally accepted accounting
principles except (a) Liabilities that are fully reflected or reserved against
in the April 30, 1996 balance sheet (the "Balance Sheet"), which reserves are
adequate, appropriate and reasonable, (b) Liabilities incurred in the ordinary
course of business and consistent with past practice since the date of the
Balance Sheet and (c) as set forth in the Disclosure Schedule.
2.9 Absence of Certain Changes. Except as and to the extent set forth in
the Disclosure Schedule, since the date of the Balance Sheet, Target Corporation
has not:
4
<PAGE>
(a) Suffered any material adverse change in its condition (financial
or otherwise), working capital, assets, Liabilities, reserves, business,
operations or prospects;
(b) Suffered any loss, damage, destruction or other casualty
materially and adversely affecting any of the properties, assets or business
of Target Corporation (whether or not covered by insurance);
(c) Borrowed or agreed to borrow any funds or incurred, or assumed
or became subject to, whether directly or by way of guarantee or otherwise,
any Liability except those incurred in the ordinary course of business and
consistent with past practice;
(d) Paid, discharged or satisfied any claims or Liabilities other
than the payment, discharge or satisfaction in the ordinary course of business
and consistent with past practice of Liabilities reflected or reserved against
in the Balance Sheet or incurred in the ordinary course of business and
consistent with past practice since the date of the Balance Sheet;
(e) Permitted or allowed any of its property or assets (real, personal
or mixed, tangible or intangible) to be subjected to any mortgage, pledge, lien,
security interest, encumbrance, restriction or charge of any kind, except those
of a kind permitted under Section 2.10 hereof;
(f) Written down the value of any inventory or written off as
uncollectible any notes or accounts receivable, except for write-downs and
write-offs in the ordinary course of business and consistent with past
practice, none of which is material;
(g) Cancelled any debts or waived any claims or rights of substantial
value, or sold, transferred, or otherwise disposed of any of its properties or
assets (real, personal or mixed, tangible or intangible), except in the ordinary
course of business and consistent with past practice;
(h) Licensed, disposed of or permitted to lapse any rights to the use
of any patent, trademark, trade name, technology, process, or other intangible
asset, copyright, or disposed of or disclosed to any Person any trade secret,
formula, technology, process or know-how not theretofore a matter of public
knowledge;
(i) Granted any general increase in the compensation of officers or
employees (including any such increase pursuant to any bonus, pension, profit-
sharing or other plan or commitment) or any increase in the compensation payable
or to become payable to any officer or employee, except for normal periodic
increases made pursuant to Target Corporation's established compensation
policies applied on a basis consistent with that of the prior two years, which
policies are briefly summarized in the Disclosure Schedule;
(j) Made any capital expenditure or commitment in excess of $25,000
individually or in excess of $50,000 in the aggregate for additions to
property, plant or equipment;
5
<PAGE>
(k) Declared, paid or set aside for payment any dividend or other
distribution in respect of its capital stock or, directly or indirectly,
redeemed, purchased or otherwise acquired any shares of its capital stock or
other securities;
(l) Made any change in any method of accounting or accounting
practice;
(m) Paid, loaned or advanced any amount to, or sold, transferred or
leased any properties or assets (real, personal or mixed, tangible or
intangible) to, or entered into any agreement or arrangement with any of its
officers or directors or any Affiliate or Associate of any of its officers or
directors, except for directors' fees, and compensation to officers at rates not
exceeding the rates of compensation paid during the fiscal quarter ended March
31, 1996;
(n) Entered into any other transaction, contract or commitment other
than in the ordinary course of business; and
(o) Agreed, whether in writing or otherwise, to take any action
described in this Section 2.9.
2.10 Title to Properties; Encumbrances. Except as set forth in the
Disclosure Schedule, Target Corporation has good and marketable title to or a
valid leasehold interest in all its properties and assets (real, personal and
mixed, tangible and intangible), including, without limitation, all the
properties and assets reflected in the Balance Sheet (except for properties and
assets sold since the date of the Balance Sheet in the ordinary course of
business and consistent with past practice), and all the properties and assets
purchased or otherwise acquired by Target Corporation since the date of the
Balance Sheet. Except as set forth in the Disclosure Schedule, all such
properties and assets reflected in the Balance Sheet have a fair market or net
realizable value at least equal to the value thereof as reflected therein, and
none of such properties or assets is subject to any mortgage, pledge, lien,
security interest, encumbrance, restriction, variance, charge or limitation of
any kind except the following: (a) liens shown on the Balance Sheet securing
specified Liabilities or obligations with respect to which no default exists (or
event that, whether with or without notice, lapse of time, or the happening or
occurrence of any other event would constitute a default); (b) mechanics',
carriers', worker's and other similar liens arising in the ordinary course of
business and consistent with past practice since the date of the Balance Sheet;
(c) exceptions disclosed in the Disclosure Schedule; (d) minor imperfections of
title, if any, none of which is substantial in amount, materially detracts from
the value or impairs the use of the property subject thereto, or impairs the
operations of Target Corporation; (e) zoning laws that do not impair the present
or anticipated use of the property subject thereto; and (f) liens for current
taxes not yet due and payable for which adequate reserves have been provided.
The properties and assets of the Target Corporation include all rights,
properties and other assets necessary to permit Target Corporation to conduct
its business in all material respects in the same manner as it is conducted on,
and has been conducted prior to, the date of this agreement.
2.11 Plants and Equipment. Except as set forth in the Disclosure Schedule,
the plants, structures and equipment of Target Corporation are structurally
sound with no material defects and in good operating condition and repair and
are adequate for the uses to which they are
6
<PAGE>
being put; and none of such plants, structures or equipment is in need of
maintenance or repairs except for ordinary, routine maintenance and repairs. All
buildings, plants and structures owned by Target Corporation lie wholly within
the boundaries of the real property owned by Target Corporation and do not
encroach upon the property of, or otherwise conflict with the rights of, any
other Person.
2.12 Leases. The Disclosure Schedule contains (a) an accurate and complete
list of all leases pursuant to which Target Corporation leases real property,
including for each lease a brief description of Target Corporation's financial
obligations under such lease, its expiration date and renewal terms and (b) a
complete list and description by generic category of all leases pursuant to
which Target Corporation leases personal property. All such leases are valid,
binding and enforceable in accordance with their terms, and are in full force
and effect; except as set forth in such Disclosure Schedule, there are no
existing defaults by Target Corporation or the other party thereunder; no event
of default has occurred which (whether with or without notice, lapse of time or
the happening or occurrence of any other event) would constitute a default
thereunder; and all lessors under such leases have consented (where such consent
is necessary) to the consummation of the transactions contemplated by this
Agreement.
2.13 Patents, Trademarks, Trade Names. Target Corporation owns, or is
licensed or otherwise has the full right to use, all patents, trademarks, trade
names, copyrights, technology, know-how and processes used in or necessary for
the conduct of its business as heretofore conducted. The Disclosure Schedule
contains an accurate and complete description of (a) all patents, trademarks,
trade names and copyrights used or proposed to be used by Target Corporation,
all applications therefor, and the terms of all licenses and other agreements
relating thereto, and (b) the terms of all agreements relating to technology,
know-how or processes that Target Corporation is licensed or authorized to use
by others. Except as set forth in the Disclosure Schedule, Target Corporation
has the sole and exclusive right to use the licenses, patents, trademarks, trade
names, copyrights, technology, know-how and processes referred to in the
Disclosure Schedule, and the consummation of the transactions contemplated
hereby will not alter or impair any such rights; no claims have been asserted by
any Person to the use of any such licenses, patents, trademarks, trade names,
copyrights, technology, know-how or processes or challenging or questioning the
validity or effectiveness of any such license or agreement, and there is no
valid basis for any such claim; and the use of such licenses, patents,
trademarks, trade names, copyrights, technology, know-how or processes by Target
Corporation does not infringe on the rights of any Person.
2.14 Litigation. Except as set forth in the Disclosure Schedule, there is
no legal, administrative, arbitration or other proceeding, claim, or action of
any nature or investigation pending or threatened against or involving Target
Corporation, or which questions or challenges the validity of this Agreement or
any action taken or to be taken by Target Corporation pursuant to this Agreement
or in connection with the transactions contemplated hereby; and Target
Corporation does not know or have any reason to know of any valid basis for any
such legal, administrative, arbitration or other proceeding, claim, or action of
any nature or investigation. Target Corporation is not subject to any judgment,
order or decree entered in any lawsuit or proceeding which has had an adverse
effect on its business practices or on its ability to acquire any property or
conduct its business in any area.
7
<PAGE>
2.15 Tax Returns. Target Corporation has duly filed all federal, state,
local and foreign tax reports and returns required to be filed by it and, except
as set forth in the Disclosure Schedule, has duly paid all taxes and other
charges due or claimed to be due from it by federal, state, local or foreign
taxing authorities; the reserves for taxes reflected in the Balance Sheet are
adequate; and there are no tax liens upon any property or assets of Target
Corporation. The consolidated federal income tax returns of Target Corporation
and the federal income tax returns of each Subsidiary obligated to file a
federal income tax return whose results of operations are not consolidated in
the federal income tax returns of Target Corporation have been examined by the
Internal Revenue Service for all periods to and including those expressly set
forth in the Disclosure Schedule; and, except to the extent shown therein, all
deficiencies asserted as a result of such examinations have been paid or finally
settled and no issue has been raised by the Internal Revenue Service in any such
examination which, by application of similar principles, reasonably could be
expected to result in a proposed deficiency for any other period not so
examined. Except as set forth in the Disclosure Schedule, the tax returns of
each Subsidiary which is based or incorporated outside of the United States have
been examined by the relevant national and local taxing authorities or closed
without examination in the jurisdictions of their organization or principal
place of business for all periods to and including those expressly set forth in
the Disclosure Schedule and, except to the extent shown therein, all
deficiencies and assessments resulting from such examinations of each Subsidiary
have been paid or finally settled and no issue has been raised by any of the
relevant taxing authorities in any such examination which, by application of
similar principles, reasonably could be expected to result in a proposed
deficiency for any other period not so examined. Further, no state of facts
exists or has existed which would constitute grounds for the assessment of any
further tax liability with respect to the periods which have not been audited by
the Internal Revenue Service or the applicable state, local, or foreign tax
authorities. All deficiencies and assessments resulting from examination of
state, local and foreign tax returns and reports of Target Corporation and each
Subsidiary have been paid. Except to the extent set forth in the Disclosure
Schedule, there are no outstanding agreements or waivers extending the statutory
period of limitation applicable to any federal, state, local, or foreign tax
return or report for any period. Neither Target Corporation nor any Subsidiary
is a "consenting corporation" within the meaning of Section 341(f)(1) of the
Internal Revenue Code of 1986, as amended (the "Code"), a "United States real
property holding corporation" within the meaning of Section 897(c)(2) of the
Code, or a "purchasing corporation," a "target" or a "target affiliate" within
the meaning of Section 338 of the Code with respect to any transaction to which
Section 338 applies (other than the transaction contemplated by this Agreement).
2.16 Insurance. Target Corporation has maintained and now maintains, with
reputable and responsible insurance companies or associations, insurance in such
amounts and covering such risks as is usually carried by companies engaged in
similar businesses and owning similar properties in the same general area in
which Target operates. The Disclosure Schedule contains an accurate and complete
description of all policies of fire, liability, worker's compensation and other
forms of insurance owned or held by Target Corporation. All such policies are in
full force and effect; are sufficient for compliance with all requirements of
law and of all agreements to which Target Corporation is a party; are valid,
outstanding and enforceable policies; provide adequate insurance coverage for
the assets and operations of Target Corporation; will remain in full force and
effect through the respective dates set forth in the
8
<PAGE>
Disclosure Schedule; and will not in any way be affected by, or terminate or
lapse by reason of, the transactions contemplated by this Agreement.
2.17 Benefit Plans. Neither Target Corporation nor any Subsidiary
maintains or contributes to, or has maintained or contributed to any "employee
pension benefit plan" as such term is defined in Section 3(2) of the Employee
Retirement Income Security Act of 1974, as amended ("ERISA"). Neither Target
Corporation nor any Subsidiary maintains a welfare, pension or other employee
benefit plan outside the United States. Except as set forth in the Disclosure
Schedule, neither Target Corporation nor any Subsidiary maintains or contributes
to any "employee welfare benefit plan" ("Target Corporation Welfare Plans"), as
such term is defined in Section 3(1) of ERISA, whether insured or otherwise, and
each such Target Corporation Welfare Plan is in material compliance with the
provisions of ERISA. Except as set forth in the Disclosure Schedule, neither
Target Corporation nor any Subsidiary maintains any bonus, incentive
compensation, deferred compensation, stock option, stock purchase, severance or
other fringe benefit plan, whether formal or informal.
2.18 Bank Accounts. The Disclosure Schedule sets forth the names and
locations of all banks, trust companies, savings and loan associations and other
financial institutions at which Target Corporation maintains accounts of any
nature and the names of all persons authorized to draw thereon or make
withdrawals therefrom.
2.19 Contracts and Commitments; No Default.
(a) Except as set forth in the Disclosure Schedule:
(i) Target Corporation has no employment agreement with any
officer, employee or agent, nor any agreement that contains any severance or
termination pay Liabilities or obligations;
(ii) Target Corporation has no employee to whom it is paying
aggregate direct remuneration at the annual rate of more than $60,000 for
services rendered or commissions at a rate, which based on sales by such
employee during the last fiscal year, would exceed $60,000;
(iii) Target Corporation has no collective bargaining or union
contracts or agreements;
(iv) Target Corporation is not restricted by agreement from
carrying on its business or any part thereof anywhere in the world or from
competing in any line of business with any Person;
(v) Target Corporation has no debt obligation for borrowed
money, including guarantees of or agreements to acquire any such debt obligation
of others;
(vi) Target Corporation has no outstanding loan to any Person;
9
<PAGE>
(vii) Target Corporation has no obligation or liability as
guarantor, surety, co-signer, endorser, co-maker, indemnitor or otherwise in
respect of the obligation of any other Person;
(viii) Target Corporation is not subject to any obligation or
requirement to provide funds to or make any investment (in the form of a loan,
capital contribution or otherwise) in any Person;
(ix) Target Corporation is not a party to any agreement,
contract, commitment or loan to which any of its officers or directors or any
Affiliate or Associate of Target Corporation or its officers and directors is a
party;
(x) There are no outstanding sales or purchase contracts,
commitments or proposals of Target Corporation that will result in any loss
exceeding $25,000 upon completion or performance thereof;
(xi) Target Corporation is not a party to any purchase or
sale contract or agreement that continues for a period of more than twelve
months (including periods covered by any option to renew by either party);
(xii) Target Corporation is not under any liability or
obligation with respect to the return of inventory or merchandise in the
possession of wholesalers, distributors, retailers or other customers;
(xiii) Target Corporation has not given any irrevocable power
of attorney to any person, firm, corporation or other entity for any purpose
whatsoever, except the appointment of agents to accept service of process; and
(b) Except for agreements, contracts, commitments or restrictions
referred to in Subsections 2.19(a)(i)-(xiii) or elsewhere specifically disclosed
pursuant to this Agreement, Target Corporation has no agreements, contracts,
commitments or restrictions that are material to its business, operations or
prospects (for the purpose of this subsection, any agreement, contract,
commitment or restriction may be deemed "immaterial" if it may be cancelled in
thirty (30) days' notice without premium, penalty or forfeiture and it calls for
fixed and/or contingent payments thereunder of less than $10,000 per year).
(c) True and complete copies of all documents (including all
amendments thereto) referred to in Section 2.19(a) have either been delivered to
Acquiring Corporation or shall be delivered upon request. All contracts,
agreements, commitments or restrictions referred to in Section 2.19(a) are valid
and enforceable in accordance with their respective terms, Target Corporation is
not in default in the performance of any its obligations thereunder, no event of
default has occurred which (whether with or without notice, lapse of time, or
both, or the happening or the occurrence of any other event) would constitute a
default thereunder and, to the best knowledge of Target Corporation, all other
parties thereto are not in default thereunder.
10
<PAGE>
2.20 Inventory. Except as set forth in the Disclosure Schedule, all
inventory of Target Corporation, whether or not reflected in the Balance Sheet,
consists of a quality and quantity usable and salable in the ordinary course of
business, except for items of obsolete materials and materials of below standard
quality, all of which have been written down in the Balance Sheet to net
realizable market value or for which adequate reserves have been provided
therein. The quantities of each type of inventory (whether raw materials, work-
in-process, or finished goods) of Target Corporation are not excessive, but are
reasonable in the present circumstances of its business.
2.21 Accounts Receivable. Except as set forth in the Disclosure
Schedule, all accounts receivable of Target Corporation, whether or not
reflected in the Balance Sheet, represent sales actually made in the ordinary
course of business, and are current and collectible net of any reserves shown on
the Balance Sheet (which reserves are adequate and were calculated consistent
with past practice).
2.22 Labor Difficulties. Except to the extent set forth in the Disclosure
Schedule, (a) Target Corporation is and has been in compliance with all
applicable laws respecting employment and employment practices, terms and
conditions of employment and wages and hours, including, without limitation, any
such laws respecting employment discrimination and occupational safety and
health requirements, and, is not engaged in any unfair labor practice; (b) there
is no unfair labor practice complaint against Target Corporation pending or
threatened before the National Labor Relations Board; (c) there is no labor
strike, dispute, slowdown or stoppage actually pending or threatened against or
directly affecting Target Corporation; (d) no union representation question
exists respecting the employees of Target Corporation; (e) no grievance that
might have a material adverse effect on Target Corporation or the conduct of its
business nor any arbitration proceeding arising out of or under collective
bargaining agreements is pending and no claims therefor exist; (f) there is no
organizational effort being made or threatened involving any employees of the
Target Corporation; (g) no collective bargaining agreement that is binding on
Target Corporation restricts it from relocating or closing any of its
operations; and (h) Target Corporation has not experienced any material work
stoppage or other material labor difficulty during the last twelve (12) months.
2.23 Permits and Other Operating Rights. Except as set forth in the
Disclosure Schedule, Target Corporation does not require the consent of any
third Person to permit it to operate its business in the manner in which it
presently is being conducted, and possesses all permits and other authorizations
from third Persons, including without limitation, federal, foreign, state and
local governmental authorities, presently required by applicable provisions of
law, including statutes, regulations and existing judicial decisions, and by the
property and contract rights of third Persons, necessary to permit it to operate
its business in the manner in which it presently is being conducted.
2.24 Compliance with Law. Target Corporation is in compliance in all
material respects with all laws, regulations and orders applicable to its
business, including, without limitation, applicable environmental, anti-
pollution, building, zoning or health laws, ordinances
11
<PAGE>
and regulations in respect of its plants, structures and equipment. Except as
set forth in the Disclosure Schedule, Target Corporation has not received any
notification that it is in violation of any such laws, regulations or orders and
no such violation exists. Neither Target Corporation nor any employee or agent
of Target Corporation has made any payments to any Persons that violate any
statute or law or are required to be disclosed under applicable disclosure
policies of the Commission.
2.25 Brokerage. Except as otherwise disclosed to UTP in writing, no
broker, finder, agent or similar intermediary has acted on behalf of FAS or any
of the Principal Shareholders in connection with this Agreement or the
transactions contemplated hereby, and there are no brokerage commissions,
finders' fees or similar fees or commissions payable in connection herewith
based on any agreement, arrangement or understanding with FAS or any of the
Principal Shareholders, or any action taken by any of them.
2.26 Hazardous Materials.
(a) There are no Hazardous Materials (as hereinafter defined)
generated, used, handled or stored by FAS the proper disposal of which will
require any material expenditure by FAS. There has been no generation, use
handling, storage or disposal of any Hazardous Materials in violation of common
law or any applicable environmental law at any site owned or premises leased by
FAS or during the period of FAS's ownership or lease. Nor has there been or is
there threatened any release of any Hazardous Materials on or at any such site
or premises during such period in violation of common law or any applicable
environmental law or which created or will create an obligation to report or
remediate such release. "Hazardous Materials" means any "hazardous waste" as
defined in either the United States Resource Conservation and Recovery Act or
regulations adopted pursuant to said Act, and any "hazardous substances" or
"hazardous materials" as defined in the United States Comprehensive
Environmental Response, Compensation and Liability Act.
(b) There is no environmental of health and safety matter that could
have a material adverse effect on the Business of FAS. FAS has previously
furnished to UTP and copies of any environmental audits or risk assessments,
site assessments, documentation regarding off-site disposal of Hazardous
Materials, spill control plans and material correspondence with any governmental
agency regarding the foregoing.
2.27 Net Operating Losses. There has been no change in ownership of FAS
that would limit UTP's ability to utilize the net operating losses of FAS.
2.28 Disclosure. No representations or warranties by Target Corporation
or the Principal Shareholders in this Agreement and no statement contained in
any document (including, without limitation, financial statements and the
Disclosure Schedule), certificate, or other writing furnished or to be furnished
by Target Corporation to Acquiring Corporation pursuant to the provisions hereof
or in connection with the transactions contemplated hereby, contain or will
contain any untrue statement of material fact or omit or will omit to state any
material fact necessary in order to make the statements herein or therein, in
light of the circumstances under which they were made, not misleading.
12
<PAGE>
2.29 Assets of Business. The assets owned or leased by Target Corporation
constitute all of the assets held for use or used primarily in connection with
the business of Target Corporation and are adequate to carry on such business as
presently conducted. Except as set forth in the Disclosure Schedule, the
Exchange will effectively convey the business of Target Corporation to Acquiring
Corporation, including all tangible and intangible assets and goodwill relating
to such business.
REPRESENTATION AND WARRANTIES OF SHAREHOLDERS
Each Shareholder severally and not jointly represents and warrants to
Acquiring Corporation as follows:
3.1 Ownership of Shares. Except for the number of Shares set forth
opposite such Shareholder's name in Exhibit B attached hereto, such Shareholder
does not own any other securities and holds no option, warrant or other right to
purchase or otherwise acquire any other equity securities of the Target Company
and has, and shall transfer to Uniphase at the Closing, good and valid title to
all of such Shares free and clear of any liens, pledges, security interests,
adverse claims, equities, options, proxies, charges, encumbrances or
restrictions.
3.2 Power and Authority; Binding Nature. Such Shareholder has full power
and authority to enter into this Agreement and to perform his obligations
hereunder or thereunder. This Agreement is valid and contains binding
obligations of such Shareholder enforceable in accordance with the terms hereof
and thereof. Such Shareholder agrees that Uniphase, and any other person or
entity, may rely upon all acts and decisions of the Shareholders' Representative
(as defined below) in connection with the Agreement, and any other agreement
which is part of, or necessary to, the transactions contemplated thereby,
without any further question or inquiry of the Shareholders' Representative or
any other action of the part of the relying party. The authority of the
Shareholders' Representative to act as set forth above shall be conclusively
evidenced by the signature of the Shareholders' Representative on whatever
agreement, instrument or other document the Shareholders' Representative
executes.
3.3 Litigation. There is no action, suit, proceeding, dispute, litigation,
claim, complaint or investigation by or before any court, tribunal, governmental
body, governmental agency or arbitrator pending or, to the best knowledge of
such Shareholder, threatened against such Shareholder which challenges or would
challenge any of the actions required to be taken by the undersigned under
the Agreement.
3.4 Non-Contravention. Neither the execution or delivery of this Agreement
nor the performance hereof (i) will result in any violation or breach of any
agreement or other instrument to which such shareholder is a party or by which
such Shareholder or any of the Shares owned (beneficially or of record) by such
Shareholder is bound, or (ii) will result in a violation of any law, rule,
regulation, treaty, ruling, directive, order, arbitration award, judgment or
decree to which such Shareholder or any of the Shares is subject.
3.5 Approvals. No authorization, consent or approval of, or registration
or filing with, any governmental authority or any other person is required to be
obtained or made by such Shareholder in connection with execution and delivery
of this Agreement or the performance hereof.
REPRESENTATIONS AND WARRANTIES
OF ACQUIRING CORPORATION
Acquiring Corporation represents and warrants to and covenants with Target
Corporation as follows:
4.1 Corporate Organization; Etc. Acquiring Corporation is a corporation
duly organized, validly existing and in good standing under the laws of the
State of Delaware.
4.2 Authorization; Etc. Acquiring Corporation has full corporate power and
authority to enter into this Agreement and to carry out the transactions
contemplated hereby. The Board of Directors of Acquiring Corporation has taken
all action required by law, its respective Certificate of Incorporation and
Bylaws or otherwise to authorize the execution and delivery of this Agreement
and the transactions contemplated hereby, and this Agreement is a valid and
binding obligation of Acquiring Corporation enforceable in accordance with its
terms.
4.3 No Violation. Neither the execution and delivery of this Agreement nor
the consummation of the transactions contemplated hereby will violate any
provisions of the Certificate of Incorporation or Bylaws of Acquiring
Corporation, violate, or be in conflict with, or constitute a default under or
cause the acceleration of the maturity of any debt or obligation pursuant to,
any agreement or commitment to which Acquiring Corporation is a party or by
which Acquiring Corporation is bound, or violate any statute or law or any
judgment, decree, order, regulation, or rule of any court or governmental
authority.
4.4 Consents and Approvals of Government Authorities. Except as set forth
in the Disclosure Schedule, no consent, approval or authorization of, or
declaration, filing or registration with, any governmental or regulatory
authority is required in connection with the execution, delivery and performance
of this Agreement by Acquiring Corporation and the consummation of the
transactions contemplated hereby.
ARTICLE 5
CONDUCT OF TARGET CORPORATION'S BUSINESS
PENDING THE CLOSING DATE
Pending the Closing Date, and except as otherwise consented to or approved
by Acquiring Corporation in writing:
13
<PAGE>
5.1 Regular Course of Business. Target Corporation will carry on its
business diligently and substantially in the same manner as heretofore
conducted, and Target Corporation shall not institute any new methods of
manufacture, purchase, sale, lease, management, distribution, accounting or
operation or engage in any transaction or activity, enter into any agreement or
make any commitment except in the ordinary course of business and consistent
with past practice.
5.2 Amendments. No change or amendment shall be made in the Articles of
Incorporation or Bylaws of Target Corporation.
5.3 Capital Changes. Target Corporation shall not issue or sell, or
issue options, warrants to purchase, conversion privileges or other rights to
subscribe to or enter into any arrangement or contract with respect to, any
shares of its capital stock or any of its other securities, or make any other
changes in its capital structure.
5.4 Dividends. Target Corporation shall not declare, pay or set aside for
payment any dividend or other distribution in respect of its capital stock, nor
shall Target Corporation, directly or indirectly, redeem, purchase or otherwise
acquire any shares of its capital stock.
5.5 Organization. Target Corporation shall use its best efforts to
preserve its corporate existence and business organization intact, to keep
available to Target Corporation its officers and key employees, and to preserve
for Target Corporation its relationships with suppliers, dealers, licensors,
licensees, franchisees, distributors, customers and others having business
relations with it.
5.6 Certain Changes. Target Corporation will not, except as contemplated
in the Disclosure Schedule:
(a) Borrow or agree to borrow any funds or incur, or assume or
become subject to, whether directly or by way of guarantee or otherwise, any
obligation or liability except obligations and Liabilities incurred in the
ordinary course of business and consistent with past practice;
(b) Pay, discharge or satisfy any claim, liability or obligation
other than the payment, discharge or satisfaction in the ordinary course of
business and consistent with past practice of Liabilities or obligations
reflected or reserved against in the Balance Sheet or incurred in the ordinary
course of business and consistent with past practice since the date of the
Balance Sheet;
(c) Permit or allow any of its property or assets (real, personal
or mixed, tangible or intangible) to be subjected to any mortgage, pledge, lien,
security interest, encumbrance, restriction, charge or limitation of any kind,
except for those of a kind permitted under Section 2.10 hereof;
14
<PAGE>
(d) Write down the value of any inventory or write off as
uncollectible any notes or accounts receivable, except for write-downs and
write-offs in the ordinary course of business and consistent with past
practice, none of which is material;
(e) Cancel any debts or waive any claims or rights of substantial
value or sell, transfer, or otherwise dispose of any of its properties or assets
(real, personal or mixed, tangible or intangible), except in the ordinary course
of business and consistent with past practice;
(f) License or dispose of or permit to lapse any rights to the use
of any patent, trademark, trade name, technology, process, copyright or other
intangible asset of material value, or dispose of or disclose to any Person any
trade secret, formula, process or know-how of material value not theretofore a
matter of public knowledge;
(g) Grant any general increase in the compensation of officers or
employees (including any such increase pursuant to any bonus, pension, profit-
sharing or other plan or commitment) or any increase in the compensation payable
or to become payable to any officer or employee, except for increases in the
ordinary course of business, provided that they are made in accordance with
established compensation policies applied on a basis consistent with that of the
previous two years;
(h) Pay, loan or advance any amount to, or sell, transfer or lease
any properties or assets (real, personal or mixed, tangible or intangible) to,
or enter into any agreement or arrangement with, any of its officers or
directors or any Affiliate or Associate of any of its officers or directors
except for directors' fees and compensation to officers at rates not exceeding
the rates of compensation set forth in the Disclosure Schedule;
(i) Enter into any other transaction, other than in the ordinary
course of business; or
(j) Agree, whether in writing or otherwise, to do any of the
foregoing.
5.7 Contracts. No contracts or commitments shall be entered into by or
on behalf of Target Corporation, except contracts or commitments made in the
ordinary course of business.
5.8 Insurance; Property. Target Corporation and all property, real,
personal and mixed, owned or leased by Target Corporation, shall be insured in
the manner contemplated by Section 2.16 hereof; and all such property shall be
used, operated, maintained and repaired in a careful and reasonably efficient
manner.
5.9 No Default; Amendment. Target Corporation shall not do any act or
omit to do any act, or permit any act or omission to act, that will cause a
material breach of any material contract or commitment of Target Corporation.
The Target Corporation shall not amend any material contract.
15
<PAGE>
5.10 Compliance with Laws. Target Corporation shall duly comply with all
laws applicable to it and its properties, operations, business and employees.
5.11 Tax Returns; Consent. Target Corporation shall prepare and file all
federal, state, local and foreign tax returns and amendments thereto required to
be filed by it. Acquiring Corporation shall have a reasonable opportunity to
review all income tax returns and amendments thereto. Target Corporation shall
not and will cause each of its Subsidiaries not to consent to have the
provisions of Section 341(f)(2) of the Code apply to such corporation.
5.12 No Acquisitions. Neither Target Corporation nor any Subsidiary will
approve or undertake, either as the surviving, disappearing, acquiring or
selling corporation, any other merger, consolidation, assets acquisition or
disposition or tender offer or other takeover transaction or furnish or cause to
be furnished any information concerning its business, properties or assets to
any Person (other than to Acquiring Corporation or Disappearing Corporation)
that is interested in any such transaction, or solicit or encourage any
inquiries or proposals for the acquisition of all or any part of the capital
stock, assets or business of Target Corporation or any Subsidiary thereof.
ARTICLE 6
COVENANTS
Target Corporation hereby covenants and agrees with Acquiring Corporation,
and Acquiring Corporation hereby covenants and agrees with Target Corporation,
that:
6.1 Full Access. Target Corporation shall afford to Acquiring Corporation,
its counsel, accountants and other authorized representatives full access to
Target Corporation's plants, properties, books and records in order that
Acquiring Corporation may have full opportunity to make such investigations as
they shall desire to make of the affairs of Target Corporation; provided,
however, that any such investigation shall be conducted in such a manner as not
to interfere unreasonably with the operation of the business of Target
Corporation; and Target Corporation will cause its officers and accountants to
furnish such additional financial and operating data and other information as
Acquiring Corporation shall from time to time reasonably request, including
access to the working papers of Target Corporation's independent certified
public accountants,
6.2 Confidentiality. Acquiring Corporation will, and will cause its
officers and authorized representatives to, hold in confidence, and not disclose
to others for any reason whatsoever, all information received by them from
Target Corporation in connection with the transactions contemplated hereby that
Target Corporation identifies with reasonable specificity in writing as
proprietary ("Proprietary Information"), except to the extent that such
Proprietary Information was previously known to Acquiring Corporation or
otherwise available from third Persons without restriction on its further use or
disclosure or otherwise not legally protectible as proprietary information, or,
as required by order of any court or for such of the Proprietary Information as
is or becomes publicly known other than through actions of Acquiring Corporation
or its officers or representatives; provided, that nothing herein contained
shall be deemed to preclude Acquiring Corporation from (a) asserting that any
documents or information (whether or
16
<PAGE>
not embodied in a document) asserted by Target Corporation to be proprietary
are not entitled to protection as such on the ground that such Proprietary
Information was previously known to Acquiring Corporation or otherwise available
from third Persons without restriction on its further use or disclosure or
otherwise not legally protectible as proprietary information, and (b) thereafter
freely using or disclosing such Proprietary Information unless a court of
competent jurisdiction finally determines that this proviso does not apply to
such Proprietary Information.
6.3 Supplements to Disclosure Schedule. From time to time prior to the
Second Closing Date, Target Corporation will promptly supplement or amend the
Disclosure Schedule with respect to any matter hereafter arising that, if
existing or occurring at or prior to the date of this Agreement, would have been
required to be set forth or described in the Disclosure Schedule or that is
necessary to correct any information in the Disclosure Schedule or in any
representation and warranty of Target Corporation that has been rendered
inaccurate thereby. For purposes of determining the accuracy of the
representations and warranties of Target Corporation contained in Article 2 in
order to determine the fulfillment of the condition set forth in Section 7.1,
the Disclosure Schedule delivered by Target Corporation shall be deemed to
include only that information contained therein on the date of this Agreement
and shall be deemed to exclude any information contained in any subsequent
supplement or amendment thereto.
6.4 Expenses. Each of the Constituent Corporations shall bear its
respective expenses incurred in connection with this Agreement and the
transactions contemplated hereby, provided that any such expenses incurred by
FAS or the Shareholders shall be borne and paid by the Shareholders.
17
<PAGE>
6.5 Authorization from Others. Prior to the Closing Date, the parties
shall use all reasonable efforts to obtain all authorizations, consents and
permits required to permit the consummation of the transactions contemplated by
this Agreement, including without limitation all consents required from third
parties who have contractual relationships with FAS.
6.6 Consummation of Agreement. Each party shall use all reasonable
efforts to perform and fulfill all conditions and obligations to be performed
and fulfilled by it under this Agreement and to ensure that to the extent within
its control or capable of influence by it, no breach of any of the respective
representations, warranties and agreements hereunder occurs or exists on or
prior to the Effective Date, all to the end that the transactions contemplated
by this Agreement shall be fully carried out in a timely fashion.
6.7 Further Assurances. Each of the parties shall execute such documents,
further instruments of transfer and assignment and other papers and take such
further actions as may be reasonably required or desirable to carry out the
provisions hereof and the transactions contemplated hereby.
6.8 No Solicitation. FAS and the Shareholders will not (i) solicit,
initiate or encourage discussions with any person, other than UTP and Uniphase,
relating to the possible acquisition of FAS or all or a material portion of the
assets or capital stock of FAS or any merger or other business combination with
FAS or (ii) except to the extent reasonably required by fiduciary obligations
under applicable law as advised in writing by independent legal counsel,
participate in any negotiations regarding, or furnish to any other person
information with respect to, any effort or attempt by any other person to do or
to seek any such transaction. FAS and the Shareholders agree to inform Uniphase
in reasonable detail within one business day of their receipt of any offer,
proposal or inquiry relating to any such transaction.
6.9 Covenants Not to Compete. Each of the Shareholders agrees to execute
and deliver to Acquiring Corporation at the Closing Date a Non-Compete Agreement
in substantially the form attached hereto as Exhibit C.
ARTICLE 7
CONDITIONS TO ACQUIRING CORPORATION'S OBLIGATIONS
The obligation of Acquiring Corporation to effect the transactions
contemplated herein shall be subject to the satisfaction, on or before the
Closing Date of each of the following conditions:
7.1 Representations and Warranties True. The representations and
warranties of Target Corporation and the Shareholders contained herein, in the
Disclosure Schedule, and in all certificates and other documents delivered by
Target Corporation to Acquiring Corporation, pursuant hereto or in connection
with the transactions contemplated hereby shall be in all material respects true
and accurate as of the date when made and at and as of the Closing Date as
though such representations and warranties were made at and as of such date,
except for changes permitted or contemplated by the terms of this Agreement.
7.2 Performance. Target Corporation shall have performed and complied
with all agreements, obligations and conditions required by this Agreement to
be performed or complied with by it on or prior to the Closing Date.
7.3 Simultaneous Closing. The closing of the Acquiring Corporation's
acquisition of GCA Fiberoptics, Ltd., a corporation organized under the laws of
England.
7.4 Adverse Changes. No material adverse change shall have occurred in
the financial condition, working capital, assets, Liabilities, reserves,
business, operations or prospects of Target Corporation and its Subsidiaries
taken as a whole, since the date of the Balance Sheet.
7.5 No Governmental Proceeding or Litigation. No suit, action,
investigation, inquiry or other proceeding by any governmental body or other
Person or entity or legal or administrative proceeding shall have been
instituted or threatened that questions the validity or legality of the
transactions contemplated hereby or that, if successfully asserted, would
otherwise have a material adverse effect on the conduct of Target Corporation's
business or on its properties.
7.6 Opinion of Target Corporation Counsel. Target Corporation shall have
delivered to Acquiring Corporation an opinion of Timothy P. McHugh, Esq.,
counsel to Target Corporation, dated as of the Closing Date, substantially in
the form attached hereto as Exhibit D.
7.7 Board of Directors Authorization. All action required to be taken
by the Board of Directors of Target Corporation to authorize the execution,
delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby shall have been duly and validly taken by the
Board of Directors of Target Corporation.
7.8 Absence of Order. No restraining order or injunction of any court
which prevents consummation of the Exchange shall be in effect.
7.9 Escrow Agreement. The Escrow Agreement, substantially in the form
attached hereto as Exhibit C, shall have been executed and delivered by all
parties thereto.
7.10 Certificates. Target Corporation will furnish Acquiring Corporation
with such certificates of its officers and others to evidence compliance with
the conditions set forth in this Article 6 as may be reasonably requested by
Acquiring Corporation.
7.11 Consent and Agreement of Dukane Corporation. Target Corporation shall
have the written agreement of Dukane Corporation ("Dukane"), in form approved by
Acquiring Corporation, which approval shall not be unreasonably withheld, that
serves to: (i) approve the sale of Shares hereunder as required by Section 6.2
of that certain Agreement, dated as of June 10, 1994 (the "Dukane Agreement");
and (ii) amend the Dukane Agreement as Acquiring Corporation shall reasonably
determine to permit Acquiring Corporation and its parent corporation to operate
and expand the Business after the Closing Date.
7.12 Resignation of Officers and Directors. Acquiring Corporation shall
have obtained the resignations of each member of the Board of Directors of
Target Corporation and those officers of Target Corporation as requested by
Acquiring Corporation.
7.13 Amount of Bank Debt. The aggregate principal and interest owing to
First National Bank pursuant to the Guaranteed Loans shall not exceed $175,000.
ARTICLE 8
CONDITIONS TO TARGET CORPORATION'S OBLIGATIONS
The obligation of Target Corporation to effect the transactions
contemplated herein shall be subject to the satisfaction, on or before the
Closing Date, of each of the following conditions:
8.1 Representations and Warranties True. The representations and
warranties of Acquiring Corporation contained herein shall be in all material
respects true and accurate as of the date when made and at and as of the
Closing Date as though such representations and warranties were made at and as
of such date.
8.2 Performance. Acquiring Corporation shall have performed and
complied with all agreements, obligations and conditions required by this
Agreement to be performed or complied with by them on or prior to the Closing
Date.
18
<PAGE>
8.3 No Governmental Proceeding or Litigation. No suit, action,
investigation, inquiry or other proceeding by any governmental body or other
Person or legal or administrative proceeding shall have been instituted or
threatened that questions the validity or legality of the transactions
contemplated hereby or that, if successfully asserted, would otherwise have a
material adverse effect on the conduct of Target Corporation's Business.
8.4 Opinion of Counsel to Acquiring Corporation. Acquiring Corporation
shall have delivered to Target Corporation an opinion of Messrs. Morrison &
Foerster, counsel to Acquiring Corporation, dated as of the Closing Date
substantially in the form attached hereto as Exhibit E.
8.5 Board of Directors Authorizations. All action required to be taken
by the Board of Directors of Acquiring Corporation to authorize the execution,
delivery and performance of this Agreement by Acquiring Corporation and the
consummation of the transactions contemplated hereby shall have been duly and
validly taken by the Board of Directors of Acquiring Corporation, respectively.
8.6 Certificates. Acquiring Corporation will furnish Target Corporation
with such certificates of its officers and others to evidence compliance with
the conditions set forth in this Article 8 as may be reasonably requested by
Target Corporation.
ARTICLE 9
INDEMNITY
9.1 Survival. Notwithstanding any right of any party to fully
investigate the affairs of the other party and notwithstanding any knowledge of
facts determined or determinable by such party pursuant to such investigation
or right of investigation, each party has the right to rely fully upon the
representations, warranties, covenants and agreements of each other party in
this Agreement or in any certificate, financial statement or other document
delivered by any party pursuant hereto. All such representations, warranties,
covenants and agreements shall survive the execution and delivery hereof and
the Closing hereunder, subject to the limitations set forth in Section 9.4.
9.2 Obligation of FAS and its Shareholders to Indemnify.
(a) Subsequent to the Closing Date, the Shareholders shall
19
<PAGE>
hold harmless Uniphase (and its directors, officers, employees, agents,
affiliates and assigns) from and against all losses, liabilities, damages,
deficiencies, costs or expenses, including interest and penalties imposed or
assessed by any judicial or administrative body and reasonable attorneys' fees,
whether or not arising out of third-party claims and including all amounts paid
in investigations, defense or settlement of the foregoing pursuant to this
Section 9 ("Losses") based upon, arising out of or otherwise in respect of any
inaccuracy in, or breach of, any representation, warranty continued in Article 2
hereof or any covenant of FAS and the Shareholders contained herein or in any
certificate delivered pursuant hereto.
(b) Subsequent to the Closing Date, each Shareholder shall,
severally and not jointly, indemnify and hold harmless Uniphase (and its
directors, officers, employees, agents, affiliates and assigns) from and against
all Losses based upon, arising out of or otherwise in respect of any inaccuracy
in, or breach of, any representation, warranty of such Shareholder contained
herein or in Article 3 hereof.
9.3 Obligation of Uniphase to Indemnify. Subsequent to the Closing Date,
Uniphase agrees to indemnify and hold harmless the Shareholders (and their
respective assigns) from and against any Losses based upon, arising out of or
otherwise in respect of any inaccuracy in, or breach of, any representation,
warranty or covenant of Uniphase contained herein or in any certificate
delivered pursuant hereto.
9.4 Limitations on Indemnification. Notwithstanding the foregoing, the
right to indemnification under this Article 9 shall be subject to the following
terms:
(a) No indemnification shall be payable pursuant to Section 9.2 or
Section 9.3: (i) unless and until the amount of all claims for indemnification
pursuant to the applicable Section exceeds $50,000 in the aggregate, whereupon
indemnification pursuant to such Section shall be payable for all such claims
without any deduction or (ii) as to any claim for indemnification that is in an
amount less than $5,000 (provided that each such claim which is less than $5,000
shall count and be credited towards the $50,000 amount described in the
preceding clause (i)).
(b) No indemnification shall be payable pursuant to Section 9.2 or
Section 9.3 at any time after August 31, 1998 (the "Expiration Date"), except
with respect to claims made prior to the Expiration Date, but not resolved by
the Expiration Date. Subject to the foregoing, the representations and
warranties contained herein or in any certificate delivered pursuant hereto
shall expire at the close of business on the Expiration Date.
(c) Except for claims arising out of any inaccuracy in or breach of
a representation or warranty of a Shareholder contained in Article 3 hereof, all
indemnification claims under Section 9.2 shall be satisfied in full from amounts
off-set against the Notes pursuant to Section 9.6 below, and no person shall
have any further right to recovery from any Shareholder. Without limitation of
the foregoing, the maximum liability of any Shareholder (other than as provided
in Section 9.4(d) below) for any breach of a representation, warranty or
covenant of FAS shall be limited to ten percent (10%) of that portion of the
Purchase Price paid or otherwise delivered to such person pursuant to Section
1.2 hereof.
(d) The limitations of Sections 9.3(a), (b) and (c) shall not apply
in the case of a fraudulent or intentional misrepresentation or breach by any
party, but no person shall be liable for any such misrepresentation or breach by
any other person (except to the extent of such person's share of the funds held
under the Escrow Agreement or amounts subject to off-set under the Notes if
such misrepresentation or breach is by FAS).
(e) In determining the amount of any indemnity, there shall be taken
into account any tax benefit, insurance proceeds or other similar recovery or
offset realized, directly or indirectly, by the party to be indemnified.
9.5 Notice and Defense of Claims. Promptly after receipt of notice of any
claim, liability or expense for which a party seeks indemnification hereunder,
such party shall given written notice thereof to the indemnifying party, but
such notification shall not be a condition to indemnification hereunder except
to the extent of actual prejudice to the indemnifying party. If such claim
is by Uniphase for indemnification pursuant to Section 9.2(a) above, such notice
shall be given by Uniphase to the Shareholders Representative (as defined
below). If such claim is by Uniphase for indemnification pursuant to
Section 9.2(b) above, such notice shall be given by Uniphase to the Shareholder
against whom such claim is to be made. The notice shall state the information
then available regarding the amount and nature of such claim, liability or
expense and shall specify the provision or provisions of this Agreement under
which the liability or obligation is asserted. If within thirty (30) days after
receiving such notice the indemnifying party gives written notice to the
indemnified party stating that it intends to defend against such claim,
liability or expense at its own cost and expense, then defense of such matter,
including selection of counsel (subject to the consent of the indemnified party
which consent shall not be unreasonably withheld), shall be by the indemnifying
party and the indemnified party shall make no payment on such claim, liability
or expense as long as the indemnifying party is conducting a good faith and
diligent defense. Notwithstanding the foregoing, the indemnified party shall at
all times have the right to fully participate in such defense at its own expense
directly or through counsel; provided, however, if the named parties to the
action or proceeding include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be
inappropriate under applicable standards of professional conduct, the expense of
separate counsel for the indemnified party shall be paid by the indemnifying
party. If no such notice of intent to dispute and defend is given by the
indemnifying party, or if such diligent good faith defense is not being or
ceases to be conducted, the indemnified party shall, at the expense of the
indemnifying party, undertake the defense of such claim, liability or expense
with counsel selected by the indemnified party, and shall have the right to
compromise or settle the same exercising reasonable business judgment. The
indemnified party shall make available all information and assistance that the
indemnifying party may reasonably request and shall cooperate with the
indemnifying party in such defense.
9.6 Right of Off-Set.
(a) In the event that Acquiring Corporation shall become entitled to
indemnification for any Losses pursuant to Section 9.2(a) above prior to the
Note Payment Date (as defined below), Acquiring Corporation shall have the right
to receive payment and reimbursement from such Losses by way of an off-set
against any then outstanding Notes on a pro rata basis against the Shareholders
so that the contribution by each Shareholder to such indemnification shall be
equal on a percentage basis to that percentages of the total outstanding Shares
held by such Shareholder immediately prior to the Closing Date. Following the
Note Payment Date, Uniphase shall have the right to pursue any subsequent claims
directly against the Shareholders. To the extent amounts are paid from an
off-set from the Notes against any Shareholder on the basis of an
indemnification claim under Section 9.2(b), such Shareholder agrees that such
amounts shall not reduce the ten percent (10%) amount that such Shareholder is
obligated to contribute for indemnification claims pursuant to Section 9.2(a)
above.
(b) At any time or times prior to the Note Payment Date, Uniphase
makes claims for indemnification under this Article 9 and in the further event
that the amount subject to the claim is unliquidated, Uniphase shall make a good
faith estimate as to the amount of the claim for purposes of determining the
amount to be withheld from the payments under the Notes by Uniphase if such
claim is not resolved or otherwise adjudicated by the date such Notes are due
for payment ("Note Payment Date"). If the Shareholder Representative shall
dispute such claim, the Shareholder Representative shall give written notice
thereof to Uniphase within thirty (30) days after receipt of notice of the
claim, in which case Uniphase shall be entitled to withhold such payments
pending resolution of such claim; otherwise, such claim shall be deemed to have
been acknowledged to be payable from the Notes in the full amount thereof as set
forth in the claim as an off-set against the Notes.
(c) If the Shareholder Representative shall give notice to Uniphase
pursuant to Section 9.6(b) above disputing a Uniphase claim, no payment under
the Notes shall be made of the Set Aside Amount (as defined in Section 9.6(d)
below) with respect to such claim until either: (i) such disputed claim has
been resolved as evidenced by a written notice executed by Uniphase and the
Shareholder Representative; or (ii) such dispute shall have been adjudicated in
accordance with the arbitration procedures described in Section 9.6(e) below.
(d) If the Shareholder Representative shall dispute an
indemnification claim of Uniphase as above provided, Uniphase shall be
authorized to set aside a portion of the amounts due under the Notes equal to
the amount of the claim as set forth in the notice of the claim (the "Set Aside
Amount"). In the event Uniphase reasonably believes that it has made or
anticipates that it will incur legal expenses in connection with any such
disputed claim with respect to which it is entitled to be indemnified hereunder,
that portion of the payments due under the Notes equal to such incurred or
anticipated expenditures shall also be set aside and added to and become a part
of the Set Aside Amount; provided, that in the event that it shall be agreed (as
evidenced by a written notice executed by Uniphase and the Shareholder
Representative as described in Section 9.6(c) above) or determined through an
arbitration proceeding described in Section 9.6(d) below that Uniphase is not
entitled to indemnification with respect to such claim, Uniphase shall not be
entitled to such funds.
(e) In the event of a disputed indemnification claim that has not
been resolved within sixty (60) days of Uniphase's original notice of such claim
pursuant to Section 9.6(b) above, the indemnification claim shall be referred to
an arbitrator chosen by agreement of the Shareholder Representative and
Uniphase. If no agreement is reached regarding selection of the arbitrator
within thirty (30) days after written request from either party to the other,
Uniphase or the Shareholder Representative may submit the matter or dispute to
the American Arbitration Association, to be settled by arbitration in San
Francisco, California in accordance with the commercial arbitration rules of
such Association. Uniphase and the Shareholder Representative agree to act in
good faith to mutually select an arbitrator. The fees and expenses of any
arbitration shall be borne by the Shareholders and Uniphase in such proportions
as shall be determined by the arbitrator, or if there is no such determination,
then such fees and expenses shall be borne equally by the Shareholders and
Uniphase. The determination of the arbitrator as to the amount, if any, of the
indemnification claim that is properly allowable shall be conclusive and binding
upon the parties hereto and judgment may be entered thereon in any court having
jurisdiction thereof, including, without limitation, any Superior Court in the
State of California.
9.7 Shareholder Representative.
(a) The Shareholders shall be represented with respect to all claims
by Uniphase pursuant to this Article 9 by a single representative ("Shareholder
Representative"), who shall initially be J.T. Greaves.
(b) In the event the Shareholder Representative shall die or resign
or otherwise terminate his status as such, his successor shall be any
Shareholder appointed by the Shareholder Representative or, in the case of the
death of the Shareholder Representative or where the Shareholder Representative
fails to appoint a successor after a vacancy has been created, elected by the
vote or written consent of a majority in interest of the Shareholders. If the
Shareholders fail for any reason to elect a new Shareholder Representative and
during any period in which a vacancy exists, Aaron Hollander shall serve as the
Shareholder Representative until a new Shareholder Representative is elected.
All decisions of the Shareholder Representative shall be binding upon the
Shareholders. The Shareholder Representative shall keep the Shareholders
reasonably informed of his or her decisions of a material nature.
(c) The Shareholder Representative is authorized to take any action
deemed by him appropriate or necessary to carry out the provisions of, and to
determine the rights of the Shareholders under this Agreement. The Shareholder
Representative shall serve as the agent of the Shareholders for all purposes
related to this Agreement, including without limitation service of process upon
the Shareholders. By his or her execution of this Agreement, the Shareholder
Representative accepts and agrees to diligently discharge the duties and
responsibilities of the Shareholder Representative set forth in this Agreement.
The authorization and designation of the Shareholder Representative under this
9.7(c) shall be binding upon the successors and assigns of each Shareholder.
Uniphase shall be entitled to rely upon such authorization and designation and
shall be fully protected in dealing with the Shareholder Representative, and
shall have no duty to inquire into the authority of any person reasonably
believed by any of them to be the Shareholder Representative.
(d) The Shareholder Representative (i) shall not be liable to any of
the Shareholders for any error of judgment, act done or omitted by him in good
faith, or mistake of fact of law unless caused by his own gross negligence or
willful misconduct; (ii) shall be entitled to treat as genuine any letter or
other document furnished to him by Uniphase or, the Shareholders and believed by
him to be genuine and have been signed and presented by the proper party or
parties; and (iii) shall be reimbursed by the Shareholders for counsel fees and
other out of pocket expenses incurred by the Shareholder Representative in
connection with this Agreement.
(e) The Shareholder Representative shall not be entitled to any
compensation for services hereunder. To the extent the Shareholder
Representative shall incur out of pocket costs in the performance of his duties
hereunder.
20
<PAGE>
ARTICLE 10
TERMINATION AND ABANDONMENT
10.1 Methods of Termination. This Agreement may be terminated and the
transactions herein contemplated may be abandoned at any time, but not later
than the Closing Date:
(a) By mutual written consent of the respective Boards of Directors
of Acquiring Corporation and Target Corporation; or
(b) By the Board of Directors of Acquiring Corporation on or after
June 15, 1996 or such later date as may be established pursuant to Section 1.3
hereof, if any of the conditions provided for in Article 7 of this Agreement
shall not have been met or waived in writing by Acquiring Corporation prior to
such date; or
(c) By the Board of Directors of Target Corporation on or after
June 15, 1996 or such later date as may be established pursuant to Section 1.3
hereof, if any of the conditions provided for in Article 8 of this Agreement
shall not have been met or waived in writing by Target Corporation prior to
such date.
In the event of any termination of this Agreement by Acquiring
Corporation or Target Corporation pursuant to Subsection (b) or (c) of this
Section 10.1 as a result of a breach by the other party of any warranty,
representation or covenant contained herein, such termination shall not serve to
limit any of the legal or equitable remedies arising in favor of the
terminating party as a result of such breach. Any such termination shall be
effective ten (10) days after notice to the other party.
10.2 Procedure Upon Termination. In the event of termination and
abandonment by the Board of Directors of Acquiring Corporation or by the Board
of Directors of Target Corporation, or both, pursuant to Section 10.1 hereof,
written notice thereof shall forthwith be given to the other party, and this
Agreement shall terminate without further action by Acquiring Corporation or
Target Corporation. If this Agreement is terminated as provided herein:
(a) Each party will redeliver all documents, work papers and other
material of any other party relating to the transactions contemplated hereby,
whether so obtained before or after the execution hereof, to the party
furnishing the same; and
(b) All Proprietary Information received by any party hereto with
respect to the business of any other party or its Subsidiaries shall not at any
time be used for the advantage of, or disclosed to third Persons by, such party
for any reason whatsoever except as contemplated in Section 6.2 hereof.
ARTICLE 11
MISCELLANEOUS PROVISIONS
11.1 Brokerage and Finder's Fees; Indemnity. Each party hereby
represents and warrants to the others that neither it nor its representatives
have taken, nor will they take, any action that would cause the other parties
hereto to have any obligation or liability to any person for any finders' fees,
brokerage fees, agents' commissions, or like payments in connection with the
transactions contemplated hereby. Each party shall indemnify and hold harmless
the others from any claim that is asserted by any person for a finder's fee or
like payment with respect to this Agreement arising from any act,
representation or promise of the indemnifying party or its representative.
11.2 Amendment and Modification. Subject to applicable law, this
Agreement may be amended or supplemented only by written agreement of all
parties; such agreement may be accomplished by written agreement of the
respective Boards of Directors of Target Corporation, Acquiring Corporation and
Disappearing Corporation or by their respective officers authorized by such
Boards of Directors at any time prior to the Effective Date with respect to any
of the terms contained herein.
21
<PAGE>
11.3 Waiver of Compliance. Any failure of Target Corporation, on the one
hand, or Acquiring Corporation and Disappearing Corporation, jointly or
severally, on the other, to comply with any provision of this Agreement may be
expressly waived in writing by Acquiring Corporation or Target Corporation,
respectively, but such waiver or failure to insist upon strict compliance with
such provision shall not operate as a waiver of, or estoppel with respect to,
any subsequent or other failure. No failure to exercise and no delay in
exercising any right, remedy or power hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any right, remedy or power
hereunder preclude any other or further exercise thereof or the exercise of any
other right, remedy or power provided herein or by law or in equity. The waiver
by any party of the time for performance of any act or condition hereunder does
not constitute a waiver of the act or condition itself.
11.4 Attorney's Fees. If any legal action, arbitration or other
proceeding is brought to interpret or enforce the terms of this Agreement, the
prevailing party shall be entitled to recover reasonable attorneys' fees and
any other costs incurred in that proceeding, in addition to any other relief to
which it is entitled.
11.5 Notices. All notices, demands, and other communications required or
permitted hereunder shall be made in writing and shall be deemed to have been
duly given if delivered by hand, against receipt, or mailed, postage prepaid,
certified or registered mail, return receipt requested, and addressed to Target
Corporation at:
203 Oswald Avenue
Batavia, Illinois 60510
Attn: Aaron Hollander and J.T. Greaves
telefax: (708) 406-8692
and to Acquiring Corporation at:
163 Baypointe Parkway
San Jose, California 95134
Attn: Chief Financial Officer
telefax: (408) 954-0760
and to the Shareholders:
J.T. Greaves
c/o Ian Shane
Evans Dodd
5 Balfour Place
Mount Street
London W1Y 5RG
telefax: 0171 499 2297
All notices complying with this Section shall be deemed to have been received on
the date of delivery or on the third business day after mailing.
22
<PAGE>
11.6 Assignment; Successors and Assigns. Except as otherwise provided
herein, each party agrees that it will not assign, sell, transfer, delegate or
otherwise dispose of, whether voluntarily or involuntarily, or by operation of
law, any right or obligation under this Agreement. Any purported assignment,
transfer or delegation in violation of this Section shall be null and void.
Subject to the foregoing limits on assignment and delegation, this Agreement
shall be binding upon and shall inure to the benefit of the parties and their
respective successors and assigns. Except for those enumerated above, this
Agreement does not create, and shall not be construed as creating, any rights
or claims enforceable by any person or entity not a party to this Agreement.
11.7 Governing Law. The validity, interpretation, enforceability and
performance of this Agreement shall be governed by and construed in accordance
with the law of the State of California.
11.8 Counterparts. This Agreement may be executed in counterparts, each
of which shall be deemed an original.
11.9 Headings. The headings of the Sections and Articles of this
Agreement and Table of Contents are for reference purposes only and shall not
constitute a part hereof or affect the meaning or interpretation of this
Agreement.
11.10 Entire Agreement. The parties intend that the terms of this
Agreement, including the Disclosure Schedule and other documents referred to
herein, shall be the final expression of their agreement with respect to the
subject matter hereof and may not be contradicted by evidence of any prior or
contemporaneous agreement. The parties further intend that this Agreement
shall constitute the complete and exclusive statement of its terms and that no
extrinsic evidence whatsoever may be introduced in any judicial, administrative
or other legal proceeding involving this Agreement.
11.11 Disclosure Schedule. The Disclosure Schedule to be prepared by any
party, as appropriate, shall be divided into sections corresponding to the
sections of this Agreement. Disclosure in any section of the Disclosure
Schedule shall only constitute disclosure for purposes of the corresponding
section of the Agreement and not for any other purpose.
11.12 Certain Definitions.
"Liabilities" shall mean Liabilities or obligations of any nature
(absolute, accrued, contingent or otherwise, and whether due or to become due).
"Person" shall include any individual, firm, corporation,
partnership, government, governmental agency or other entity, whether acting
in an individual, fiduciary or any other capacity.
"Subsidiary" shall mean, as to any particular parent corporation, any
corporation as to which more than fifty percent of the outstanding stock having
ordinary voting rights or power (and excluding stock having voting rights only
upon the occurrence of a contingency unless and until such contingency occurs
and such rights are to be exercised) at the time is owned or controlled,
directly or indirectly, by such parent corporation and/or by one or more
Subsidiaries.
The parties have caused this Agreement to be duly executed and their
respective corporate seals, if any, to be affixed hereto, as of the date first
above written.
SEAL Target Corporation
FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
ATTEST:
By: Aaron A. Hollander
_____________________________
Fred Kautz By Aaron Hollander President
_____________________________ Title: _____________________________
Secretary Attorney-in-fact
SEAL Acquiring Corporation
UNIPHASE TELECOMMUNICATIONS
PRODUCTS, INC.
ATTEST:
By: Kevin Kalkhoven
_____________________________
D. Pettit President & CEO
_____________________________ Title: _____________________________
Secretary
SEAL
ATTEST:
_____________________________
Secretary
23
<PAGE>
SHAREHOLDERS
Timothy Greaves
- --------------------------
Aaron A. Hollander
- --------------------------
Fred Kautz by Aaron Hollander Attorney-in-fact
- ------------- --------------- ----------------
Dan Crews by Aaron Hollander Attorney-in-fact
- ------------ --------------- ----------------
Steve Seylles by Aaron Hollander Attorney-in-fact
- ---------------- --------------- ----------------
24
<PAGE>
EXHIBITS
--------
A-1 Note Form
A-2 Greaves Note
B Shareholder Schedule
C Covenants Not to Compete
D Opinion of Timothy P. McHugh, Esq.
E Opinion of Morrison & Foerster
<PAGE>
EXHIBIT A-1
PROMISSORY NOTE
$ May___, 1996
_________
FOR VALUE RECEIVED, and pursuant to Section 1.2 of the Stock Purchase
Agreement (the "Stock Purchase Agreement") made between and by the undersigned,
Uniphase Corporation, a Delaware corporation ("Maker"), Fiberoptic Alignment
Solutions, Inc. ("FAS"), an Illinois corporation, and the holders of all of the
outstanding shares of the common stock of FAS (the "Shareholders"), Maker
promises to pay to ________________________ (the "Shareholder") as set forth in
Exhibit B to the Stock Purchase Agreement, at _________________________ ______,
or such other place as the Shareholder may from time to time designate, without
counterclaim, deduction or offset of any kind, except the right of offset as
provided for in Section 3 below, in lawful money of the United States, the
principal sum of $________________ plus interest thereon, as set forth below.
1. INTEREST. Interest on the principal sum of this Note shall accrue at
the rate of 6% per annum, compounded annually, based on a 365 day year and the
actual number of days elapsed.
2. PAYMENTS. Subject to Section 3 below, accrued interest and
principal shall be payable in one payment due on August 31, 1997.
3. PREPAYMENT;RIGHT OF OFFSET. This Note may be prepaid in whole or in
part, at any time, without penalty or premium. This Note shall be subject to a
right of offset in favor of Maker as provided in Section 9.6 of the Stock
Purchase Agreement.
4. APPLICATION OF PAYMENTS. All payments and prepayments received by
the Shareholder shall be applied first to accrued interest, then to other
charges due with respect to this Note and then to the unpaid principal balance.
1
<PAGE>
5. DEFAULT AND REMEDIES.
a. Default. Maker will be in default under this Note if (i)
Maker fails to make a payment of principal and/or interest hereunder when due or
declared due, whether at scheduled maturity, by acceleration or otherwise,
within ten (10) business days after receipt of written notice of such
nonpayment; (ii) Maker breaches any other material covenant, agreement or
understanding under this Note and such breach continues for ten (10) or more
business days after the receipt of written notice from the Shareholder of the
occurrence of such breach; or (iii) Maker files a petition in bankruptcy, is
adjudicated insolvent, petitions or applies to any tribunal for the appointment
of a receiver, custodian, or any trustee for Maker or commences any proceeding
under any bankruptcy, reorganization, arrangement, readjustment of debt,
dissolution or liquidation law or statute of any jurisdiction or any such
proceeding has been commenced against Maker which remains undismissed for a
period of sixty days.
b. Remedies. Upon Maker's default, the Shareholder may (i) upon
written notice to Maker, declare the entire principal sum and all accrued and
unpaid interest hereunder immediately due and payable and (ii) exercise any and
all of the remedies provided in the Stock Purchase Agreement and applicable law.
c. Attorneys' Fees and Costs. Maker promises to pay on demand all
out-of-pocket costs and expenses of the Shareholder in connection with the
collection of amounts due hereunder, including, without limitation, attorneys'
fees and expenses incurred in connection therewith, whether or not any lawsuit
is ever filed with respect thereto.
4. MISCELLANEOUS.
a. All communications or notices required or given under this Note
shall be given in accordance with the provisions of Section 11.5 of the Stock
Purchase Agreement.
b. This Note may be modified only by a written agreement executed
by Maker and the Shareholder.
c. This Note shall be governed by California law.
d. The terms of this Note shall inure to the benefit of and bind
Maker and the Shareholder and their respective heirs, legal representatives and
successors and assigns.
e. Time is of the essence with respect to all matters set forth in
this Note.
2
<PAGE>
f. If this Note is destroyed, lost or stolen, Maker will deliver a new
note to the Shareholder on the same terms and conditions as this Note with a
notation of the unpaid principal and accrued and unpaid interest in substitution
of the prior Note. Shareholder shall furnish to Maker reasonable evidence that
the Note was destroyed, lost or stolen and any security or indemnity that may be
reasonably required by Maker in connection with the replacement of this Note.
IN WITNESS WHEREOF, Maker has executed this Note as of the date and
year first above written.
MAKER:
_____________________________
UNIPHASE CORPORATION
By:__________________________
Its:__________________________
3
<PAGE>
EXHIBIT A-2
PROMISSORY NOTE
---------------
$_____________ May___, 1996
FOR VALUE RECEIVED, and pursuant to Section [ ] of the Stock Purchase
Agreement (the "Purchase Agreement") made between and by the undersigned,
Uniphase Corporation, a Delaware corporation ("Maker"), Fiberoptic Alignment
Solutions, Inc., an Illinois corporation, Jonathan Timothy Greaves ("Greaves"),
and others, Maker promises to pay to Greaves, at such place as Greaves shall
designate, without counterclaim, deduction or offset of any kind, in lawful
money of the United Kingdom, the principal sum of (Pounds) plus
interest thereon, as set forth below.
1. INTEREST
- -- --------
Interest on the principal sum of this Note shall accrue at the rate of 6% per
annum, compounded annually, based on a 365 day year and the actual number of
days elapsed.
2. PAYMENTS
- -- --------
Subject to Section 3 below, accrued interest and principal shall be payable in
one payment due on 31st August 1997.
1
<PAGE>
3. PREPAYMENT; RIGHT OF OFFSET
- -- ---------------------------
This Note may be prepaid in whole or in part, at any time, after a date which is
6 months from the date hereof without penalty or premium. This Note shall be
subject to a right of offset in favour of Maker as provided in Section 9.6 of
the Stock Purchase Agreement.
4. PREPAYMENT IN DOLLARS
- -- ---------------------
(a) Maker shall have the option to prepay this Note in whole or in part in
US dollars.
(b) This option shall be exercisable by Maker giving Greaves notice in writing.
(c) The notice may be given at any time falling within the period commencing 6
months after the date hereof and ending 11 months after the date hereof but
not otherwise.
(d) Prepayment pursuant to this Section shall be made on the date following 14
days after the date on which the notice is given.
(e) The amount of US dollars to be prepaid pursuant to this Section shall be
calculated at the following rate of exchange namely $1.51 per (Pounds)1 of
principal being redeemed.
5. APPLICATION OF PAYMENTS
- -- -----------------------
All payments and prepayments received by Greaves shall be applied first to
accrued interest, then to other charges due with respect to this Note and then
to the unpaid principal balance.
2
<PAGE>
6. DEFAULT AND REMEDIES
- -- --------------------
A. Default
Maker will be in default under this Note if:
(i) Maker fails to make a payment of principal and/or interest hereunder
when due or declared due, whether at scheduled maturity, by
acceleration or otherwise, within ten (10) business days after
receipt of written notice of such nonpayment;
(ii) Maker breaches any other material covenant, agreement or
understanding under this Note and such breach continues for ten (10)
or more business days after the receipt of written notice from
Greaves of the occurrence of such breach; or
(iii) Maker files a petition in bankruptcy, is adjudicated insolvent,
petitions or applies to any tribunal for the appointment of a
receiver, custodian, or any trustee for Maker or commences any
proceeding under any bankruptcy, reorganisation, arrangement,
readjustment of debt, dissolution or liquidation law or statute of
any jurisdiction or any such proceeding has been commenced against
Maker which remains undismissed for a period of sixty days.
B. Remedies
--------
Upon Maker's default, Greaves may:
(i) upon written notice to Maker, declare the entire principal sum and
all accrued and unpaid interest hereunder immediately due and
payable; and
(ii) exercise any and all of the remedies provided in the Purchase
Agreement and applicable law.
3
<PAGE>
C. Attorneys' Fees and Costs
-------------------------
Maker promises to pay on demand all out-of-pocket costs and expenses of
Greaves in connection with the collection of amounts due hereunder,
including, without limitation, attorneys' fees and expenses incurred in
connection therewith, whether or not any lawsuit is ever filed with respect
thereto.
7. MISCELLANEOUS
- -- -------------
(a) All communications or notices required or given under this Note shall be
given in accordance with the provisions of Section 11.5 of the Purchase
Agreement.
(b) This Note may be modified only by a written agreement executed by
Maker and Greaves.
(c) This Note shall be governed by the laws of the State of California to
the non exclusive jurisdiction of whose courts the parties submit.
(d) The terms of this Note shall inure to the benefit of and bind Maker and
Greaves and their respective heirs, legal representatives and successors
and assigns.
(e) Time is of the essence with respect to all matters set forth in this Note.
4
<PAGE>
(f) If this Note is destroyed, lost or stolen, Maker will deliver a new note to
Greaves on the same terms and conditions as this Note with a notation of the
unpaid principal and accrued and unpaid interest in substitution of the
prior Note. Shareholder shall furnish to Maker reasonable evidence that the
Note was destroyed, lost or stolen and any security or indemnity that may be
reasonably required by Maker in connection with the replacement of this
Note.
IN WITNESS WHEREOF, Maker has executed this Note as of the date and year first
above written.
MAKER:
_____________________________
UNIPHASE CORPORATION
By:
________________
Its:
_______________
<PAGE>
EXHIBIT B
SHAREHOLDER SCHEDULE
<TABLE>
<CAPTION>
Shareholder Number of Shares Total Consideration Cash/Note
----------- ---------------- ------------------- ---------
- --------------------------------------------------------------------------------
<S> <C> <C> <C>
Tim Greaves 737.77 $4,571,891.39* $4,571,891.39 (Note)
- --------------------------------------------------------------------------------
Aaron Hollander 113.64 $ 704,216.40 $ 633,794.76 (Cash)
$ 70,421.64 (Note)
- --------------------------------------------------------------------------------
Fred Kautz 61.19 $ 379,188.68 $ 341,269.81 (Cash)
$ 37,918.87 (Note)
- --------------------------------------------------------------------------------
Dan Crews 43.71 $ 270,866.76 $ 243,780.09 (Cash)
$ 27,086.68 (Note)
- --------------------------------------------------------------------------------
Steve Seyller 43.71 $ 270,866.76 $ 243,780.09 (Cash)
$ 27,086.68 (Note)
- --------------------------------------------------------------------------------
TOTAL 1000.02 $6,197,030.00 $6,197,030.00
- --------------------------------------------------------------------------------
</TABLE>
* PAYABLE IN POUNDS STERLING AT WALL STREET JOURNAL COMMERCIAL EXCHANGE RATE
(FOR PURCHASE OF POUNDS STERLING WITH U.S. DOLLARS) AS OF THE CLOSING DATE.
<PAGE>
EXHIBIT C
NON-COMPETE AGREEMENT
This NON-COMPETE AGREEMENT (this "Agreement") dated _______ , 1996 is made
among and by Uniphase Corporation. ("Uniphase"), a Delaware corporation,
Fiberoptic Alignment Solutions, Inc. ("FAS"), an Illinois corporation and
__________________ (the "Shareholder").
RECITALS
Pursuant to a Stock Purchase Agreement dated as of May __, 1996 (the "Stock
Purchase Agreement"), by and among Uniphase, FAS and the stockholders of FAS,
Uniphase is acquiring all of the outstanding Shares of the common stock of FAS.
Capitalized terms used herein and not otherwise defined have the meanings
assigned to them in the Stock Purchase Agreement.
The Shareholder has agreed in Section 6.9 of the Stock Purchase Agreement
to execute and deliver to Uniphase at the Closing of the Exchange a Non-Compete
Agreement.
The parties hereto agree as follows:
AGREEMENT
1. Non-Compete Obligation. The Shareholder agrees that for a period
of five years after the Effective Date he shall neither directly nor indirectly:
(a) Make known to any Person the names and addresses of any of the
customers of Uniphase or FAS or any other information pertaining to them.
(b) Take away any of the customers of Uniphase or FAS on whom he has
called, or with whom he has dealt or become acquainted with, either for himself
or for any other Person.
(c) Accept a position with, or otherwise become affiliated with, any
other Person for the purpose of competing with Uniphase's or FAS' business. The
Shareholder acknowledges and understands that this provision not to compete is
necessary to protect Uniphase's and FAS' trade secrets, proprietary information,
confidential information, and know-how by avoiding such situations which would
inherently create a fraud with the potentiality of intentional or unintentional
revelations of such trade secrets, information and know-how.
(d) Interfere with the business of Uniphase or FAS in any manner
whatsoever including, without limitation, recruiting or hiring employees of
Uniphase or FAS or ex-employees of Uniphase or FAS whose employment with
Uniphase or FAS was terminated less than one (1) year prior to the date of such
interference.
1
<PAGE>
2. Specific Performance. The Shareholder acknowledges that any
violation of the provisions of this Agreement would cause irreparable damage for
which monetary damages would be inadequate and therefore agrees that Uniphase
shall have the right to obtain, in addition to all other remedies it may have,
such injunctive and other equitable relief from a court of competent
jurisdiction as may be necessary or appropriate to prevent or remedy any
violation of this Agreement.
3. Governing Law. This Agreement is governed by the laws of the
State of California without regard to its conflict of law provisions, and shall
inure to the benefit of and be binding upon the successors, assigns, heirs and
personal representatives of the parties hereto.
4. Counterparts; Amendments. This Agreement may be executed in one
or more counterparts, all of which documents shall be considered one and the
same document. This Agreement may not be changed, amended or modified, in whole
or in part, except by written agreement signed by all parties.
5. Notices. Any notice or other communication required or permitted
hereunder shall be in writing and shall be deemed given when so delivered in
person, by overnight courier, by facsimile transmission (with receipt confirmed
by telephone or by automatic transmission report) or two business days after
being sent by registered or certified mail (postage prepaid. return receipt
requested), as follows:
TO UNIPHASE:
-----------
163 Baypointe Parkway
San Jose, CA 95134
Attention: Dan E. Pettit, Vice President, Finance and CFO
Telephone: (408) 434-1800
Fax: (408) 954-0760
In each case with a copy to:
Morrison & Foerster
755 Page Mill Road
Palo Alto, CA 94304
Attention: Michael C. Phillips
Telephone: (415) 813-5620
Fax: (415) 494-0792
TO THE SHAREHOLDER:
-------------------
_________________
_________________
2
<PAGE>
_________________
Telephone
Fax:
With a copy to:
Addresses may be changed by written notice given pursuant to this section. Any
notice given hereunder may be given on behalf of any party by his counsel or
other authorized representative.
3
<PAGE>
6. Headings; Severability. All headings of this Agreement are for
reference only and shall not affect its interpretation. In the event that any
provisions of this Agreement should be held unenforceable by a court of
competent jurisdiction, all remaining provisions shall continue in full force
and effect without being impaired or invalidated in any way.
7. Attorney's Fees. In the event of any litigation among the parties
hereto (including, without limitation, any arbitration proceeding described in
Section 4(b) above), the prevailing party in such litigation or proceeding
shall be entitled to recover all costs incurred in connection therewith,
including, without limitation, reasonable attorneys fees, provided that the
costs of any arbitration proceeding shall be allocated in the manner set forth
in Section 4(b).
<PAGE>
IN WITNESS WHEREOF, the parties hereto have executed this Agreement under
seal as of the date first stated above.
UNIPHASE CORPORATION
By: ____________________________________
Title: _________________________________
FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
By:
________________________________________
Its:
________________________________________
SHAREHOLDER
________________________________________
<PAGE>
EXHIBIT D
______________ __, 1996
Uniphase Corporation
163 Baypointe Parkway
San Jose, California 95134
Attention: Chief Financial Officer
Dear Sirs:
I am furnishing this opinion to you pursuant to Section 7.6 of the
Stock Purchase Agreement dated as of May 24, 1996 (the "Stock Purchase
Agreement") among Fiberoptic Alignment Solutions, Inc., ("FAS"), an Illinois
corporation, Uniphase Corporation, a Delaware corporation, and all holders of
the outstanding shares (the "Shares") of the common stock of FAS (individually a
"Shareholder", collectively the "Shareholders"), providing for the purchase of
the Shares by Uniphase (the "Purchase"). Capitalized terms not otherwise
defined herein have the meanings set forth in the Stock Purchase Agreement.
I have acted as counsel to FAS and each Shareholder in connection with
the preparation, execution and delivery of the Stock Purchase Agreement and the
NonCompete Agreements (the "Documents") and consummation of the transactions
contemplated thereby. In addition, I have examined such records, documents and
certificates of public officials, made such inquiries of officials of FAS and
considered such questions of law as I have deemed necessary for the purpose of
rendering the opinions set forth herein.
I have assumed the genuineness of all signatures and the authenticity
of all items submitted to me as originals and the conformity with originals of
all items submitted to me as copies. In making my examination of the Documents,
I have assumed that each party to one or more of the Documents (other than FAS
and the Shareholders) has the power and authority to execute and deliver, and to
perform and observe the provisions of, the Documents and has duly authorized,
executed and delivered such Documents, and that such Documents constitute the
legal, valid and binding obligations of such party.
My opinion in paragraphs (a) and (b) below as to the qualification and
good standing of FAS is based upon certificates of public officials in the
states referred to in those paragraphs. With respect to certain matters of
fact, my opinions in paragraphs (b), (d), (e) and (f) are based on the
representations in the certificate of J.T. and Aaron Hollander, officers of FAS,
a copy of which certificate is attached hereto. Although I have made no
independent investigation as to whether such certificate is accurate or
complete, I have no actual knowledge that such certificate is inaccurate or
incomplete in any material respect.
<PAGE>
Whenever my opinion herein with respect to the existence or absence of
facts is indicated to be based on my knowledge, it is intended to signify that,
in the course of my representation of FAS, I have not acquired actual knowledge
of the existence or absence of such facts. I have not undertaken any
independent investigation to determine the existence or absence of such facts,
and no inference as to my knowledge of the existence or absence of such facts
should be drawn from the fact of my representation of FAS.
The opinions hereinafter expressed are subject to the following
further qualifications and exceptions:
(1) I express no opinion as to the effect of bankruptcy, insolvency,
reorganization, arrangement, moratorium or other similar laws relating to or
affecting the rights of creditors generally, including, without limitation, laws
relating to fraudulent transfers or conveyances, preferences and equitable
subordination.
(2) I express no opinion as to limitations imposed by general
principles of equity upon the availability of equitable remedies or the
enforcement of provisions of the Documents; and the effect of judicial decisions
which have held that certain provisions are unenforceable where their
enforcement would violate the implied covenant of good faith and fair dealing,
or would be commercially unreasonable.
(3) I express no opinion as to the effect of judicial decisions which
may permit the introduction of extrinsic evidence to modify the terms or the
interpretation of the Documents.
(4) I express no opinion as to the enforceability of provisions of the
Documents providing that rights or remedies are not exclusive, that every right
or remedy is cumulative, or that the election of a particular remedy or remedies
does not preclude recourse to one or more remedies.
(5) I express no opinion as to the enforceability of a requirement
that provisions of the Documents may only be modified in writing to the extent
that an oral agreement has been entered into modifying provisions of the
Document.
Based upon and subject to the foregoing, I am of the opinion that:
a. FAS is a corporation duly organized, validly existing and in good
under the laws of Illinois and has the corporate power and authority to enter
into and perform the Stock Purchase Agreement.
b. FAS is duly qualified or otherwise authorized to transact business
as a foreign corporation in all jurisdictions in which such qualification or
authorization is required, except for jurisdictions in which the failure to be
so qualified or authorized would not have a material adverse effect on the
business of FAS, and has the corporate power and authority to own its assets as
now owned and to conduct the Business as presently conducted.
<PAGE>
c. FAS has all requisite corporate power and corporate authority to execute
and deliver, and to perform and observe the provisions of the Documents, to the
extent it is party thereto.
d. The Documents have each been duly and validly authorized, executed and
delivered by FAS and each of the Shareholders and constitute the valid and
binding obligation of FAS and each of the Shareholders, to the extent each is a
party thereto, enforceable against FAS and the Shareholders, as the case may be,
in accordance with its terms.
e. The authorized capital stock of FAS consists of I 0,000 shares of
Common Stock, at no par value per share ("FAS Common Stock"), of which 1,000.2
shares are issued, 1,000.2 shares are outstanding, and no shares are treasury
shares. To the best of my knowledge, there are no outstanding warrants, options,
preemptive rights or other rights of any kind to purchase or receive from FAS
any shares of capital stock or other securities of FAS.
f. To the best of my knowledge, there are no lawsuits, claims or
proceedings pending or threatened against FAS that individually or in the
aggregate would have a material adverse effect upon the business of FAS or on
the ability of FAS to consummate the transactions contemplated by the Stock
Purchase Agreement.
g. Except for such filings, notices, permits, consents and approvals as
have been made, given or obtained, the execution, delivery, and performance of
the Documents by FAS and the Shareholders will not (i) violate any provision of
the Articles of Incorporation or By-Laws of FAS; (ii) violate, conflict with or
result in the breach of any of the terms or conditions or result in modification
of the effect, or otherwise give any other contracting party, other than Dukane
Corporation, the right to terminate, or constitute (or with notice or lapse of
time or both constitute) a default under any material instrument, contract or
other agreement known to us to which FAS is a party or to which it may be bound
or subject; (iii) violate any law, ordinance or regulation or, to the best of my
knowledge, any order, judgment, injunction, decree or other requirement of any
court, arbitrator or of any governmental or regulatory body applicable to FAS;
(iv) require any filing with, notice to, or permit, consent to or approval of,
any governmental or regulatory body; or (v) result in the creation of any lien
or other encumbrance on the assets of properties of FAS, excluding from the
foregoing clauses (ii), (iii), (iv and (v) any exceptions to the foregoing that,
in the aggregate, would not have a material adverse effect on the business of
FAS or on the ability of FAS and the Shareholders to consummate the transactions
contemplated by the Documents.
h. In the absence of any intent to defraud, the delivery of the
certificates representing the Shares and the endorsements thereof by the
Shareholders and the consummation of the actions contemplated by the Stock
Purchase Agreement will be legally sufficient to convey title to all of the
shares to Uniphase.
I express no opinion as to matters governed by any laws other than the
substantive laws of the State of Illinois and federal laws of the United States
which are in effect on the date hereof.
<PAGE>
This opinion is solely for your benefit and may not be relied upon by,
nor may copies be delivered to, any other person without my prior written
consent.
Yours sincerely,
Timothy P. McHugh
<PAGE>
EXHIBIT E
__________ ___, 1996
Fiberoptic Alignment Solutions, Inc.
203 Oswald Avenue
Batavia, Illinois 10510
Attention: Aaron Hollander
Ladies and Gentlemen:
We are furnishing this opinion to you pursuant to the Stock Purchase
Agreement dated as of May ___, 1996 (the "Stock Purchase Agreement") among
Fiberoptic Alignment Solutions, Inc., ("FAS"), an Illinois corporation, Uniphase
Corporation, ("Uniphase"), a Delaware corporation, and all holders of the
outstanding shares (the "Shares") of the common stock of FAS (individually a
"Shareholder", collectively the "Shareholders"), providing for the purchase of
the Shares by Uniphase (the "Purchase"). Capitalized terms not otherwise
defined herein have the meanings set forth in the Stock Purchase Agreement.
We have acted as counsel to Uniphase in connection with the
preparation, execution and delivery of the Stock Purchase Agreement, the Escrow
Agreement and the Non-Compete Agreements (the "Documents") and consummation of
the transactions contemplated thereby. In addition, we have examined such
records, documents and certificates of public officials, made such inquiries of
officials of Uniphase and considered such questions of law as we have deemed
necessary for the purpose of rendering the opinions set forth herein.
We have assumed the genuineness of all signatures and the authenticity
of all items submitted to us as originals and the conformity with originals of
all items submitted to us as copies. In making our examination of the
Documents, we have assumed that each party to one or more of the Documents
(other than Uniphase) has the power and authority to execute and deliver, and to
perform and observe the provisions of, the Documents and has duly authorized,
executed and delivered such Documents, and that such Documents constitute the
legal, valid and binding obligations of such party.
Our opinion in paragraph (a) below as to the qualification and good
standing of Uniphase is based upon certificates of public officials in the
states referred to in that paragraph.
Whenever our opinion herein with respect to the existence or absence
of facts is indicated to be based on our knowledge, it is intended to signify
that, in the course of our representation of Uniphase and none of Michael C.
Phillips, Stephan Goeckeler, or Janet S. Herman (the attorneys performing
significant substantive work in connection with such representation) has
acquired actual knowledge of the existence or absence of such facts. We
1
<PAGE>
__________________________
________ ___, 1996
Page 2
have not undertaken any independent investigation to determine the existence or
absence of such facts, and no inference as to our knowledge of the existence or
absence of such facts should be drawn from the fact of our representation of
Uniphase.
The opinions hereinafter expressed are subject to the following further
qualifications and exceptions:
(1) We express no opinion as to the effect of bankruptcy, insolvency,
reorganization, arrangement, moratorium or other similar laws relating to or
affecting the rights of creditors generally, including, without limitation, laws
relating to fraudulent transfers or conveyances, preferences and equitable
subordination.
(2) We express no opinion as to limitations imposed by general principles
of equity upon the availability of equitable remedies or the enforcement of
provisions of the Documents; and the effect of judicial decisions which have
held that certain provisions are unenforceable where their enforcement would
violate the implied covenant of good faith and fair dealing, or would be
commercially unreasonable.
(3) We express no opinion as to the effect of judicial decisions which may
permit the introduction of extrinsic evidence to modify the terms or the
interpretation of the Documents.
(4) We express no opinion as to the enforceability of provisions of the
Documents providing that rights or remedies are not exclusive, that every right
or remedy is cumulative, or that the election of a particular remedy or remedies
does not preclude recourse to one or more remedies.
(5) We express no opinion as to the enforceability of a requirement that
provisions of the Documents may only be modified in writing to the extent that
an oral agreement has been entered into modifying provisions of the Document.
Based upon and subject to the foregoing, we are of the opinion that:
a. Uniphase is a corporation duly organized, validly existing and in good
standing under the laws of Delaware and has the corporate power and authority to
enter into and perform the Documents.
b. The execution and delivery of the Documents and the consummation of the
transactions contemplated thereby have been duly authorized by all necessary
corporate action on the part of Uniphase. The Documents have been duly executed
and delivered by Uniphase and constitute the valid and binding obligation of
Uniphase, enforceable against Uniphase in accordance with its terms.
We express no opinion as to matters governed by any laws other than the
substantive laws of the State of California, the General Corporation Law of the
State of Delaware and federal laws of the United States which are in effect on
the date hereof.
2
<PAGE>
__________________________
________ ___, 1996
Page 3
This opinion is solely for your benefit and may not be relied upon by,
nor may copies be delivered to, any other person without our prior written
consent.
Very truly yours,
Morrison & Foerster
<PAGE>
AMENDMENT NO. 1 TO
STOCK PURCHASE AGREEMENT
among
UNIPHASE CORPORATION.
FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
and
THE SHAREHOLDERS OF FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
This Amendment No. 1 (the "Amendment No. 1") dated and effective as of
May 31, 1996, is made by and among Fiberoptic Alignment Solutions, Inc., a
corporation organized and existing under the laws of the State of Illinois
("FAS"), Uniphase Corporation, a corporation organized and existing under the
laws of the State of Delaware ("Uniphase") and each and every shareholder of FAS
identified on the signature pages hereto (individually, a "Shareholder", and,
collectively, the "Shareholders").
Certain capitalized terms in this Amendment No. 1 shall have the
meanings ascribed to them in the Stock Purchase Agreement (the "Agreement"),
dated and effective as of May 24, 1996, and made by and among the parties
hereto.
RECITALS
WHEREAS, the parties hereto entered into the Agreement and now wish to
amend the Agreement and Exhibit B hereto as set forth below;
NOW THEREFORE, in consideration of the foregoing and the mutual
promises contained herein, the parties agree as follows:
AGREEMENT
1. Section 1.2 of the Agreement shall be, and hereby is, restated in
its entirety as follows:
"PURCHASE PRICE. In consideration of the sale of the Shares by
the Shareholders, and in consideration of the representations, warranties and
covenants of the Target Corporation and the Shareholders, the Acquiring
Corporation agrees to pay to the Shareholders an aggregate consideration of
$3,932,184 (the "Purchase Price"). The Purchase Price shall be paid by Uniphase
to the Shareholders at the Closing by way of a certified or bank cashier's check
or wire transfer ("Same Day Funds") or pursuant to an unsecured
1
<PAGE>
promissory note delivered to the Shareholders at Closing in substantially the
form attached hereto as Exhibit A-1 and, in the case of the promissory note
deliverable to J. Timothy Greaves, Exhibit A-2 (the "Note(s)"). The allocation
of the Purchase Price as to amounts and between cash and Notes to each
Shareholder is set forth in Exhibit B, as revised and attached to this Amendment
No. 1.
2. Section 9.4(c) shall be, and hereby is, restated in its entirety as
follows:
"(c) Except for claims arising out of an inaccuracy in or breach of a
representation or warranty of a Shareholder contained in Article 3 hereof, all
indemnification claims under Section 9.2 shall be satisfied in full from amounts
off-set against the Notes pursuant to Section 9.6 below, and no person shall
have any further right to recovery from any Shareholder. Without limitation of
the foregoing, the maximum liability of any Shareholder (other than the
Shareholder J. Timothy Greaves as provided in Section 9.4(d) below) for any
breach of a representation, warranty or covenant of FAS shall be limited to ten
percent (10%) of that portion of the Purchase Price paid or otherwise delivered
to such person pursuant to Section 1.2 hereof; and the maximum liability of the
Shareholder J. Timothy Greaves (other than as provided in Section 9.4(d) below
for any breach of a representation, warranty or covenant of FAS shall be limited
to the sum of $457,190.
3. Section 9.6(a) of the Agreement shall be, and is hereby, restated in
its entirety as follows:
(a) In the event that Acquiring Corporation shall become entitled to
indemnification for any Losses pursuant to Section 9.2(a) above prior to the
Note Payment Date (as defined below), Acquiring Corporation shall have the right
to receive payment and reimbursement from such Losses by way of an off-set
against any then outstanding Notes on a pro rata basis against the Shareholders
so that the contribution by each Shareholder to such indemnification shall be
equal on a percentage basis to that percentages of the total outstanding Shares
held by such Shareholder immediately prior to the Closing Date. Following the
Note Payment Date, Uniphase shall have the right to pursue any subsequent claims
directly against the Shareholders. To the extent amounts are paid from an off-
set from the Notes against any Shareholder on the basis of an indemnification
claim under Section 9.2(b), such Shareholder agrees that such amounts shall not
reduce the amount that such Shareholder is obligated to contribute for
indemnification claims pursuant to Section 9.2(a) above.
4. Counterparts. This Amendment No. 1 may be executed in counterparts,
each of which shall be deemed an original.
2
<PAGE>
The parties have caused this Agreement to be fully executed and their
respective corporate seals, if any, to be affixed hereto as of the date first
above written.
SEAL Target Corporation
FIBEROPTIC ALIGNMENT SOLUTIONS, INC.
ATTEST:
By: /s/ Aaron Hollander
---------------------------------
- -------------------------- Title: President
Secretary ------------------------------
SEAL Acquiring Corporation
UNIPHASE CORPORATION
ATTEST:
By: /s/ Joyce Appiah
---------------------------------
- -------------------------- Title: Vice President and Controller
Secretary ------------------------------
SHAREHOLDERS
/s/ Timothy Greaves
- --------------------------
Timothy Greaves
/s/ Aaron Hollander
- --------------------------
Aaron Hollander
/s/ Fred Kautz
- --------------------------
Fred Kautz
/s/ Dan Crews
- --------------------------
Dan Crews
/s/ Steve Seyller
- --------------------------
Steve Seyller
3
<PAGE>
EXHIBIT B
SHAREHOLDER SCHEDULE
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------
Shareholder Number of Shares Total Consideration Cash/Note
----------- ---------------- ------------------- ---------
- --------------------------------------------------------------------------------
<S> <C> <C> <C>
Tim Greaves 737.77 $2,307,045.39* $2,307,045.39 (Note)
- --------------------------------------------------------------------------------
Aaron Hollander 113.64 $ 704,216.40 $ 633,794.76 (Cash)
$ 70,421.64 (Note)
- --------------------------------------------------------------------------------
Fred Kautz 61.19 $ 379,188.68 $ 341,269.81 (Cash)
$ 37,918.87 (Note)
- --------------------------------------------------------------------------------
Dan Crews 43.71 $ 270,866.76 $ 243,780.09 (Cash)
$ 27,086.68 (Note)
- --------------------------------------------------------------------------------
Steve Seyller 43.71 $ 270,866.76 $ 243,780.09 (Cash)
$ 27,086.68 (Note)
- --------------------------------------------------------------------------------
TOTAL 1000.02 $3,932,184.00 $3,932,184.00
- --------------------------------------------------------------------------------
</TABLE>
* PAYABLE IN POUNDS STERLING AT WALL STREET JOURNAL COMMERCIAL EXCHANGE RATE
(FOR PURCHASE OF POUNDS STERLING WITH U.S. DOLLARS) AS OF THE CLOSING DATE.
<PAGE>
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected
Consolidated Financial Data" and "Experts" and to the use of our report dated
July 31, 1995 with respect to the consolidated financial statements of
Uniphase Corporation and to the use of our report dated May 28, 1996 with
respect to the combined financial statements of GCA Fibreoptics Ltd. and
Fiberoptic Alignment Solutions, Inc., in Amendment No. 1 to the Registration
Statement (Form S-3 No. 333-04855) and related Prospectus of Uniphase
Corporation for the registration of 2,300,000 shares of its common stock.
Ernst & Young LLP
San Jose, California
June 7, 1996
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C> <C>
<PERIOD-TYPE> YEAR 9-MOS
<FISCAL-YEAR-END> JUN-30-1995 JUN-30-1996
<PERIOD-START> JUL-01-1994 JUL-01-1995
<PERIOD-END> JUN-30-1995 MAR-31-1996
<CASH> 2,880 18,581
<SECURITIES> 4,679 33,187
<RECEIVABLES> 8,957 13,058
<ALLOWANCES> 164 234
<INVENTORY> 5,478 8,810
<CURRENT-ASSETS> 24,197 60,717
<PP&E> 8,387 24,911
<DEPRECIATION> 4,935 7,892
<TOTAL-ASSETS> 31,910 96,700
<CURRENT-LIABILITIES> 6,881 9,684
<BONDS> 0 0
0 0
0 0
<COMMON> 10 14
<OTHER-SE> 24,798 86,831
<TOTAL-LIABILITY-AND-EQUITY> 31,910 96,700
<SALES> 42,282 47,342
<TOTAL-REVENUES> 42,282 47,342
<CGS> 24,113 25,102
<TOTAL-COSTS> 24,113 25,102
<OTHER-EXPENSES> 17,588 14,240
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 25 20
<INCOME-PRETAX> 1,131 8,887
<INCOME-TAX> 396 3,226
<INCOME-CONTINUING> 735 5,661
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 735 5,661
<EPS-PRIMARY> 0.07 0.44
<EPS-DILUTED> 0.07 0.44<F1>
<FN>
<F1>All information has been adjusted to reflect a two-for-one stock split in the
form of a 100% stock dividend to be paid on June 3, 1996.
</FN>
</TABLE>
